<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>g24854exv2w1.htm
<DESCRIPTION>EX-2.1
<TEXT>
<HTML>
<HEAD>
<TITLE>exv2w1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>Exhibit&nbsp;2.1</B>
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>EXECUTION COPY</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><DIV style="width: 100%; border-bottom: 3px double #000000; FONT-size: 1px">&nbsp;</DIV><BR>
AGREEMENT AND PLAN OF MERGER
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">dated as of
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">October&nbsp;11, 2010
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">among
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">PFIZER INC.
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">KING PHARMACEUTICALS, INC.
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">and
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">PARKER TENNESSEE CORP.
</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><DIV style="width: 100%; border-bottom: 3px double #000000; FONT-size: 1px">&nbsp;</DIV>
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">TABLE OF CONTENTS
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000">Page</TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center">ARTICLE I</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 6pt">
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center">THE OFFER</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;1.01 The Offer</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;1.02 Company Action</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;1.03 Top-Up Option</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;1.04 Board of Directors</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center">ARTICLE II</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 6pt">
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center">THE MERGER</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;2.01 The Merger</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">8</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;2.02 Closing</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">8</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;2.03 Effective Time</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;2.04 Effects of the Merger</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;2.05 Company Charter</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;2.06 By-Laws</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;2.07 Directors and Officers</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;2.08 Effect on Capital Stock</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;2.09 Company Compensatory Awards</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;2.10 Adjustments</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">11</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;2.11 Merger Without Meeting of Shareholders</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center">ARTICLE III</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 6pt">
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center">EXCHANGE OF SHARES</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;3.01 Exchange Agent</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;3.02 Exchange Procedures</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;3.03 Stock Transfer Books</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;3.04 Termination of Exchange Fund</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;3.05 Withholding Rights</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;3.06 Lost Certificates</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;3.07 No Further Ownership Rights</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;3.08 Further Assurances</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center">ARTICLE IV</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 6pt">
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center">REPRESENTATIONS AND WARRANTIES OF THE COMPANY</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;4.01 Organization, Standing and Corporate Power</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-i-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000">Page</TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;4.02 Corporate Authorization</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;4.03 Governmental Authorization</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;4.04 No-Conflict</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;4.05 Capitalization</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">17</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;4.06 Subsidiaries</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">18</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;4.07 SEC Filings and the Sarbanes-Oxley Act</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">19</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;4.08 Indebtedness</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">21</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;4.09 Information Supplied</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">21</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;4.10 Absence of Certain Changes</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">21</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;4.11 No Undisclosed Liabilities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">22</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;4.12 Compliance with Laws and Court Orders; Permits</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">22</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;4.13 Material Contracts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">23</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;4.14 Litigation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">25</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;4.15 Properties</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">25</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;4.16 Intellectual Property</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">26</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;4.17 Taxes</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">30</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;4.18 Employee Benefit Plans</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">32</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;4.19 Employment Matters</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">35</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;4.20 Environmental Matters</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">36</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;4.21 Regulatory Matters</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">37</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;4.22 Insurance</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">40</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;4.23 Brokers and Finder&#146;s Fees</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">41</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;4.24 Opinion of Financial Advisor</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">41</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;4.25 Antitakeover Statutes</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">41</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;4.26 Foreign Corrupt Practices and International Trade Practices</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">41</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center">ARTICLE V</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 6pt">
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center">REPRESENTATIONS AND WARRANTIES OF PARENT</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;5.01 Organization, Standing and Corporate Power</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">42</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;5.02 Corporate Authorization</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">42</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;5.03 Governmental Authorization</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">42</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;5.04 No-Conflict</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">42</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;5.05 Ownership and Operations of Merger Sub</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">43</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;5.06 Information Supplied</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">43</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;5.07 Brokers and Other Advisors</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">43</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;5.08 Sufficient Funds</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">43</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 6pt">
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center">ARTICLE VI</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 6pt">
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center">COVENANTS</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;6.01 Conduct of the Company</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">44</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;6.02 Company Shareholder Meeting</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">48</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;6.03 No Solicitation; Other Offers</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">49</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;6.04 Reasonable Best Efforts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">53</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-ii-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000">Page</TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;6.05 Public Announcements</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">54</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;6.06 Access to Information</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">55</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;6.07 Shareholder Litigation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">56</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;6.08 Section&nbsp;16 Matters</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">56</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;6.09 Employee Matters</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">56</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;6.10 Resignations</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">58</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;6.11 Company Convertible Notes</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">58</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;6.12 Director and Officer Liability</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">58</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;6.13 Notices of Certain Events</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">59</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;6.14 Takeover Statute</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">60</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;6.15 Deregistration; Stock Exchange Delisting</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">60</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;6.16 Fees and Expenses</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">60</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;6.17 Company Cooperation on Certain Matters</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">60</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;6.18 FIRPTA Affidavit</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">60</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;6.19 Merger Sub Obligations</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">61</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center">ARTICLE VII</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 6pt">
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center">CONDITIONS PRECEDENT TO THE MERGER</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;7.01 Conditions to Each Party&#146;s Obligation to Effect the Merger</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">61</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center">ARTICLE VIII</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 6pt">
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center">TERMINATION</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;8.01 Termination</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">61</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;8.02 Effect of Termination</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">63</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;8.03 Termination Fee</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">63</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center">ARTICLE IX</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 6pt">
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center">MISCELLANEOUS</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;9.01 No Additional Representations</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">66</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;9.02 No Survival of Representations and Warranties</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">66</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;9.03 Amendment or Supplement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">66</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;9.04 Extension of Time, Waiver, etc.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">66</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;9.05 Assignment</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">67</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;9.06 Counterparts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">67</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;9.07 Entire Agreement; No Third-Party Beneficiaries</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">67</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;9.08 Governing Law; Jurisdiction; Waiver of Jury Trial</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">67</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;9.09 Specific Enforcement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">68</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;9.10 Notices</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">68</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;9.11 Severability</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">69</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-iii-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000">Page</TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center">ARTICLE X</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 6pt">
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center">DEFINITIONS</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
<TD colspan="5">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;10.01 Certain Definitions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">69</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Section&nbsp;10.02 Other Definitional and Interpretative Provisions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">78</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left">Annex A&nbsp;Conditions to the Offer</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
<TD colspan="5">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-iv-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>INDEX OF DEFINED TERMS</B></U>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="95%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">Page</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Acceptable Confidentiality Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">69</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Acceptance Time
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">2</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Acquisition Proposal
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">70</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Action
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">25</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Affiliate
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">70</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">1</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Articles of Merger
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">9</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Bankruptcy and Equity Exception
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">16</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Business Day
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">70</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Canceled Restricted Awards
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">10</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Capitalization Date
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">17</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Change in the Company Recommendation
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">51</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Closing
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">8</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Code
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">70</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Collective Bargaining Agreements
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">35</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Common Stock Certificates
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">12</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Company
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">1</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Company Acquisition Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">70</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Company Board Recommendation
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">16</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Company Capital Stock
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">70</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Company Charter
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">70</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Company Charter Documents
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">15</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Company Common Stock
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">70</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Company Compensatory Award
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">71</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Company Convertible Notes
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">71</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Company Disclosure Schedule
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">71</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Company Financial Advisor
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">41</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Company Financial Statements
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">71</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Company Intellectual Property
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">71</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Company Material Adverse Effect
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">71</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Company Patents, Trademarks and Copyrights
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">28</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Company Permits
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">37</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Company Plans
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">33</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Company Preferred Stock
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">72</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Company Products
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">72</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Company PSU
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">72</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Company Regulatory Agency
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">37</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Company Restricted Stock Award
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">72</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Company RSU
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">72</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Company SEC Documents
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">14</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Company Securities
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">45</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Company Shareholder Approval
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">15</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Company Shareholders
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">1</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-v-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="95%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">Page</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Company Shareholders Meeting
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">49</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Company Stock Option
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">72</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Company Stock Plan
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">72</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Confidentiality Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">72</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Continuation Period
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">56</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Continuing Directors
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">7</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Contract
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">72</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Copyrights
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">75</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Covered Employees
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">56</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Credit Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">72</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">DEA
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">37</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Director Appointment Date
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">7</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">EDGAR
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">14</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Effective Time
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">9</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Environmental Claim
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">73</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Environmental Laws
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">73</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Environmental Liability
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">73</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Equity Interest
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">73</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">ERISA
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">74</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">ERISA Affiliate
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">74</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exchange Act
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">74</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exchange Agent
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">12</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exchange Fund
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">12</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Excluded Shares
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">10</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Expenses
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">74</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Expiration Date
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">3</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">FASB
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">31</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">FDA
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">37</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">FDCA
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">37</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">FIN 48
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">31</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Foreign Government
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">74</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Foreign Official
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">74</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Foreign Plan
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">35</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">GAAP
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">74</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Governmental Authority
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">74</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Hazardous Materials
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">74</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Health Care Laws
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">39</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">HSR Act
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">74</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Indebtedness
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">75</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Indenture
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">71</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Initial Expiration Date
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">3</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Inquiry
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">50</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Insurance Policies
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">40</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Intellectual Property
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">75</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Intervening Event
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">75</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">IP Governmental Authority
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">76</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-vi-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="95%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">Page</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">ISRA
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">36</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">IT Assets
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">29</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">knowing and willful
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">76</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Knowledge
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">76</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Known
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">76</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Law
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">76</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Leased Real Property
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">25</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Lien
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">76</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Material Contracts
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">24</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Merger
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">1</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Merger Consideration
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">10</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Merger Sub
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">1</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Minimum Condition
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">1</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">NYSE
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">76</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">OFAC
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">41</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Offer
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">1</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Offer Documents
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">3</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Offer Price
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">1</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Order
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">76</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Ordinary Course Agreements
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">76</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Owned Real Property
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">25</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Parent
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">1</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Parent Disclosure Letter
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">42</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Parent Employee Benefit Plan
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">57</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Parent Financial Advisor
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">43</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Parent Material Adverse Affect
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">76</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Parent Stock
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">76</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Patents
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">75</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Permits
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">22</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Permitted Liens
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">76</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Person
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">77</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">PHSA
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">37</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Proxy Statement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">49</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Real Property
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">26</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Real Property Lease
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">26</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Recommendation Change Notice
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">52</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Regulatory Condition
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">1</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Release
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">77</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Representatives
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">49</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Represented Employee
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">57</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Restraints
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">61</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Safety Notices
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">38</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Sarbanes-Oxley Act
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">77</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Schedule&nbsp;14D-9
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">4</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">SEC
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">77</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Securities Act
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">77</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-vii-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="95%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">Page</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Short Form&nbsp;Threshold
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">5</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Subsequent Offering Period
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">4</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Subsidiary
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">77</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Superior Proposal
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">77</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Surviving Corporation
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">8</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Tax Return
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">78</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Taxes
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">78</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">TBCA
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">1</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Tender Offer Conditions
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">2</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Termination Date
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">3</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Termination Fee
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">64</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Third Party
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">78</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Third Party Intellectual Property
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">78</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Tier I Termination Fee
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">64</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Tier II Termination Fee
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">64</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Top-Up Option
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">5</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Top-Up Option Shares
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">5</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Trade Secrets
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">75</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Trademarks
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">75</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Transactions
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">78</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Treasury Regulations
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">78</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Uncertificated Shares
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="bottom">&nbsp;</TD>
    <TD align="right" valign="bottom">12</TD>
    <TD nowrap valign="bottom">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->-viii-<!-- /Folio -->
</DIV>



<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">AGREEMENT AND PLAN OF MERGER
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AGREEMENT AND PLAN OF MERGER (this &#147;<B>Agreement</B>&#148;) dated as of October&nbsp;11, 2010 among Pfizer
Inc., a Delaware corporation (&#147;<B>Parent</B>&#148;), King Pharmaceuticals, Inc., a Tennessee corporation (the
&#147;<B>Company</B>&#148;), and Parker Tennessee Corp., a Tennessee corporation and a subsidiary of Parent owned
directly by Parent and/or indirectly by Parent through one or more of its wholly-owned subsidiaries
(&#147;<B>Merger Sub</B>&#148;).
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">W I T N E S S E T H:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, on the terms and subject to the conditions set forth in this Agreement, Merger Sub
shall commence a cash tender offer (such tender offer, as it may be extended, amended and
supplemented from time to time as permitted by this Agreement, the &#147;<B>Offer</B>&#148;) to purchase all of the
issued and outstanding shares of Company Common Stock, at a price per share equal to $14.25, net to
the seller in cash (such amount or any greater amount per share paid pursuant to the Offer, the
&#147;<B>Offer Price</B>&#148;);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, on the terms and subject to the conditions set forth in this Agreement, following the
consummation of the Offer, Merger Sub shall merge with and into the Company with the Company
surviving as a direct or indirect wholly-owned Subsidiary of Parent (the &#147;<B>Merger</B>&#148;), pursuant to
which each outstanding share of Company Common Stock shall be converted into the right to receive
the Offer Price, except for shares of Company Common Stock to be canceled pursuant to
<U>Section&nbsp;2.08(b)</U>;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, the Board of Directors of the Company has authorized and adopted this Agreement and
resolved that the Transactions, including the consummation of the Offer and the Merger, upon the
terms and subject to the conditions set forth in this Agreement and in accordance with the relevant
provisions of the Tennessee Business Corporation Act (the &#147;<B>TBCA</B>&#148;), are advisable, fair to and in
the best interests of the Company and the Company Shareholders;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, the Board of Directors of Parent has authorized the consummation of the Transactions;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, the Board of Directors of Merger Sub has authorized and adopted this Agreement and
resolved that the Transactions, including the consummation of the Offer and the Merger, upon the
terms and subject to the conditions set forth in this Agreement and in accordance with the relevant
provisions of the TBCA, are advisable and in the best interests of Merger Sub and its shareholders;
and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, the Board of Directors of the Company, as of the date hereof, has resolved to
recommend that the holders of Company Common Stock (the &#147;<B>Company Shareholders</B>&#148;) accept the Offer,
tender their shares of Company Common Stock in the Offer,
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">and, to the extent required by applicable Law, approve the Merger
and this Agreement, in each case, upon the terms and subject to the conditions set forth in this
Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NOW, THEREFORE, in consideration of the foregoing and the representations, warranties,
covenants and agreements contained herein, the parties hereto agree as follows:
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE I</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>THE OFFER</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;1.01 <U>The Offer</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Commencement of the Offer</U>. <U>Provided</U> that this Agreement shall not have
been terminated in accordance with <U>Section&nbsp;8.01</U>, as promptly as practicable (but in no
event later than ten Business Days) after the date hereof, Merger Sub shall, and Parent shall cause
Merger Sub to, commence (within the meaning of Rule&nbsp;14d-2 under the Exchange Act), the Offer at the
Offer Price, <U>provided</U>, <U>however</U>, that Parent and Merger Sub shall not be deemed to
be in breach of this <U>Section&nbsp;1.01(a)</U> if the Company fails to comply with its obligations
under <U>Section&nbsp;1.02</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Conditions of Offer</U>. The obligations of Merger Sub to, and of Parent to cause
Merger Sub to, accept for payment and pay for any shares of Company Common Stock pursuant to the
Offer is subject to the terms and the satisfaction or waiver (as provided in <U>Section
1.01(c)</U> below) of the conditions set forth in <U>Annex A</U> (the &#147;<B>Tender Offer Conditions</B>&#148;).
On the terms and conditions of the Offer and this Agreement, Merger Sub shall, and Parent shall
cause Merger Sub to, accept and pay for all shares of Company Common Stock validly tendered and not
validly withdrawn pursuant to the Offer as soon as practicable after the expiration date of the
Offer and in compliance with applicable Law (the date and time of acceptance for payment, the
&#147;<B>Acceptance Time</B>&#148;). Parent shall provide, or cause to be provided, to Merger Sub on a timely basis
funds necessary to purchase and pay for any and all shares of Company Common Stock that Merger Sub
becomes obligated to accept for payment and purchase pursuant to the Offer.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Parent and Merger Sub expressly reserve the right to waive any of the Tender Offer
Conditions, to increase the Offer Price or to make any other changes in the terms and conditions of
the Offer; <U>provided</U> that, without the prior written consent of the Company, Parent and
Merger Sub shall not: (i)&nbsp;decrease the Offer Price or change the form of consideration payable in
the Offer; (ii)&nbsp;decrease the number of shares of Company Common Stock subject to or sought to be
purchased in the Offer; (iii)&nbsp;impose conditions on the Offer in addition to the Tender Offer
Conditions or amend any condition in a manner adverse to the holders of shares of Company Common
Stock; (iv)&nbsp;waive or amend the Minimum Condition; (v)&nbsp;amend any other term of the Offer in a manner
that is materially adverse to the Company Shareholders; or (vi)&nbsp;extend or otherwise change the
Expiration Date except as required or permitted by <U>Section&nbsp;1.01(e)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <U>Schedule&nbsp;TO; Offer Documents</U>. On the date the Offer is commenced, Merger Sub
shall, and Parent shall cause Merger Sub to, file with the SEC a Tender Offer Statement on Schedule
TO with respect to the Offer, which Tender Offer Statement shall include
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->-2-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">an offer to purchase, letter of transmittal, summary advertisement and other required ancillary offer documents (such
Schedule&nbsp;TO and the documents included therein pursuant to which the Offer will be made, together
with any supplements or amendments thereto, the &#147;<B>Offer Documents</B>&#148;) and cause the Offer Documents to
be disseminated to the Company Shareholders in accordance with the applicable requirements of the
Exchange Act. Subject to <U>Section&nbsp;6.03</U>, the Company hereby consents to the inclusion in the
Offer Documents of the Company Board Recommendation. Merger Sub shall, and Parent shall cause
Merger Sub to, cause the Offer Documents to comply as to form in all material respects with the
requirements of the applicable Laws. The Company shall promptly furnish to Parent and Merger Sub
all information concerning the Company required by the Exchange Act to be set forth in the Offer
Documents. The Company, Parent and Merger Sub each agree promptly to correct any information
provided by it for use in the Offer Documents if and to the extent that it shall have become false
or misleading in any material respect, and Parent and Merger Sub further agree to take all steps
necessary to cause the Offer Documents as so corrected to be filed with the SEC and disseminated to
the Company Shareholders, in each case as and to the extent required by applicable Law. The Company
and its counsel shall be given a reasonable opportunity to review and comment on the Offer
Documents sufficiently in advance of its filing with the SEC (including any amendments or
supplements thereto), and Parent and Merger Sub shall give reasonable and good faith consideration
to any comments made by the Company and its counsel. Parent and Merger Sub shall provide the
Company and its counsel with (i)&nbsp;any comments or other communications, whether written or oral,
that Parent, Merger Sub or their counsel may receive from time to time from the SEC or its staff
with respect to the Offer Documents promptly after receipt of those comments or other
communications and (ii)&nbsp;a reasonable opportunity to participate in the response of Parent and
Merger Sub to those comments and to provide comments on that response (to which reasonable and good
faith consideration shall be given). The Parent and Merger Sub shall use reasonable efforts to
respond promptly to any such comments.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <U>Expiration of the Offer</U>. Subject to the terms and conditions set forth in the
Offer Documents, the Offer shall remain open until midnight, New York City time, at the end of the
twentieth (20th) business day (for purposes of this <U>Section&nbsp;1.01(e)</U> calculated in
accordance with Rule&nbsp;14d-1(g)(3) under the Exchange Act) after the date that the Offer is commenced
(the &#147;<B>Initial Expiration Date</B>&#148;) or, if the period of time for which the Offer is open shall have
been extended pursuant to, and in accordance with, this <U>Section&nbsp;1.01(e)</U> or as may be
required by applicable Law, the time and date to which the Offer has been so extended (the Initial
Expiration Date or such later time and date to which the Offer has been extended in accordance with
this <U>Section&nbsp;1.01(e)</U>, the &#147;<B>Expiration Date</B>&#148;). Notwithstanding the foregoing, (i)&nbsp;if, on the
Expiration Date, any of the Tender Offer Conditions are not satisfied or waived, Merger Sub may
extend the Offer for successive extension periods of not more than five (5)&nbsp;business days (or for
such longer period as the parties may agree) each in order to permit the satisfaction of the
conditions to the Offer, (ii)&nbsp;if, on the Expiration Date, any of the Tender Offer Conditions are
not satisfied or waived and there has not been a Change in the Company Recommendation then, to the
extent requested in writing by the Company no less than one (1)&nbsp;business day prior to the
Expiration Date, Merger Sub shall, and Parent shall cause Merger Sub to, extend the Offer for up to five (5)&nbsp;business
days (or such longer period as the parties may agree) per extension until such condition(s) has
been satisfied or waived; <U>provided</U>, that Merger Sub shall not be required to extend the
Offer beyond March&nbsp;31, 2011 (the &#147;<B>Termination Date</B>&#148;);
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->-3-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><U>provided</U>, <U>further</U>, that if the only Tender Offer Condition which has not been satisfied as of the Termination Date is the
Regulatory Condition, the Termination Date shall be April&nbsp;30, 2011, and (iii)&nbsp;Merger Sub shall, and
Parent shall cause Merger Sub to, extend the Offer for any period required by any rule, regulation,
interpretation or position of the SEC or its staff applicable to the Offer or necessary to resolve
any comments of the SEC or its staff applicable to the Offer or the Offer Documents. Nothing in
this <U>Section&nbsp;1.01(e)</U> shall be deemed to impair, limit or otherwise restrict in any manner
the right of Parent or Merger Sub to terminate this Agreement pursuant to <U>Section&nbsp;8.01</U>
hereof. If the Offer is terminated or withdrawn by Merger Sub, or this Agreement is terminated in
accordance with <U>Section&nbsp;8.01</U>, prior to the acceptance for payment of shares of Company
Common Stock tendered in the Offer, Merger Sub shall, and Parent shall cause Merger Sub to,
promptly return, and shall cause any depository acting on behalf of Merger Sub to return, all
tendered Company Common Stock to the registered holders thereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <U>Subsequent Offering Period</U>. If necessary to obtain sufficient shares of Company
Common Stock to reach the Short Form&nbsp;Threshold (without regard to shares tendered pursuant to
guaranteed delivery procedures that have not yet been delivered in settlement or satisfaction of
such guarantee and without regard to the Top-Up Option), Merger Sub may, in its sole discretion,
provide for a subsequent offering period (and one or more extensions thereof) after the Acceptance
Time in accordance with Rule&nbsp;14d-11 under the Exchange Act (each a &#147;<B>Subsequent Offering Period</B>&#148;).
Subject to the terms and conditions of this Agreement and the Offer, the Merger Sub shall, and
Parent shall cause Merger Sub to, immediately accept for payment, and pay for, all shares of
Company Common Stock that are validly tendered pursuant to the Offer during such Subsequent
Offering Period. The Offer Documents shall provide for the possibility of a Subsequent Offering
Period in a manner consistent with the terms of this <U>Section&nbsp;1.01(f)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;1.02 <U>Company Action</U>. (a)&nbsp;On or as promptly as practicable after the date the
Offer Documents are filed with the SEC, the Company shall file with the SEC, a
Solicitation/Recommendation Statement on Schedule&nbsp;14D-9 pertaining to the Offer (together with any
amendments or supplements thereto, the &#147;<B>Schedule&nbsp;14D-9</B>&#148;) that, subject to <U>Section&nbsp;6.03</U>,
contains the Company Board Recommendation and shall promptly mail the Schedule&nbsp;14D-9 to the Company
Shareholders together with the Offer Documents as required by Rule&nbsp;14d-9 under the Exchange Act.
The Company shall cause the Schedule&nbsp;14D-9 to comply as to form in all material respects with the
requirements of the applicable Laws. Parent and Merger Sub shall as promptly as reasonably
practicable furnish to the Company all information concerning Parent and Merger Sub that is
required or reasonably requested by the Company for inclusion in the Schedule&nbsp;14D-9. The Company,
Parent and Merger Sub each agree promptly to correct any information provided by it for use in the
Schedule&nbsp;14D-9 if and to the extent that it shall have become false or misleading in any material
respect, and the Company further agrees to take all steps necessary to cause the Schedule&nbsp;14D-9 as
so corrected to be filed with the SEC and disseminated to the Company Shareholders, in each case as
and to the extent required by applicable Law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Except in connection with (i)&nbsp;an Acquisition Proposal that the Company&#146;s Board of
Directors determines in good faith constitutes or could reasonably be expected to result in a
Superior Proposal or (ii)&nbsp;a Change in the Company Recommendation: (A)&nbsp;Parent, Merger Sub and their
counsel shall be given a reasonable opportunity to review and comment on the
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->-4-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Schedule&nbsp;14D-9 sufficiently in advance of its filing with the SEC (including any amendments or supplements
thereto), and the Company shall give reasonable and good faith consideration to any comments made
by Parent, Merger Sub and its counsel; and (B)&nbsp;the Company shall provide Parent, Merger Sub and
their counsel with (i)&nbsp;any comments or other communications, whether written or oral, that the
Company or its counsel may receive from time to time from the SEC or its staff with respect to the
Schedule&nbsp;14D-9 promptly after receipt of those comments or other communications and (ii)&nbsp;a
reasonable opportunity to participate in the response of the Company to those comments and to
provide comments on that response (to which reasonable and good faith consideration shall be
given). The Company shall use reasonable efforts to respond promptly to any such comments.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;The Company shall as promptly as practicable after the date of this Agreement provide to
Parent, or cause to be provided to Parent, (i)&nbsp;a list of the Company&#146;s shareholders as well as
mailing labels and any available listing or computer file containing the names and addresses of all
record holders of Company Common Stock and lists of securities positions of Company Common Stock
held in stock depositories, in each case true and complete as of the most recent practicable date
and shall promptly furnish Merger Sub with such additional information and assistance (including
updated lists of the Company Shareholders, mailing labels and lists of securities positions) as
Merger Sub or its agents may reasonably request in order to communicate the Offer to the Company
Shareholders. Except as required by applicable Law, and except as necessary to communicate
regarding the Transactions with the Company Shareholders, Parent and Merger Sub (and their
respective Representatives) shall hold in confidence the information contained in any such labels,
listings and files, shall use such information solely in connection with the Transactions, and, if
this Agreement is terminated or the Offer is otherwise terminated, shall promptly deliver or cause
to be delivered to the Company or destroy all copies of such information, labels, listings and
files then in their possession or in the possession of their Representatives.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;1.03 <U>Top-Up Option</U>. (a)&nbsp;The Company hereby grants to Parent and/or Merger
Sub an irrevocable option (the &#147;<B>Top-Up Option</B>&#148;), exercisable only upon the terms and subject to the
conditions set forth in this Agreement, to purchase from the Company at a price per share equal to
the Offer Price paid in the Offer, up to that number of newly issued shares of Company Common Stock
(the &#147;<B>Top-Up Option Shares</B>&#148;) equal to the number of shares of Company Common Stock that, when added
to the number of shares of Company Common Stock owned by Parent (or any of its Subsidiaries) or
Merger Sub at the time of exercise of the Top-Up Option, would constitute one (1)&nbsp;share more than
ninety percent (90%) of the shares of Company Common Stock then outstanding on a fully-diluted
basis (on a &#147;fully-diluted basis&#148; meaning the number of shares of Company Common Stock then issued
and outstanding plus all shares of Company Common Stock which the Company may be required to issue
as of such date pursuant to options (whether or not then vested or exercisable), rights,
convertible or exchangeable securities (only to the extent then convertible or exchangeable into
shares of Company Common Stock) or similar obligations then outstanding, after giving effect to the
issuance of the Top-Up Option Shares) (the &#147;<B>Short Form&nbsp;Threshold</B>&#148;). Parent may assign the Top-Up Option and its rights and
obligations pursuant to this <U>Section&nbsp;1.03</U>, in its sole discretion, to any of its
Subsidiaries, including Merger Sub.
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->-5-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The Top-Up Option may be exercised at any time after consummation of the Offer and prior
to the earlier of (i)&nbsp;the Effective Time and (ii)&nbsp;the termination of this Agreement in accordance
with its terms; <U>provided</U>, <U>however</U>, the Top-Up Option shall not be exercisable to
the extent (i)&nbsp;the number of shares of Company Common Stock subject to the Top-Up Option exceed the
number of authorized and unissued shares of Company Common Stock and shares of Company Common Stock
held in the treasury of the Company available for issuance, (ii)&nbsp;any Restraint or Law shall
prohibit the exercise or delivery of the Top-Up Option, (iii)&nbsp;immediately after such exercise and
issuance of shares of Company Common Stock pursuant thereto, the Short Form&nbsp;Threshold would not be
reached or (iv)&nbsp;Merger Sub has not accepted for payment all shares of Company Common Stock validly
tendered in the Offer (or during any subsequent offering period) and not validly withdrawn.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;In the event that Parent or Merger Sub wishes to exercise the Top-Up Option, Parent or
Merger Sub shall give the Company written notice specifying the number of shares of Company Common
Stock that are or will be owned by Parent or any of its Subsidiaries or Merger Sub immediately
following the Acceptance Time and specifying a place and a time for the closing of the purchase.
The Company shall, as soon as practicable following receipt of such notice, deliver written notice
to Parent or Merger Sub specifying the number of Top-Up Option Shares. At the closing of the
purchase of the Top-Up Option Shares, (i)&nbsp;Parent or Merger Sub shall pay (or cause to be paid) to
the Company an amount equal to the product of (x)&nbsp;the number of shares of Company Common Stock
purchased pursuant to the Top-Up Option and (y)&nbsp;the Offer Price, which amount may be paid, at the
election of Parent or Merger Sub, either in cash (by wire transfer or cashier&#146;s check) or by
delivery of a promissory note having a principal amount equal to the balance of the aggregate
purchase price for the Top Up Option Shares, and (ii)&nbsp;the Company shall cause the Top-Up Option
Shares to be issued to Parent (or any of its Subsidiaries designated by Parent) or Merger Sub,
represented by either certificates or book-entry shares, at the sole option of Parent or Merger
Sub. Any promissory note issued pursuant to the immediately preceding sentence shall be on terms
as provided by Parent or Merger Sub, which terms shall be reasonably satisfactory to the Company.
Prior to the closing of the purchase of the Top-Up Option Shares, upon Parent&#146;s or Merger Sub&#146;s
request, the Company shall cause its transfer agent to certify in writing to Parent or Merger Sub
the number of shares of Company Common Stock issued and outstanding as of immediately prior to the
exercise of the Top-Up Option and after giving effect to the issuance of the Top-Up Option Shares.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Parent and/or Merger Sub acknowledges that the Top-Up Option Shares which Parent (or any
of its Subsidiaries) or Merger Sub may acquire upon exercise of the Top-Up Option shall not be
registered under the Securities Act, and shall be issued in reliance upon an exemption for
transactions not involving a public offering. Parent and/or Merger Sub agrees that the Top-Up
Option, and the Top-Up Option Shares to be acquired upon exercise of the Top-Up Option, if any, are
being and shall be acquired by Parent (or any of its Subsidiaries) or Merger Sub for the purpose of
investment and not with a view to, or for resale in connection with, any distribution thereof
(within the meaning of the Securities Act). Each of Parent and Merger Sub hereby represents and
warrants to the Company that Merger Sub is, and will be, upon the purchase of the Top-Up Option Shares, an &#147;accredited investor,&#148; as defined in Rule
501 of Regulation&nbsp;D under the Securities Act.
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->-6-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;1.04 <U>Board of Directors</U>. (a)&nbsp;Promptly upon the Acceptance Time and at all
times thereafter, Parent shall be entitled to elect or designate such number of directors, rounded
up to the next whole number, on the Company Board as shall give Parent representation on the
Company&#146;s Board of Directors equal to the product of the total number of directors on the Company&#146;s
Board of Directors (giving effect to the directors elected or designated by Parent pursuant to this
<U>Section&nbsp;1.04</U>) multiplied by the percentage that the aggregate number of Company Common
Stock then owned directly or indirectly by Parent bears to the total number of shares of Company
Common Stock then outstanding. Prior to, and effective upon, the Acceptance Time, the Company
shall, upon request by Parent, take all actions as are necessary to enable Parent&#146;s designees to be
so elected or appointed to the Company&#146;s Board of Directors, including by promptly filling
vacancies or newly created directorships on the Company&#146;s Board of Directors, promptly increasing
the size of the Company&#146;s Board of Directors (including by amending the by-laws of the Company if
necessary to increase the size of the Company&#146;s Board of Directors) and/or promptly securing the
resignations of such number of its incumbent directors as is necessary to provide Parent with such
level of representation, and shall cause Parent&#146;s designees to be so elected or appointed at such
time (the date on which Parent&#146;s designees are so elected or appointed to the Company&#146;s Board of
Directors, the &#147;<B>Director Appointment Date</B>&#148;). Subject to <U>Section&nbsp;1.04(b)</U>, after the
Acceptance Time, the Company shall also, upon Parent&#146;s request, cause the directors elected or
designated by Parent to the Company&#146;s Board of Directors to serve on and constitute the same
percentage as such individuals represent of the entire Board of Directors of the Company (but not
less than a majority) (rounded up to the next whole number) of: (i)&nbsp;each committee of the Company&#146;s
Board of Directors and (ii)&nbsp;each board of directors (or similar body) and each committee thereof
(or similar body) of each Subsidiary of the Company, in each case to the extent permitted by
applicable Law and the rules of the NYSE. The provisions of this <U>Section&nbsp;1.04(a)</U> are in
addition to and shall not limit any rights that Parent, Merger Sub or any of their respective
Affiliates may have as a record holder or beneficial owner of Company Common Stock as a matter of
applicable Law with respect to the election of directors or otherwise. The Company&#146;s obligations
to appoint or elect Parent&#146;s designees to the Company&#146;s Board of Directors shall be subject to
Section 14(f) of the Exchange Act and Rule&nbsp;14f-1 promulgated thereunder. At the request of Parent,
the Company shall take all actions necessary to effect any such appointment or election of Parent&#146;s
designees, including mailing to the Company Shareholders the information required by Section 14(f)
of the Exchange Act and Rule&nbsp;14f-l promulgated thereunder which, unless Parent otherwise elects,
shall be so mailed together with the Schedule&nbsp;14D-9. Parent shall supply to the Company, and be
solely responsible for, all information with respect to itself and its officers, directors and
affiliates as is required by such Section and Rule.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;After Parent&#146;s designees are appointed or elected to, and constitute a majority of, the
Company&#146;s Board of Directors pursuant to <U>Section&nbsp;1.04(a)</U>, and prior to the Effective Time,
the Company shall cause the Company&#146;s Board of Directors to maintain at least three directors who
are members of the Company&#146;s Board of Directors on the date hereof, each of whom shall be an
&#147;independent director&#148; as defined by Rule&nbsp;303A.02 of the NYSE Listed Company Manual and eligible to
serve on the Company&#146;s audit committee under the Exchange Act and NYSE rules and, at least one of whom shall be an &#147;audit committee financial expert&#148; as
defined in Item&nbsp;407(d)(5) of Regulation&nbsp;S-K and the instructions thereto (the &#147;<B>Continuing
Directors</B>&#148;); <U>provided</U>, <U>however</U>, that if the number of Continuing Directors is
reduced below three for any reason, the remaining Continuing Directors shall be entitled to elect
or designate a
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->-7-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">person meeting the foregoing criteria to fill such vacancy who shall be deemed to be
a Continuing Director for purposes of this Agreement or, if no Continuing Directors then remain,
the other directors shall designate three persons meeting the foregoing criteria to fill such
vacancies, and such persons shall be deemed to be Continuing Directors for purposes of this
Agreement. The Company and the Company&#146;s Board of Directors shall promptly take all action as may
be necessary to comply with their obligations under this <U>Section&nbsp;1.04(b)</U>. Notwithstanding
anything to the contrary set forth in this Agreement, in the event that Parent&#146;s designees are
elected or appointed to the Company&#146;s Board of Directors prior to the Effective Time pursuant to
<U>Section&nbsp;1.04(a)</U>, the approval of a majority of such Continuing Directors (or the sole
Continuing Director if there shall be only one (1)&nbsp;Continuing Director) shall be required in order
to (i)&nbsp;amend, modify or terminate this Agreement, or agree or consent to any amendment,
modification or termination of this Agreement, in any case on behalf of the Company, (ii)&nbsp;extend
the time for performance of, or waive, any of the obligations or other acts of Parent or Merger Sub
under this Agreement, (iii)&nbsp;waive or exercise any of the Company&#146;s rights under this Agreement,
(iv)&nbsp;waive any condition to the Company&#146;s obligations under this Agreement, (v)&nbsp;amend the Company
Charter Documents, (vi)&nbsp;authorize any agreement between the Company or any of the Subsidiaries of
the Company, on the one hand, and Parent, Merger Sub or any of their Affiliates, on the other hand,
or (vii)&nbsp;make any other determination with respect to any action to be taken or not to be taken by
or on behalf of the Company relating to this Agreement or the Transactions. For purposes of
considering any matter set forth in this <U>Section&nbsp;1.04(b)</U>, the Continuing Directors shall be
permitted to meet without the presence of the other directors. The Continuing Directors shall have
the authority to retain such counsel (which may include current counsel to the Company) and other
advisors at the expense of the Company as determined by the Continuing Directors and shall have the
authority to institute any action on behalf of the Company to enforce performance of this Agreement
or any of the Company&#146;s rights hereunder.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE II</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>THE MERGER</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.01 <U>The Merger</U>. At the Effective Time, upon the terms and subject to the
conditions set forth in this Agreement and in accordance with the applicable provisions of the
TBCA, Merger Sub shall be merged with and into the Company. As a result of the Merger, the separate
corporate existence of Merger Sub shall cease and the Company shall continue as the surviving
entity following the Merger (the &#147;<B>Surviving Corporation</B>&#148;) and shall continue to be governed by the
Laws of the State of Tennessee.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.02 <U>Closing</U>. Unless otherwise mutually agreed in writing between the Company
and Parent, the closing of the Merger (the &#147;<B>Closing</B>&#148;) shall take place in New York, New York at the
offices of Cadwalader, Wickersham &#038; Taft LLP, One World Financial Center, New York, New York 10281
no later than the third (3rd) Business Day after the date the conditions set forth in Article&nbsp;VII (other than conditions that by their
nature are to be satisfied at the Closing, but subject to the satisfaction or, to the extent
permissible, waiver of those conditions at the Closing) have been satisfied or, to the extent
permissible, waived by the party or parties hereto entitled to the benefit of such conditions;
<U>provided</U>, that, the Closing shall not
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->-8-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">take place earlier than one (1)&nbsp;month after the date a copy of this Agreement was mailed to the Company Shareholders (to the extent required by
Section&nbsp;48-21-105(e) of the TBCA).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.03 <U>Effective Time</U>. At the Closing, the Company shall cause the Merger to be
consummated by (i)&nbsp;executing, delivering and filing articles of merger (the &#147;<B>Articles of Merger</B>&#148;)
with the Secretary of State of the State of Tennessee in accordance with the relevant provisions of
the TBCA and other applicable Law of the State of Tennessee and (ii)&nbsp;making all other filings or
recordings required under the TBCA in connection with the Merger. The Merger shall become effective
at such time as the Articles of Merger are duly filed with the Secretary of State of the State of
Tennessee, or at such later date or time as may be agreed by Parent and the Company in writing and
specified in the Articles of Merger in accordance with the TBCA (such time as the Merger becomes
effective is referred to herein as the &#147;<B>Effective Time</B>&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.04 <U>Effects of the Merger</U>. The Merger shall have the effects set forth in
this Agreement, the Articles of Merger and the applicable provisions of the TBCA. Without limiting
the generality of the foregoing, and subject thereto, at the Effective Time, all the properties,
rights, privileges, immunities, powers and franchises of the Company and Merger Sub shall vest in
the Surviving Corporation, and all debts, liabilities and duties of the Company and Merger Sub
shall become the debts, liabilities and duties of the Surviving Corporation.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.05 <U>Company Charter</U>. The Company Charter, as in effect immediately prior to
the Effective Time, shall be the charter of the Surviving Corporation following the Merger until
thereafter amended in accordance with the provisions thereof or by applicable Law, subject to
<U>Section&nbsp;6.12</U> hereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.06 <U>By-Laws</U>. At the Effective Time, the by-laws of Merger Sub, as in effect
as of immediately prior to the Effective Time, shall by virtue of the Merger, be the by-laws of the
Surviving Corporation until thereafter amended in accordance with the provisions thereof or by
applicable Law, subject to <U>Section&nbsp;6.12</U> hereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.07 <U>Directors and Officers</U>. The parties hereto shall take all actions
necessary so that, from and after the Effective Time, (i)&nbsp;the directors of Merger Sub as of
immediately prior to the Effective Time shall be the initial directors of the Surviving Corporation
and shall hold office until their respective successors are duly elected and qualified, or their
earlier death, resignation or removal and (ii)&nbsp;the officers of Merger Sub as of immediately prior
to the Effective Time shall be the initial officers of the Surviving Corporation and shall hold
office until their respective successors are duly elected and qualified, or their earlier death,
resignation or removal.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.08 <U>Effect on Capital Stock</U>. At the Effective Time, by virtue of the Merger
and without any action on the part of Parent, Merger Sub, the Company or the holders of any shares
of Company Common Stock or any shares of capital stock of Merger Sub:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Conversion of Company Common Stock</U>. Except as otherwise provided in
<U>Section&nbsp;1.08(b)</U>, each share of Company Common Stock outstanding immediately prior to the
Effective Time shall, by virtue of the Merger and without any action on the part of the holder
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-9-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">thereof, be converted into the right to receive an amount in cash, without interest, equal to the
Offer Price (subject to any applicable withholding Tax) (the &#147;<B>Merger Consideration</B>&#148;);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Cancellation of Company Common Stock</U>. Each share of Company Common Stock (i)&nbsp;held
by the Company as treasury stock or (ii)&nbsp;owned by Parent or any Subsidiary of Parent immediately
prior to the Effective Time (collectively, the &#147;<B>Excluded Shares</B>&#148;) shall be canceled without any
conversion and shall cease to exist, and no payment or distribution shall be made with respect
thereto; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <U>Common Stock of Merger Sub</U>. At the Effective Time, each share of common stock of
Merger Sub issued and outstanding immediately prior to the Effective Time shall be converted into
and become one validly issued, fully paid and non-assessable share of common stock of the Surviving
Corporation with the same rights, powers and privileges as the shares so converted.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.09 <U>Company Compensatory Awards</U>. (a)&nbsp;Each Company Stock Option that is
outstanding immediately prior to the Change in Control, whether or not then vested and exercisable,
shall become fully vested and exercisable immediately prior to the Change in Control. With respect
to such Company Stock Options:
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) each Company Stock Option for which, as of the Change in Control, the Offer Price
exceeds the exercise price per Share shall be canceled immediately following the Change in
Control and, in exchange therefor, the Company shall pay to each former holder of such
Company Stock Option as soon as practicable, but in no event later than fifteen (15)
Business Days following the Change in Control, an amount in cash (without interest, and
subject to deduction for any required withholding Tax) equal to the product of (1)&nbsp;the
excess, if any, of the Offer Price over the exercise price per Share under such Company
Stock Option and (2)&nbsp;the number of shares of Company Common Stock subject to such Company
Stock Option; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) each Company Stock Option that is outstanding immediately prior to the Change in
Control for which, as of the Change in Control, the Offer Price does not exceed the exercise
price per Share shall be cancelled without any cash payment being made in respect thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Each Company RSU and Company Restricted Stock Award that is outstanding immediately prior
to the Change in Control, whether or not then vested, shall become fully vested immediately prior
to, and then shall be canceled at, the Change in Control (the &#147;<B>Canceled Restricted Awards</B>&#148;), and,
in exchange therefor, the Company shall pay to each former holder of any such Canceled Restricted
Awards, as soon as practicable but in no event later than fifteen (15)&nbsp;Business Days following the
Change in Control, an amount in cash (without interest, and subject to deduction for any required
withholding Tax) equal to the product of (1)&nbsp;the Offer Price and (2)&nbsp;the number of shares of
Company Common Stock subject to such Canceled Restricted Awards.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Each Company PSU that is outstanding immediately prior to the Change in Control, whether
or not then vested, shall vest as provided in (ii)&nbsp;below immediately prior to,
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->-10-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">and then shall be canceled in full at, the Change in Control, and, in exchange therefor, the Company shall pay to
each former holder of any such Company PSUs, as soon as practicable but in no event later than
fifteen (15)&nbsp;Business Days following the Change in Control, an amount in cash (without interest,
and subject to deduction for any required withholding Tax) equal to the product of (1)&nbsp;the Offer
Price and (2)&nbsp;the number of shares of Company Common Stock subject to such Company PSUs that vest
in accordance with this subsection (c); notwithstanding anything herein to the contrary, Parent and
the Company shall cause all such payments with respect to Company PSUs to be paid in a manner which
complies with the requirements of Section&nbsp;409A of the Code. For the avoidance of doubt, (i)&nbsp;in the
event the Change in Control occurs prior to the end of the relevant fiscal period, the number of
Company PSUs vesting pursuant to the prior sentence shall be based on a deemed achievement of
performance conditions at target level, and (ii)&nbsp;in the event the Change in Control occurs or has
occurred subsequent to the end of the relevant fiscal period, the number of Company PSUs vesting
pursuant to the prior sentence shall be based on the level of such actual Company performance as
determined by the Company, in accordance with the applicable Company PSU award agreement and
applicable Company Stock Plan.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;The Company shall take such actions as are necessary to approve and effectuate the
foregoing provisions of this <U>Section&nbsp;2.09</U>, including making any determinations and/or
resolutions of the Company&#146;s Board of Directors or a committee thereof or any administrator of a
Company Stock Plan as may be necessary and satisfying any requirement to notify the holders of
Company Compensatory Awards as may be required under the Company Stock Plans.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Subject to Parent&#146;s compliance with the preceding provisions of this <U>Section&nbsp;2.09</U>,
the parties hereto agree that, following the Acceptance Time, no holder of a Company Compensatory
Award or any participant in any Company Stock Plan, or other Company Plan or employee benefit
arrangement of the Company or under any employment agreement shall have any right hereunder to
acquire any Equity Interest (including, but not limited to, any &#147;phantom&#148; stock or stock
appreciation rights) in the Company, any of its Subsidiaries or the Surviving Corporation.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;To the extent the holder of any Company Compensatory Award is subject to taxation outside
of the United States, any payments under this <U>Section&nbsp;2.09</U> shall be made in the
jurisdiction and/or from the entity from which such individual is paid salary or wages in the
normal course of business, to the extent permitted by applicable Law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;For purposes of this <U>Section&nbsp;2.09</U>, the term &#147;Change in Control&#148; shall have the
meaning set forth in the Company Stock Plan applicable to each Company Stock Option, Company RSU,
Company Restricted Stock Award, or Company PSU.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.10 <U>Adjustments</U>. If, during the period between the date of this Agreement
and the Effective Time, any change in the outstanding shares of capital stock of the Company shall
occur, including by reason of any reclassification, recapitalization, stock split or combination,
exchange or readjustment of shares, or any stock dividend thereon with a record date during such
period, but excluding the grant (other than any grants not made in accordance with this Agreement),
exercise or settlement of any Company Compensatory Awards, then the
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->-11-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Merger Consideration shall be appropriately adjusted to reflect such change in capitalization. Notwithstanding the foregoing,
nothing contained herein shall be construed to permit the Company to take any action with respect
to its securities that is prohibited by the terms of this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.11 <U>Merger Without Meeting of Shareholders</U>. Notwithstanding anything to the
contrary set forth in this Agreement, in the event that Merger Sub shall own a number of shares of
Company Common Stock that meets or exceeds the Short Form&nbsp;Threshold, the parties hereto agree to
take all necessary and appropriate action to cause the Merger to become effective as soon as
practicable after the Acceptance Time without a Company Shareholders Meeting in accordance with the
applicable provisions of the TBCA.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE III</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>EXCHANGE OF SHARES</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.01 <U>Exchange Agent</U>. Prior to the Effective Time, Parent shall designate a
United States bank or trust company reasonably acceptable to the Company (the &#147;<B>Exchange Agent</B>&#148;) to
receive, for the benefit of the Company Shareholders, funds representing the aggregate Merger
Consideration to which Company Shareholders shall become entitled pursuant to
<U>Section&nbsp;1.08(a)</U> (the &#147;<B>Exchange Fund</B>&#148;) and for the purpose of exchanging the Merger
Consideration for certificates representing shares of Company Common Stock (the &#147;<B>Common Stock
Certificates</B>&#148;) or uncertificated shares of Company Common Stock (the &#147;<B>Uncertificated Shares</B>&#148;). The
Exchange Agent shall also act as the agent for the Company Shareholders for the purpose of holding
the Common Stock Certificates and shall obtain no rights or interests in the shares represented by
such Certificates. Parent shall deposit or cause to be deposited cash in an amount sufficient to
pay the aggregate Merger Consideration with the Exchange Agent by wire transfer of immediately
available funds at or prior to the Effective Time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.02 <U>Exchange Procedures</U>. (a)&nbsp;As soon as reasonably practicable after the
Effective Time, Parent and the Surviving Corporation shall cause the Exchange Agent to mail to each
record holder of shares of Company Common Stock (other than Excluded Shares) at the Effective Time
(i)&nbsp;a letter of transmittal (which shall specify that delivery shall be effected, and risk of loss
and title to the Common Stock Certificates shall pass, only upon proper delivery of the Common
Stock Certificates to the Exchange Agent, and which shall be in such form and shall have such other
customary provisions (including customary provisions with respect to delivery of an &#147;agent&#146;s
message&#148; with respect to shares held in book-entry form) as Parent may reasonably specify) and
(ii)&nbsp;instructions for use in effecting the surrender of the Common Stock Certificates in exchange
for payment of the Merger Consideration.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Each record holder of shares of Company Common Stock that have been converted into the
right to receive the Merger Consideration shall be entitled to receive, upon (i)&nbsp;surrender to the
Exchange Agent of a Common Stock Certificate, together with a properly completed and executed
letter of transmittal, or (ii)&nbsp;receipt of an &#147;agent&#146;s message&#148; by the Exchange Agent (or such other
evidence, if any, of transfer as the Exchange Agent may reasonably request) in the case of a
book-entry transfer of Uncertificated Shares, the Merger
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-12-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Consideration (subject to any applicable withholding Tax), for each share of Company Common Stock formerly represented by such Certificate,
and the Certificate so surrendered shall be canceled. Until so surrendered or transferred, as the
case may be, each such Common Stock Certificate or Uncertificated Share shall represent after the
Effective Time for all purposes only the right to receive, in accordance with the terms hereof, the
Merger Consideration.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;If any portion of the Merger Consideration is to be paid to a Person other than the Person
in whose name the surrendered Common Stock Certificate or the transferred Uncertificated Share is
registered, it shall be a condition to such payment that (i)&nbsp;either such Common Stock Certificate
shall be properly endorsed or shall otherwise be in proper form for transfer or such Uncertificated
Share shall be properly transferred, in each case, as determined by the Exchange Agent and as set
forth in the letter of transmittal and related instructions and (ii)&nbsp;the Person requesting such
payment shall pay to the Exchange Agent any Taxes required as a result of such payment to a Person
other than the registered holder of such Common Stock Certificate or Uncertificated Share or
establish to the satisfaction of the Exchange Agent and the Surviving Corporation that such Taxes
have been paid or are not payable.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.03 <U>Stock Transfer Books</U>. At the Effective Time, the stock transfer books of
the Company shall be closed and there shall be no further registration of transfers of shares of
Company Common Stock. If, after Effective Time, any Common Stock Certificates or Uncertificated
Shares are presented to Parent, the Surviving Corporation or the Exchange Agent for any reason,
they shall be canceled and exchanged for the applicable Merger Consideration with respect to the
shares of Company Common Stock formerly represented thereby in accordance with the procedures set
forth in this Article&nbsp;III.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.04 <U>Termination of Exchange Fund</U>. Any portion of the Merger Consideration
deposited or otherwise made available to the Exchange Agent (including any proceeds of any
investments thereof) that remains unclaimed by the holders of shares of Company Common Stock twelve
(12)&nbsp;months after the Effective Time shall be delivered to Parent or otherwise on the instruction
of Parent, upon demand, and any such holder who has not exchanged shares of Company Common Stock
for the Merger Consideration to which such holders are entitled to under <U>Section&nbsp;1.08</U> prior
to that time shall thereafter look only to Parent (subject to abandoned property, escheat or other
similar applicable Laws) for payment of the consideration in respect of such Company Common Stock
without any interest thereon. Any such portion of the Exchange Fund remaining unclaimed by holders
of shares of Company Common Stock five (5)&nbsp;years after the Effective Time (or such earlier date
immediately prior to such time as such amounts would otherwise escheat to or become property of any
Governmental Authority) shall, to the extent permitted by Law, become the property of the Surviving
Corporation free and clear of any claims or interest of any Person previously entitled thereto.
Notwithstanding the foregoing, neither Parent nor the Surviving Corporation shall be liable to any
holder of shares of Company Common Stock for any amounts paid to a Governmental
Authority or public official pursuant to applicable abandoned property, escheat or similar
applicable Laws.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.05 <U>Withholding Rights</U>. Notwithstanding any provision contained herein to
the contrary, each of the Exchange Agent, the Surviving Corporation and Parent shall be entitled to
deduct and withhold from the consideration otherwise payable to any Person under
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->-13-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">this Agreement such amounts as it is required to deduct and withhold with respect to the making of such payment
under any provision of applicable Law. If the Exchange Agent, the Surviving Corporation or Parent,
as the case may be, so withholds amounts, such amounts shall be treated for all purposes of this
Agreement as having been paid to the applicable Person in respect of which the Exchange Agent, the
Surviving Corporation or Parent, as the case may be, made such deduction and withholding.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.06 <U>Lost Certificates</U>. If any Common Stock Certificate shall have been lost,
stolen, defaced or destroyed, upon the making of an affidavit of that fact by the Person claiming
such certificate to be lost, stolen, defaced or destroyed and, if required by the Surviving
Corporation, an agreement of indemnification in form reasonably satisfactory to the Surviving
Corporation or the posting by such Person of a bond, in such reasonable amount as the Surviving
Corporation may direct, as indemnity against any claim that may be made against the Surviving
Corporation or the Exchange Agent with respect to such certificate, the Exchange Agent will issue,
in exchange for such lost, stolen, defaced or destroyed Common Stock Certificate, the Merger
Consideration to be paid in respect of the shares of Company Common Stock represented by such
certificate, as contemplated by <U>Section&nbsp;1.08</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.07 <U>No Further Ownership Rights</U>. From and after the Effective Time, the
holders of Common Stock Certificates that evidenced ownership of shares of Company Common Stock
outstanding immediately prior to the Effective Time shall cease to have any rights with respect to
such shares of Company Common Stock, except as otherwise provided for in this Agreement or by
applicable Law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.08 <U>Further Assurances</U>. After the Effective Time, the officers and directors
of the Surviving Corporation will be authorized to execute and deliver, in the name and on behalf
of the Company or Merger Sub, any deeds, bills of sale, assignments or assurances and to take and
do, in the name and on behalf of the Company or Merger Sub, any other actions and things to vest,
perfect or confirm of record or otherwise in the Surviving Corporation any and all right, title and
interest in, to and under any of the rights, properties or assets acquired or to be acquired by the
Surviving Corporation as a result of, or in connection with, the Merger.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE IV</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>REPRESENTATIONS AND WARRANTIES OF THE COMPANY</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except (i)&nbsp;as disclosed (A)&nbsp;in the reports, statements, schedules, forms and other documents
filed by the Company with the SEC or furnished by the Company to the SEC, in each case, on or after
January&nbsp;1, 2010 and prior to the date of this Agreement (such documents, in respect of such
periods, collectively, and in each case including all exhibits and schedules thereto and documents
incorporated by reference therein, the &#147;<B>Company SEC Documents</B>&#148;) (but, in each case, excluding any
risk factor disclosures contained under the heading &#147;Risk Factors,&#148; any disclosure of risks
included in any &#147;forward-looking statements&#148; disclaimer or any other statements that are similarly
non-specific or predictive or forward-looking in nature, in each case, other than any specific
factual information contained therein) and to the extent publicly available on the SEC&#146;s Electronic
Data Gathering Analysis and Retrieval System (&#147;<B>EDGAR</B>&#148;)or (ii)&nbsp;as set forth in the Company
Disclosure Schedule delivered by the Company to Parent prior to
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->-14-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the execution of this Agreement, which Company Disclosure Schedule identifies items of disclosure by reference to a particular
section or subsection of this Agreement (<U>provided</U>, <U>however</U>, that any information
set forth in one section or subsection of the Company Disclosure Schedule also shall be deemed to
apply to each other section and subsection of this Agreement to which its applicability is
reasonably apparent from the text of the disclosure), the Company hereby represents and warrants to
Parent and Merger Sub as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.01 <U>Organization, Standing and Corporate Power</U>. (a)&nbsp;Each of the Company and
its Subsidiaries is a corporation or other legal entity duly organized, validly existing and in
good standing (or equivalent status, to the extent such concept exists) under the Laws of the state
of its incorporation, formation or organization, as the case may be, and has all requisite
corporate, partnership or similar power and authority necessary to own, lease and operate all of
its properties and assets and to carry on its business as currently conducted, except for such
failures to be duly organized, validly existing or in good standing (or equivalent status, to the
extent such concept exists) or to have corporate, partnership or similar power or authority that
would not reasonably be expected, individually or in the aggregate, to have a Company Material
Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Each of the Company and its Subsidiaries is duly licensed or qualified to do business and
is in good standing (or equivalent status, to the extent such concept exists) in each jurisdiction
in which the nature of the business currently conducted by it or the character or location of the
properties and assets currently owned or leased by it makes such licensing or qualification
necessary, except where the failure to be so licensed, qualified or in good standing (or equivalent
status) would not reasonably be expected, individually or in the aggregate, to have a Company
Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;The Company has made available to Parent true and complete copies of the Company Charter
and by-laws of the Company (together, the &#147;<B>Company Charter Documents</B>&#148;) and the organizational or
governing documents of each of its Subsidiaries, in each case, as amended to the date of this
Agreement. All such Company Charter Documents and organizational or governing documents of each of
its Subsidiaries are in full force and effect and the Company is not in violation of any of the
provisions of the Company Charter Documents and none of the Company&#146;s Subsidiaries is in violation
of any of the provisions of its organizational or governing documents except where such failures or
violations would not reasonably be expected, individually or in the aggregate, to have a Company
Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.02 <U>Corporate Authorization</U>. (a)&nbsp;The Company has all necessary corporate
power and authority and has taken all corporate action necessary to execute and deliver this
Agreement and all other agreements and documents contemplated hereby to which it is a
party and, subject to obtaining the Company Shareholder Approval, to perform its obligations
hereunder and to consummate the Transactions. The execution, delivery and performance by the
Company of this Agreement, and the consummation by it of the Transactions, have been duly
authorized and adopted by the Company&#146;s Board of Directors. Except for (i)&nbsp;obtaining the
affirmative vote of the holders of a majority of the issued and outstanding shares of Company
Common Stock in favor of the approval of this Agreement (the &#147;<B>Company Shareholder Approval</B>&#148;) and
(ii)&nbsp;filing the Articles of Merger with the Secretary of State of the State of Tennessee, no other
corporate action or proceeding on the part of the Company is necessary to
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->-15-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">authorize the execution, delivery and performance by the Company of this Agreement and the consummation by it of the
Transactions. This Agreement has been duly executed and delivered by the Company and, assuming due
authorization, execution and delivery of this Agreement by the other parties hereto, constitutes a
legal, valid and binding obligation of the Company, enforceable against the Company in accordance
with its terms, except that such enforceability (i)&nbsp;may be limited by bankruptcy, insolvency,
fraudulent transfer, reorganization, moratorium and other similar Laws of general application
affecting or relating to the enforcement of creditors&#146; rights generally and (ii)&nbsp;is subject to
general principles of equity, whether considered in a proceeding at Law or in equity (clauses (i)
and (ii)&nbsp;together, the &#147;<B>Bankruptcy and Equity Exception</B>&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;At a meeting duly called and held, the Company&#146;s Board of Directors, by resolutions duly
adopted at such meeting (which resolutions have not as of the date hereof been subsequently
rescinded, modified or withdrawn in any substantive way), has (i)&nbsp;unanimously determined that the
terms of the Transactions and transactions contemplated hereby are advisable, fair to and in the
best interests of the Company and the Company Shareholders, (ii)&nbsp;unanimously approved, adopted and
declared advisable this Agreement and the Transactions, (iii)&nbsp;unanimously resolved, subject to
<U>Section&nbsp;6.03(e)</U>, to recommend that the Company Shareholders approve this Agreement and the
Transactions (such recommendation, the &#147;<B>Company Board Recommendation</B>&#148;) and (iv)&nbsp;has directed that
this Agreement and the Transactions be submitted to the Company Shareholders for approval, if
required.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.03 <U>Governmental Authorization</U>. Except for (a)&nbsp;filings required under, and
compliance with other applicable requirements of, (i)&nbsp;the Exchange Act, and any other applicable
federal securities Laws, (ii)&nbsp;state securities or &#147;blue sky&#148; Laws and (iii)&nbsp;the rules and
regulations of the NYSE, (b)&nbsp;the filing of the Articles of Merger with the Secretary of State of
the State of Tennessee pursuant to the TBCA, (c)&nbsp;filings required under, and compliance with other
applicable requirements of, the HSR Act or any foreign antitrust, competition or similar Laws, (d)
any notices, applications, authorizations or licenses required under the FDCA and the regulations
of the FDA promulgated thereunder and (e)&nbsp;any required applications and filings with, or approvals
from, the New Jersey Department of Environmental Protection in order to timely comply with the New
Jersey Industrial Site Recovery Act and the regulations promulgated thereunder, no consents or
approvals of, or filings with, any Governmental Authority are necessary for the execution and
delivery of this Agreement by the Company and the consummation by the Company of the Transactions,
other than such other consents, approvals or filings that, if not obtained, made or given, would
not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse
Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.04 <U>No-Conflict</U>. Neither the execution and delivery of this Agreement by the
Company nor the consummation by the Company of the Transactions, nor compliance by the Company with
any of the provisions of this Agreement, will (a)&nbsp;assuming that the Company Shareholder Approval
(if required by applicable Law to consummate the Merger) is obtained, conflict with or violate the
Company Charter Documents, (b)&nbsp;assuming that the consents, approvals and filings referred to in
<U>Section&nbsp;4.03</U> and the Company Shareholder Approval (if required by applicable Law to
consummate the Merger) are obtained and made, violate any Restraint or Law applicable to the
Company or any of its Subsidiaries or any of their respective properties or assets, or (c)&nbsp;violate,
breach, result in the loss of any benefit under,
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->-16-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">conflict with any provisions of, or constitute a default (or an event which, with the notice or lapse of time, or both, would constitute a default)
under, result in the termination of or a right of termination or cancellation under, accelerate the
performance required by, or result in the creation of any Lien upon the respective properties or
assets of the Company or any of its Subsidiaries under, any of the terms, conditions or provisions
of any Contract, to which the Company or any of its Subsidiaries is a party, or by which they and
any of their respective properties or assets may be bound or affected, except in the case of
clauses (b)&nbsp;and (c)&nbsp;for such violations, breaches, losses, conflicts, defaults, terminations,
accelerations or Liens which would not reasonably be expected to have, individually or in the
aggregate, a Company Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.05 <U>Capitalization</U>. (a)&nbsp;As of the close of business on October&nbsp;8, 2010 (the
&#147;<B>Capitalization Date</B>&#148;), the authorized capital stock of the Company consisted of (i)&nbsp;600,000,000
shares of Company Common Stock, of which 249,927,596 shares were issued and outstanding (inclusive
of shares of Company Restricted Stock Awards granted pursuant to the Company Stock Plans) and no
shares were held in the treasury of the Company and (ii)&nbsp;15,000,000 shares of Company Preferred
Stock, of which no shares were issued and outstanding. There are no other classes of capital stock
of the Company authorized or issued and outstanding. All issued and outstanding shares of the
capital stock of the Company are duly authorized, validly issued, fully paid and non-assessable,
and no class of capital stock is entitled to preemptive rights.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;From the close of business on the Capitalization Date through the date of this Agreement,
there have been no issuances of shares of Company Capital Stock or Equity Interests of the Company
or any other securities of the Company other than issuances of shares of Company Common Stock
pursuant to the exercise of Company Stock Options, the vesting of Company Restricted Stock Awards
or the settlement of Company RSUs and Company PSUs, in each case, outstanding as of the
Capitalization Date under the Company Stock Plans. As of the close of business on the
Capitalization Date, there were no options, warrants, calls, commitments, agreements, arrangements,
undertakings or any other rights to acquire capital stock from the Company other than Company Stock
Options, Company RSUs, Company PSUs and the Company Convertible Notes as set forth in Section
4.05(b) of the Company Disclosure Schedule. Section&nbsp;4.05(b)(i) of the Company Disclosure Schedule
sets forth a true and complete list, as of the Capitalization Date, of the number of shares of
Company Common Stock subject to Company Stock Options, Company RSUs, Company PSUs, Company
Restricted Stock Awards or any other rights to purchase or receive Company Common Stock granted
under the Company Stock Plans or otherwise, the dates of grant, the extent to which such options
are vested and, where applicable, the exercise prices thereof. Immediately prior to the Acceptance
Time, the Company will provide to Parent a true and complete list, as of the Acceptance Time, of the
number of shares of Company Common Stock subject to Company Stock Options, Company RSUs, Company
PSUs, Company Restricted Stock Awards or any other rights to purchase or receive Company Common
Stock granted under the Company Stock Plans or otherwise, the dates of grant, the extent to which
such options are vested and, where applicable, the exercise prices thereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Other than Company Convertible Notes, no bonds, debentures, notes or other Indebtedness of
the Company having the right to vote (or convertible into or exercisable
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-17-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">for securities having the right to vote) on any matters on which holders of capital stock of the Company may vote are issued
or outstanding.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;As of the date of this Agreement, (i)&nbsp;there are no outstanding obligations of the Company
to repurchase, redeem or otherwise acquire any shares of capital stock of the Company or any of its
Subsidiaries except for purchases, redemptions or other acquisitions of capital stock or other
securities (A)&nbsp;required by the terms of the Company Plans, (B)&nbsp;in order to pay Taxes or satisfy
withholding obligations in respect of such Taxes in connection with awards under the Company Stock
Plans or otherwise, or (C)&nbsp;as required by the terms of, or necessary for the administration of, any
plans, arrangements or agreements existing on the date hereof between the Company or any of its
Subsidiaries and any director or employee of the Company or any of its Subsidiaries and (ii)&nbsp;there
are no outstanding stock-appreciation rights, security-based performance units, &#147;phantom&#148; stock or
other security rights or other agreements, arrangements or commitments of any character (contingent
or otherwise) pursuant to which any Person is or may be entitled to receive any payment or other
value based on the stock price performance of the Company or any of its Subsidiaries (other than
under the Company Stock Plans) or to cause the Company or any of its Subsidiaries to file a
registration statement under the Securities Act.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;As of the date of this Agreement, there are no outstanding obligations of the Company (i)
restricting the transfer of, (ii)&nbsp;affecting the voting rights of, (iii)&nbsp;requiring the sales,
issuance, repurchase, redemption or disposition of, or containing any right of first refusal with
respect to, (iv)&nbsp;requiring the registration for sale of or (v)&nbsp;granting any preemptive or
anti-dilutive rights with respect to any shares of Company Common Stock, Company Preferred Stock or
other Equity Interests in the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.06 <U>Subsidiaries</U>. (a)&nbsp;Other than the Subsidiaries of the Company, the
Company does not own or control, directly or indirectly, any membership interest, partnership
interest, joint venture interest, other Equity Interest or any other capital stock of any Person,
and there are no silent partnerships, sub-partnerships and/or similar rights with respect to the
Company or any Subsidiary of the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;All outstanding shares of capital stock, voting securities or other Equity Interests of
each Subsidiary of the Company are duly authorized, validly issued and fully paid, non-assessable;
and all such securities are owned beneficially and of record by the Company or another wholly-owned
Subsidiary of the Company free and clear of all Liens (other than Permitted Liens). As of the date
of this Agreement, there are no outstanding obligations of any Subsidiary of the Company (i)
restricting the transfer of, (ii)&nbsp;affecting the voting rights of, (iii)&nbsp;requiring the sales,
issuance, repurchase, redemption or disposition of, or containing any right of
first refusal with respect to, (iv)&nbsp;requiring the registration for sale of or (v)&nbsp;granting any
preemptive or anti-dilutive rights with respect to any shares of Equity Interests in any Subsidiary
of the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;There are no (i)&nbsp;outstanding options or other rights of any kind which obligate the
Company or any of its Subsidiaries to issue, transfer, sell or deliver any shares of capital stock,
voting securities or other Equity Interests of any Subsidiary of the Company or any securities or
obligations convertible into, exchangeable or exercisable for any shares of capital stock, voting
securities or other Equity Interests of a Subsidiary of the Company or (ii)&nbsp;other
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-18-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">options, calls, warrants or other rights, agreements, arrangements or commitments relating to the capital stock,
voting securities or other Equity Interests of any Subsidiary of the Company to which the Company
or any of its Subsidiaries is a party.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Section&nbsp;4.06(d) of the Company Disclosure Schedule sets forth, as of the date hereof, for
each of the Company&#146;s Subsidiaries: (i)&nbsp;its jurisdiction of organization, (ii)&nbsp;its authorized
capital stock or other Equity Interests, (iii)&nbsp;the number of its outstanding shares of capital
stock or other Equity Interests and type(s) of such outstanding shares of capital stock or other
Equity Interests and (iv)&nbsp;the record owner(s) thereof. Except for the ownership of Equity Interests
in the Company&#146;s Subsidiaries and investments in marketable securities and cash equivalents, none
of the Company or any of its Subsidiaries owns directly or indirectly any Equity Interest in any
Person, or has any obligation or has made any commitment to acquire any such Equity Interest, to
provide funds to, or to make any investment (in the form of a loan, capital contribution or
otherwise) in, any of its Subsidiaries or any other Person that is or would reasonably be expected
to be, individually or in the aggregate, material to the Company and its Subsidiaries, taken as a
whole.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.07 <U>SEC Filings and the Sarbanes-Oxley Act</U>. (a)&nbsp;All of the Company SEC
Documents filed by the Company with the SEC in respect of reporting periods commencing on or after
January&nbsp;1, 2008 have been timely filed. As of their respective filing dates (or, if amended or
superseded by a filing prior to the date of this Agreement, then on the date of such filing), such
Company SEC Documents complied in all material respects with applicable Law, including the
Securities Act, the Exchange Act and the Sarbanes-Oxley Act, and none of such Company SEC Documents
as of their respective filing dates contained any untrue statement of a material fact or omitted to
state a material fact required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they were made, not misleading. The Company has
made available to Parent copies of all comment letters received by the Company from the SEC in
respect of reporting periods commencing on or after January&nbsp;1, 2008 (excluding all letters received
from the SEC indicating that the SEC would not be reviewing any registration statement filed with
the SEC by the Company) and relating to such Company SEC Documents, together with all written
responses of the Company thereto. As of the date of this Agreement, there are no outstanding or
unresolved comments received from the SEC staff with respect to the Company SEC Documents. To the
Knowledge of the Company, as of the date hereof, there are no ongoing SEC inquiries or
investigations regarding accounting practices of the Company or otherwise regarding the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;All of the audited consolidated financial statements and unaudited consolidated interim
financial statements of the Company included in the Company SEC
Documents (together with the related notes and schedules thereto) complied at the time they
were filed as to form in all material respects with the applicable accounting requirements and the
published rules and regulations of the SEC with respect thereto in effect at the time of filing,
were prepared in accordance with GAAP (except as may be indicated in the notes thereto), applied on
a consistent basis during the periods involved (except as may be indicated in the notes thereto)
and fairly present in all material respects the consolidated financial position of the Company and
its consolidated Subsidiaries as of the dates thereof and the consolidated results of their
operations and cash flows for the periods then ended (subject, in the case of the financial
statements for any quarter of the current fiscal year, to normal year-end audit adjustments).
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-19-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Neither the Company nor any of its Subsidiaries is a party to, or has any commitment to
become a party to, any joint venture, off-balance sheet partnership or any similar contract
(including any contract or arrangement relating to any transaction or relationship between or among
the Company and any of its Subsidiaries, on the one hand, and any unconsolidated Affiliate, on the
other hand), including any structured finance, special purpose or limited purpose entity or Person,
or any &#147;off-balance sheet arrangements&#148; (as defined in Item 303(a) of Regulation&nbsp;S-K of the SEC),
where the result, purpose or effect of such contract is to avoid disclosure of any material
transaction involving, or material liabilities of, the Company or any of its Subsidiaries in the
Company&#146;s or any of its Subsidiaries&#146; published financial statements or any Company SEC Documents.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Each of the principal executive officer of the Company and the principal financial officer
of the Company (or each former principal executive officer of the Company and each former principal
financial officer of the Company, as applicable) has made all certifications required by Rule
13a-14 or 15d-14 under the Exchange Act and Sections&nbsp;302 and 906 of the Sarbanes-Oxley Act, in each
case, with respect to the Company SEC Documents, and the statements contained in such
certifications were true and complete on the date such certifications were made. For purposes of
this Agreement, &#147;principal executive officer&#148; and &#147;principal financial officer&#148; shall have the
meanings given to such terms in the Sarbanes-Oxley Act. No executive officer of the Company has
failed to make the certifications required of him or her under Section&nbsp;302 or 906 of the Sarbanes
Oxley Act with respect to any Company SEC Document, except as disclosed in certifications filed
with the Company SEC Documents. Since January&nbsp;1, 2008 through the date of this Agreement,
(i)&nbsp;neither the Company nor any of the Company&#146;s Subsidiaries, nor, to the Knowledge of the
Company, has any director or executive officer of the Company or any of the Company&#146;s Subsidiaries
received any material complaint, allegation, assertion or claim, in writing that the Company or any
of its Subsidiaries has engaged in improper, illegal or fraudulent accounting or auditing
practices, and (ii)&nbsp;to the Knowledge of the Company, no attorney representing the Company or any of
its Subsidiaries, whether or not employed by the Company or any of its Subsidiaries, has reported
evidence of a material violation of securities Laws, breach of fiduciary duty or similar violation
by the Company or any of its officers, directors, employees or agents to the Company&#146;s Board of
Directors or any committee thereof or to any director or officer of the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;The Company has established and maintains a system of &#147;internal control over financial
reporting&#148; (as defined in Rules&nbsp;13a-15(f) and 15d-15(f) promulgated by the SEC under the Exchange
Act) sufficient to provide reasonable assurance that (i)&nbsp;transactions are executed in accordance
with management&#146;s general or specific authorizations; (ii)&nbsp;transactions
are recorded as necessary to permit preparation of financial statements in conformity with
GAAP and to maintain asset accountability; (iii)&nbsp;access to assets is permitted only in accordance
with management&#146;s general or specific authorization; and (iv)&nbsp;the recorded accountability for
assets is compared with the existing assets at reasonable intervals and appropriate action is taken
with respect to any differences.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;The Company&#146;s disclosure controls and procedures (as defined in Rules&nbsp;13a-15(e) and
15d-15(e) of the Exchange Act), as required by Rules&nbsp;13a-15(a) and 15d-15(a) of the Exchange Act,
are reasonably designed to ensure that all information required to be disclosed by the Company in
the reports it files or submits under the Exchange Act is made known to the
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->-20-<!-- /Folio -->
</DIV>



<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">chief executive officer
and the chief financial officer of the Company by others within the Company to allow timely
decisions regarding required disclosure as required under the Exchange Act and is recorded,
processed, summarized and reported within the time periods specified by the SEC&#146;s rules and forms.
The Company has evaluated the effectiveness of the Company&#146;s disclosure controls and procedures
and, to the extent required by applicable Law, presented in any applicable Company SEC Document
that is a report on Form 10-K or Form 10-Q, or any amendment thereto, its conclusions about the
effectiveness of the disclosure controls and procedures as of the end of the period covered by such
report or amendment based on such evaluation.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;The Company is in compliance in all material respects with all current listing and
corporate governance requirements of the NYSE, and is in compliance in all material respects with
all rules, regulations and requirements of the Sarbanes-Oxley Act and the SEC. Except as permitted
by the Exchange Act, including Sections&nbsp;13(k)(2) and (3), since January&nbsp;1, 2008, neither the
Company nor any of its Affiliates has made, arranged, modified (in any material way), or forgiven
personal loans to any executive officer or director of the Company. Since December&nbsp;31, 2007, to
the Knowledge of the Company, no employee of the Company or any of its Subsidiaries has provided or
is providing information to any law enforcement agency or Governmental Authority regarding the
commission or possible commission of any crime or the violation or possible violation of any
applicable legal requirements of the type described in Section&nbsp;806 of the Sarbanes-Oxley Act by the
Company or any of its Subsidiaries.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.08 <U>Indebtedness</U>. Except for Indebtedness reflected on the Company Financial Statements,
the Company has not, since December&nbsp;31, 2009 through the date hereof, incurred any Indebtedness.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.09 <U>Information Supplied</U>. (a)&nbsp;The information supplied by the Company for inclusion or
incorporation by reference in the Offer Documents will, at the time the Offer Documents are filed
with the SEC or at the time the Offer Documents are first published, sent or given to the Company
Shareholders, not contain any untrue statement of material fact or omit to state any material fact
required to be stated therein or necessary to make the statements therein, in the light of the
circumstances under which they are made, not misleading.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The Schedule&nbsp;14D-9 will, when filed with the SEC, comply as to form in all material
respects with the applicable requirements of the Exchange Act. The Schedule&nbsp;14D-9 will, at the time
the Schedule&nbsp;14D-9 is filed with the SEC or at the time the Schedule&nbsp;14D-9 is first sent to the
Company Shareholders not contain any untrue statement of material fact or omit
to state any material fact required to be stated therein or necessary to make the statements
therein, in the light of the circumstances under which they are made, not misleading; <U>provided</U>,
<U>however</U>, that no representation or warranty is made by the Company with respect to information
supplied by Parent or Merger Sub or any of their directors, officers, employees, affiliates, agents
or other representatives for inclusion or incorporation by reference in the Schedule&nbsp;14D-9.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.10 <U>Absence of Certain Changes</U>. Since January&nbsp;1, 2010 through the date hereof, the
business of the Company and its Subsidiaries has been conducted in the ordinary course consistent
with past practices in all material respects and there has not been (i)&nbsp;any event, occurrence,
development or state of circumstances, facts or condition in such period that has had
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->-21-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">or would
reasonably be expected, individually or in the aggregate, to have a Company Material Adverse Effect
or (ii)&nbsp;any action taken by the Company or any of its Subsidiaries that, if taken during the period
from the date of this Agreement through the Acceptance Time without Parent&#146;s consent, would
constitute a breach of <U>Section&nbsp;6.01(b)</U> (other than <U>Section&nbsp;6.01(b)(ii)</U> (to the
extent the Company has issued Company Compensatory Awards since the January&nbsp;1, 2010), (vii)(A)
through (E), (xiv), (xv), (xvii), (xix), (xxi), (xxii)&nbsp;and (xxiv) (to the extent that it relates to
the foregoing subsections)).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.11 <U>No Undisclosed Liabilities</U>. Except (a)&nbsp;as reflected or reserved against in the most
recent audited Company Financial Statements (or stated in the notes thereto) and (b)&nbsp;for
liabilities and obligations incurred since July&nbsp;1, 2010 in the ordinary course of business
consistent with past practice, which are not and would not reasonably be expected, individually or
in the aggregate, to have a Company Material Adverse Effect, neither the Company nor any Subsidiary
of the Company has any liabilities of any nature, whether or not accrued, contingent or otherwise,
whether known or unknown and whether due or to become due, that would be required by GAAP to be
reflected in the Company Financial Statements (or in the notes thereto).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.12 <U>Compliance with Laws and Court Orders; Permits</U>. (a)&nbsp;Since January&nbsp;1, 2008, the
Company and its Subsidiaries are and have been in compliance with all Laws applicable to them, any
of their properties or other assets or any of their businesses or operations, except where any such
failure to be in compliance has not been and would not reasonably be expected to be, individually
or in the aggregate, material to the Company and its Subsidiaries, taken as a whole. To the
Knowledge of the Company, no investigation or review by any Governmental Authority with respect to
the Company or any of its Subsidiaries is pending or threatened that, in each case, has not been
and would not reasonably be expected to be, individually or in the aggregate, material to the
Company and its Subsidiaries, taken as a whole. The Company and its Subsidiaries have been and are
in compliance with the terms of the certain Corporate Integrity Agreement between the Company and
the Office of Inspector General of Health and Human Services, dated October&nbsp;28, 2005.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The Company and each of its Subsidiaries (or their respective agents) hold all licenses,
franchises, permits, certificates, consents, orders, approvals and authorizations from Governmental
Authorities, or required by Governmental Authorities to be obtained, in each case, that are
necessary for the Company and its Subsidiaries to own, lease or operate their properties and
assets, and to carry on their businesses as currently conducted (collectively, &#147;<B>Permits</B>&#148;) and each
of the Permits is in full force and effect, except for such Permits that the
failure to hold or be in full force and effect would not reasonably be expected to be,
individually or in the aggregate, material to the Company and its Subsidiaries, taken as a whole.
Since January&nbsp;1, 2008, neither the Company nor any of its Subsidiaries has received written notice
to the effect that a Governmental Authority was considering the amendment, termination, revocation
or cancellation of any Permit that is material to the Company and its Subsidiaries taken as a
whole. Each of the Company and its Subsidiaries is, and since January&nbsp;1, 2008 has been in
compliance with the terms of its Permits, except where non-compliance with such Permit would not
reasonably be expected to be, individually or in the aggregate, material to the Company and its
Subsidiaries, taken as a whole. Neither the Company nor any of its Subsidiaries has received any
written communication since January&nbsp;1, 2008 from any Governmental Authority or to the
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-22-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Knowledge of
the Company, from any employee, licensee, licensor, vendor or supplier of the Company or any of its
Subsidiaries that alleges that the Company or any of its Subsidiaries is not in compliance in all
material respects with, or is subject to any material liability under, any Permit that is material
to the Company and its Subsidiaries taken as a whole, or relating to the revocation or modification
of any Permit that is material to the Company and its Subsidiaries taken as a whole. The
consummation of the Transactions, in and of itself, will not cause the revocation or cancellation
of any Permit that is material to the Company and its Subsidiaries, taken as a whole.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.13 <U>Material Contracts</U>. (a)&nbsp;As of the date of this Agreement, none of the Company, any
of its Subsidiaries or their respective properties or other assets is a party to or bound by any
Contract (other than Company Plans and Foreign Plans):
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) pursuant to which the Company, any of its Subsidiaries or any other party thereto
has material continuing obligations, rights or interests and including annual payments by
the Company and its Subsidiaries of $3,000,000 or more relating to the research,
development, clinical trial, distribution, supply, manufacture, marketing or co-promotion
of, or collaboration with respect to, any product or product candidate for which the Company
or any of its Subsidiaries is currently engaged in research or development, including but
not limited to: (A)&nbsp;non-disclosure agreements relating to potential business combinations
or acquisitions or similar transactions involving the Company or any of its Subsidiaries,
(B)&nbsp;material manufacture or supply services or material Contracts with contract research
organizations for clinical trials-related services (C)&nbsp;material transfer Contracts for
pre-clinical products or clinical products of the Company or any of its Subsidiaries with
commercial, pharmaceutical or biotechnology companies; (D)&nbsp;Contracts involving the payment
of royalties or other amounts calculated based upon the revenues or income of the Company or
any of its Subsidiaries or income or revenues related to any product or clinical product
candidate of the Company or any of its Subsidiaries; and (E)&nbsp;Contracts pursuant to which the
Company has minimum purchase obligations;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) that contains any non-compete or exclusivity provision or limits or purports to
limit, curtail or restrict the ability of the Company or any of its Subsidiaries (or which
following the consummation of the Transactions would reasonably be expected to limit the
ability of the Surviving Corporation) in a manner that is material to the business of the
Company and its Subsidiaries, taken as a whole, as currently conducted
(A)&nbsp;to compete in any line of business, in any geographic area or with any Person and
(B)&nbsp;to sell to or purchase from any other Person or entity;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) that is a joint-venture or partnership agreement or other similar agreement or
arrangement involving annual payments of $1,000,000;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) for the acquisition, disposition or lease of businesses (whether by merger,
purchase or sale of stock or assets or otherwise) entered into since January&nbsp;1, 2008;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) that is a loan or credit agreement, indenture, note or other Contract or instrument
relating to or evidencing Indebtedness for borrowed money (including any
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-23-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">guarantee thereto)
that has outstanding Indebtedness in a principal amount in excess of $1,000,000 or any
Contract pursuant to which Indebtedness for borrowed money may be incurred or guaranteed in
a principal amount in excess of $1,000,000, including any Contract that is a financial
derivatives master agreement or confirmation, or futures account opening agreement and/or
brokerage statement, evidencing financial hedging or similar trading activities;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) that is a mortgage, pledge, security agreement, deed of trust, capital lease or
similar agreement that creates or grants a Lien on any material property or asset of the
Company or any of its Subsidiaries, in each case involving annual payments of more than
$1,000,000;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii) that is a Collective Bargaining Agreement;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(viii) that is a &#147;standstill&#148; or similar agreement;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ix) that is a Contract granting a right of first refusal or first negotiation to any
Third Party over any material assets of the Company; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(x) that is any Contract that is a &#147;material contract&#148; (as such term is defined in Item
601(b)(10) of Regulation&nbsp;S-K of the SEC).
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">All Contracts, arrangements, commitments or understandings described in this <U>Section
4.13(a)</U>, together with all Contracts, arrangements, commitments or understandings set forth as
an exhibit to the Company SEC Documents, shall be collectively referred to as the &#147;<B>Material
Contracts</B>.&#148;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Except, in each case, as has not been and would not reasonably be expected to be,
individually or in the aggregate, material to the Company and its Subsidiaries, taken as a whole,
as of the date hereof, (i)&nbsp;each of the Material Contracts is valid, binding and in full force and
effect with respect to the Company and its Subsidiaries party thereto and, to the Knowledge of the
Company, each other party thereto and enforceable, in all material respects, in accordance with its
terms by the Company and its Subsidiaries party thereto (subject to the Bankruptcy and Equity
Exception); (ii)&nbsp;the Company and each of its Subsidiaries has performed all material obligations
required to be performed by them under the Material Contracts to which they are parties; (iii)&nbsp;to
the Knowledge of the Company, each other party to a Material Contract has performed all material
obligations required to be performed by it under such Material
Contract and (iv)&nbsp;no party to any Material Contract has given the Company or any of its
Subsidiaries written notice of its intention to cancel, terminate, change the scope of rights under
or fail to renew any Material Contract and neither the Company nor any of its Subsidiaries, nor, to
the Knowledge of the Company, any other party to any Material Contract, has repudiated in writing
any material provision thereof. Neither the Company nor any of its Subsidiaries has Knowledge of,
or has received written notice of, any violation or default under any Material Contract or any
other Contract to which it is a party or by which it or any of its material properties or assets is
bound, except for violations or defaults that have not been and would not reasonably be expected to
be, individually or in the aggregate, material to the Company and its Subsidiaries, taken as a
whole.
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->-24-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.14 <U>Litigation</U>. There is no complaint, claim, action, suit, arbitration, mediation or
proceeding (each, an &#147;<B>Action</B>&#148;) pending or, to the Knowledge of the Company, any Action or
investigation pending and not served or threatened, to which the Company or any of its Subsidiaries
is a party that would reasonably be expected, individually or in the aggregate, to have a Company
Material Adverse Effect. There are no outstanding judgments, writs, injunctions, decrees or orders
of any Governmental Authority against or binding on the Company or its Subsidiaries that have had
or would reasonably be expected, individually or in the aggregate, to have a Company Material
Adverse Effect. There are no internal investigations or internal inquiries that, since January&nbsp;1,
2008, have been conducted by or at the direction of the Company&#146;s Board of Directors (or any
committee thereof) concerning any financial, accounting or other misfeasance or malfeasance issues.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.15 <U>Properties</U>. (a)&nbsp;Section&nbsp;4.15(a)(i) of the Company Disclosure Schedule sets forth a
true and complete list (by address, if available) of all real property owned in fee by the Company
or any of its Subsidiaries as of the date of this Agreement and material to the business of the
Company and its Subsidiaries, taken as a whole (collectively, the &#147;<B>Owned Real Property</B>&#148;). The
Company or one of its Subsidiaries, as the case may be, holds good, indefeasible, insurable,
marketable (subject to any state of facts an accurate survey would show, <U>provided</U> same does
not prohibit or materially impair the current use and operation of such parcel of Owned Real
Property) and valid fee simple title to the Owned Real Property, free and clear of all Liens,
except for Permitted Liens. There are no outstanding options or rights of first refusal or offer to
purchase or lease the Owned Real Property, or any portion thereof or interest therein. There are
no parties (other than the Company and its Subsidiaries) in possession of any Owned Real Property.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Section&nbsp;4.15(b)(i) of the Company Disclosure Schedule sets forth a true and complete list
of all real property leased, subleased or otherwise occupied by the Company or any of its
Subsidiaries as tenant, subtenant or occupant as of the date of this Agreement and material to the
business of the Company and its Subsidiaries, taken as a whole (collectively, the &#147;<B>Leased Real
Property</B>&#148;). To the Knowledge of the Company or the applicable Subsidiary of the Company, no Real
Property Lease is subject to any Lien, including without limitation, any right to the use or
occupancy of any Real Property (as defined below), other than Permitted Liens. Each Real Property
Lease constitutes the entire agreement between the parties thereto with respect to the Real
Property leased thereunder, and is, with respect to the Company or the applicable Subsidiary of the
Company, a valid and subsisting agreement in full force and effect and constitutes a valid and
binding obligation of the Company
or the applicable Subsidiary of the Company, subject to the Bankruptcy and Equity Exception.
The Company has not received any written notice of termination or cancellation of or of a breach or
default under any Real Property Lease that remains uncured as of the date of the Agreement nor, to
the Knowledge of the Company, has any event occurred which, with notice or lapse of time or both,
would constitute a breach or default under any such Real Property Lease, or permit the termination
or cancellation of any such Real Property Lease. With respect to the Real Property, Section
4.15(b)(ii) of the Company Disclosure Schedule also contains a true and complete list as of the
date hereof of all agreements under which the Company or any of its Subsidiaries is, as of the date
hereof, the landlord, sublandlord, tenant, subtenant or occupant that have not been terminated or
expired as of the date hereof and are material to the business of the Company and its Subsidiaries,
taken as
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-25-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">a whole (each a &#147;<B>Real Property Lease</B>&#148;). The Company has heretofore made available to
Parent true and complete copies of the Real Property Leases.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;The Owned Real Property and the Leased Real Property are referred to collectively herein
as the &#147;<B>Real Property</B>.&#148; Neither the Company nor any of its Subsidiaries has received written
notice of any proceedings in eminent domain, condemnation or other similar proceedings that are
pending, and the Company has not received written notice threatening any such proceedings, in each
case, affecting any material portion of the Real Property. Neither the Company nor any of its
Subsidiaries has received written notice of the existence of any outstanding writ, injunction,
decree, order or judgment or of any pending proceeding pertaining to or affecting any material
portion of the Real Property. As of the date hereof, none of the material improvements located on
any parcel of Real Property that is material to the business of the Company and its Subsidiaries,
taken as whole, has been damaged by a fire or other casualty and not been restored and repaired
either (i)&nbsp;to substantially the same condition they were in prior to such event or (ii)&nbsp;to a
condition necessary for the use of the Company in the ordinary course.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;To the Knowledge of the Company, there are no conditions or defects, latent or otherwise,
to the Real Property that would, individually or in the aggregate, reasonably be expected to have a
Company Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.16 <U>Intellectual Property</U>. (a)&nbsp;Section&nbsp;4.16(a) of the Company Disclosure Schedule sets
forth a true and complete list as of October&nbsp;3, 2010, of all material (i)&nbsp;unexpired and unabandoned
(as reflected in the records of the appropriate IP Governmental Authority, assuming such records of
such IP Governmental Authority have been timely and accurately updated as of October&nbsp;3, 2010)
Patents, Trademarks, and Copyrights included in the Company Intellectual Property that are issued
by or registered with an IP Governmental Authority, and domain names included in the Company
Intellectual Property (regardless of whether filed by the Company or any of its Subsidiaries, or by
any other Person) that are registered to the Company or any of its Subsidiaries, or to any other
Person (according to the records of any domain registrars); and (ii)&nbsp;applications for registration
of Patents or Trademarks included in the Company Intellectual Property pending with any IP
Governmental Authority (regardless of whether filed by the Company or any of its Subsidiaries, or
by any other Person), in each case, with an IP Governmental Authority; indicating for each item (as
applicable) the registration or application numbers, the filing, registration, or issue dates, the
applicable filing jurisdiction(s), titles of pending or unexpired and unabandoned (as reflected in
the records of the
appropriate IP Governmental Authority, assuming such records of such IP Governmental Authority
have been timely and accurately updated as of October&nbsp;3, 2010) issued Patents and registered
Copyrights, and, to the Knowledge of the Company, all third party co-owners or joint owners, if
any, of such Company Intellectual Property.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Section&nbsp;4.16(b)(i) of the Company Disclosure Schedule sets forth a true and complete list
as of the date of this Agreement, of all material Contracts (other than Ordinary Course Agreements;
Contracts for standard, off-the-shelf software commercially available on standard terms from
Third-Party vendors; and non-material software and other information technology Contracts,
including non-material click-wrap, shrink-wrap, and subscription services agreements) pursuant to
which the Company or any of its Subsidiaries licenses in or otherwise is
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-26-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">authorized to practice any
material Third-Party Intellectual Property that is necessary for the conduct of the business and
operations (including both marketed products and product candidates under clinical or preclinical
trial or development) of the Company and its Subsidiaries, taken as a whole, as presently
conducted. Section&nbsp;4.16(b)(ii) of the Company Disclosure Schedule sets forth a true and complete
list as of the date hereof, of all material Contracts, other than Ordinary Course Agreements,
pursuant to which the Company or any of its Subsidiaries licenses or otherwise provides a right to
practice any material Company Intellectual Property to Third Parties. As of the date hereof, the
Company has provided the Parent with access to true and complete copies of all Contracts listed on
Section&nbsp;4.16(b) of the Company Disclosure Schedule. To the Knowledge of the Company, there are no
agreements listed on Section&nbsp;4.16(b)(i) or Section&nbsp;4.16(b)(ii) of the Company Disclosure Schedule
between the Company or any of its Subsidiaries and any Third Party relating to Third Party
Intellectual Property or Company Intellectual Property under which there is, as of the date of this
Agreement, any material dispute that is evidenced in writing addressed to or by the Company or any
of its Subsidiary regarding the scope of the performance of such agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;With respect to the Company Intellectual Property (other than domain names) listed on
Section&nbsp;4.16(a) of the Company Disclosure Schedule, to the Knowledge of the Company, (i)&nbsp;the
Company and/or at least one of its Subsidiaries own, jointly-own, or co-own (with any third party,
as applicable) all right, title, and interest in and to such Company Intellectual Property; (ii)
such Company Intellectual Property is free and clear of all Liens (other than Permitted Liens); and
(iii)&nbsp;all issued Patents and registered Trademarks set forth on Section&nbsp;4.16(a) of the Company
Disclosure Schedule are valid, subsisting, and enforceable. To the Knowledge of the Company, none
of the Company Intellectual Property is the subject of any outstanding written injunction, decree,
order, or judgment, in each case, in which the Company or any of its Subsidiaries, or third party
co-owners or joint owners is a party, that adversely restricts the use, transfer, registration, or
licensing thereof by the Company or any of its Subsidiaries, or otherwise adversely affects the
validity, scope, use, registrability, or enforceability of any such Company Intellectual Property.
Subject to <U>Section&nbsp;4.16(d)</U> and with the exception that the Company makes no such
representation or warranty with respect to the Patents, or the right to use the Patents, listed in
Section&nbsp;4.16(c) of the Disclosure Schedule, to the Knowledge of the Company, the Company and its
Subsidiaries have rights to use all material Intellectual Property necessary to the conduct of the
business or operations of the Company and its Subsidiaries, taken as a whole, as currently
conducted (including the current operations with respect to marketed products and the current
operations with respect to the development and marketing, if any, of product candidates under
current clinical or current preclinical trial or
development). Upon the execution of this Agreement and the consummation of the Merger, the
Company and its Subsidiaries shall have the right to exercise all of their rights under agreements
granting rights to the Company or any of its Subsidiaries with respect to Intellectual Property of
Third Parties to the same extent and in the same manner they would have been able to had the Merger
not occurred, without the payment of any additional consideration as a direct result of the
execution of this Agreement and the consummation of the Merger and without the necessity of any
Third Party consent as a result of such transactions, except in the case where the failure to have
any such rights would not reasonably be expected, individually or in the aggregate, to have a
Company Material Adverse Effect.
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->-27-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;To the Knowledge of the Company, the conduct of the business and the operations of the
Company as currently conducted do not infringe, misappropriate, dilute, or otherwise violate the
Intellectual Property of any Third Party, with the exception that the Company makes no such
representation or warranty with respect to the Patents listed in Section&nbsp;4.16(d) of the Disclosure
Schedule. No claim is pending and either served or noticed in writing, on, upon, or against the
Company or any of its Subsidiaries, or to the Knowledge of the Company, threatened in writing
against the Company or any of its Subsidiaries, nor has the Company or any of its Subsidiaries
received any written notice since October&nbsp;11, 2008 (i)&nbsp;alleging that the conduct of the business
and operations of the Company and its Subsidiaries, taken as a whole, as currently conducted
infringes, dilutes, misappropriates, or otherwise violates the Intellectual Property of any Third
Party in a manner that is material to the conduct of the business or operations of the Company and
its Subsidiaries, taken as a whole, or (ii)&nbsp;challenging the validity, scope, use, or registrability
of any Company Intellectual Property or the ownership by the Company or its Subsidiaries of such
Company Intellectual Property or the right of the Company or any of its Subsidiaries to use such
Company Intellectual Property.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;To the Knowledge of the Company, no Person is infringing, misappropriating, diluting, or
otherwise violating any material Company Intellectual Property, and since October&nbsp;11, 2008, no such
claims have been asserted in writing or, to the Knowledge of the Company, threatened in writing
against any Person by the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;As of the date hereof, (i)&nbsp;none of the Company Intellectual Property that consists of
Patents, Trademarks, and Copyrights and is listed on Section&nbsp;4.16(a) of the Company Disclosure
Schedule (the &#147;<B>Company Patents, Trademarks, and Copyrights</B>&#148;) is the subject of any pending
litigation, reissue, interference, reexamination, or opposition proceeding that has been served
upon, or for which written notice has been provided to, the Company or its Subsidiaries, (ii)&nbsp;the
Company and its Subsidiaries have not received any written notice within the two (2)&nbsp;year period
occurring immediately prior to the date hereof that any of the foregoing will hereafter be
commenced, and (iii)&nbsp;to the Knowledge of the Company, the Company Patents, Trademarks, and
Copyrights have been prosecuted in compliance in all material respects with all applicable Laws.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;To the Knowledge of the Company, no funding, facilities, or personnel of any Governmental
Authority anywhere in the world were used, directly or indirectly, to develop or create in whole or
in part, any material Company Intellectual Property, except for the use of any of such funding,
facilities or personnel that would not reasonably be expected, individually or in the aggregate, to
be material to the Company and its Subsidiaries, taken as a whole, with
respect to the ownership or other rights of the Company and its Subsidiaries in or to the
Company Intellectual Property, taken as a whole.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;To the Knowledge of the Company, all current employees of the Company and its Subsidiaries
who have contributed in any material respect to the creation or development of any Company
Intellectual Property have been advised of, and consented to comply with, the Company policy as set
out in the Company Employee Handbook, regarding the assignment to the Company or any of its
Subsidiaries of any Intellectual Property arising or resulting from services performed for or on
behalf of the Company or its Subsidiaries by such Persons during or in the scope of their
employment. To the Knowledge of the Company, all consultants and
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->-28-<!-- /Folio -->
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">independent contractors of the Company or its Subsidiaries who have contributed in any material respect to the creation or
development of any Company Intellectual Property have entered into written agreements requiring
such consultants and independent contractors either (i)&nbsp;to assign their rights, title and interests
to such Company Intellectual Property to the Company or any of its Subsidiaries, or (ii)&nbsp;to
authorize either the Company or its Subsidiary to use such Company Intellectual Property in the
manner intended by the Company or such Subsidiary. To the Knowledge of the Company, no current or
former employee, officer, director, consultant, or independent contractor of the Company or its
Subsidiaries owns, or since October&nbsp;11, 2008, has claimed in a writing addressed to the Company or
any Subsidiary, any rights in any material Company Intellectual Property.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;The Company and its Subsidiaries have used commercially reasonable efforts to protect the
secrecy and confidentiality of the Company&#146;s and its Subsidiaries&#146; material Trade Secrets that are
owned by the Company or its Subsidiaries, or co-owned or jointly-owned by them with any third
parties. To the Knowledge of the Company, all current and former employees of the Company and its
Subsidiaries with access to the Company&#146;s and its Subsidiaries&#146; material Trade Secrets that are
owned by the Company or its Subsidiaries, or co-owned or jointly-owned by them with any third
parties have been advised of, and consented to comply with, the Company policy as set out in the
Company Employee Handbook regarding maintaining the confidentiality of such Trade Secrets of the
Company and its Subsidiaries and not using such Trade Secrets except as authorized by the Company
or any of its Subsidiaries. To the Knowledge of the Company, none of such current or former
employees, officers, or directors is in violation of such confidentiality policy, except for
violations that would not reasonably be expected, individually or in the aggregate, to be material
to the Company and its Subsidiaries, taken as a whole. To the Knowledge of the Company, all
consultants and independent contractors of the Company or its Subsidiaries who have access to or
use any material Trade Secrets that are owned by the Company or its Subsidiaries, or co-owned or
jointly-owned by them with any third parties have entered into written agreements regarding
maintaining the confidentiality of such Trade Secrets of the Company and its Subsidiaries and not
using such Trade Secrets except as authorized by the Company or any of its Subsidiaries.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)&nbsp;The Company and its Subsidiaries have used commercially reasonable efforts to (i)&nbsp;protect
from unauthorized disclosure all personally identifiable information of employees and any Third
Parties (including participants in clinical trials) that they own or control, and (ii)&nbsp;protect from
unauthorized disclosure by the Company or its Subsidiaries, or their respective employees acting
within the scope of their employment, all personally identifiable information of employees and any
Third Parties (including participants in clinical trials) that they have access to, including (for both (i)&nbsp;and (ii)&nbsp;herein) (x)&nbsp;complying with their own internal
policies and procedures, and (y)&nbsp;to the Knowledge of the Company, complying in all material
respects with all applicable Laws (if any) relating to such personally identifiable information.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k)&nbsp;To the Knowledge of the Company, the Company&#146;s and its Subsidiaries&#146; computers, computer
software, firmware, middleware, user interface, source code, object code, algorithms, databases,
servers, workstations, tools, routers, hubs, switches, data communications lines, and all other
information technology equipment (the &#147;<B>IT Assets</B>&#148; ) (x)&nbsp;operate and perform in all material
respects as necessary to their business and operations as presently conducted, except for those
failures to operate or perform that would not reasonably be expected, individually or in the
aggregate, to have a Company Material Adverse Effect; and (y)&nbsp;have not materially failed within the
past two years, except for those failures that would not reasonably be expected,
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->-29-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">individually or in the aggregate, to have a Company Material Adverse Effect. To the Knowledge of the Company, no
person has gained unauthorized access to the IT Assets, except where the unauthorized access would
not reasonably be expected, individually or in the aggregate, to have a Company Material Adverse
Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l)&nbsp;To the Knowledge of the Company, the Company does not own any material proprietary
software, including object code and source code, that are used in or necessary for use in the
Company&#146;s business or operations. The Company has implemented commercially reasonable backups and
security measures to duplicate, store, and protect its material information that is stored in
electronic form or media.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m)&nbsp;Notwithstanding any other provision of this Agreement, this <U>Section&nbsp;4.16</U> sets
forth the sole and exclusive representations and warranties of the Company with respect to Company
Intellectual Property.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.17 <U>Taxes</U>. (a)&nbsp;The Company and each of its Subsidiaries have timely filed (or caused to
be timely filed) all material Tax Returns required to be filed by them, which Tax Returns are true
and complete in all material respects, and have paid (or caused to be paid) all material amounts of
Taxes required to be paid by them (whether or not shown to be payable on such Tax Returns and
including any assessed deficiency resulting from an audit, examination or other proceeding with
respect to a material amount of Taxes), other than any such Taxes for which adequate reserves have
been established, in accordance with GAAP, on the consolidated financial statements included in the
most recent Company SEC Documents. The Company and each of its Subsidiaries have withheld and paid
over to the appropriate Governmental Authorities all material amounts of Taxes required to have
been withheld and paid over by them, and have complied in all material respects with all
information reporting and backup withholding requirements in connection with amounts paid or owing
to any employee, creditor, independent contractor or other Person. No audit, examination or other
proceeding is pending against the Company or any of its Subsidiaries for any alleged deficiency
involving a material amount of Taxes, and neither the Company nor any of its Subsidiaries has been
notified of any such potential audit, examination or other proceeding. Neither the Company nor any
of its Subsidiaries has executed a waiver or extension of any applicable statute of limitations to
assess any amount of Taxes. There are no outstanding requests by the Company or any of its
Subsidiaries for any extension of time within which to file any material Tax Return or within which
to pay any material amount of Taxes. There are no Liens for Taxes with respect to any
assets of the Company or any of its Subsidiaries, other than any statutory Liens for Taxes not
yet due and payable for which adequate reserves have been established, in accordance with GAAP, on
the consolidated financial statements included in the most recent Company SEC Documents. The
relevant statute of limitations is closed with respect to the federal and material state and local
(and, to the Knowledge of the Company, material foreign) income and franchise Tax Returns of the
Company and each of its Subsidiaries for all taxable periods through December&nbsp;31, 2004.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Neither the Company nor any of its Subsidiaries will be required to include a material
item of income in, or exclude a material item of deduction from, taxable
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-30-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">income for any taxable period (or portion thereof) ending after the Closing as a result of any: (i)&nbsp;change in method of
accounting for a taxable period ending on or prior to the Closing; (ii) &#147;closing agreement&#148; as
described in Section&nbsp;7121 of the Code (or any comparable or similar provisions of applicable Law)
executed on or prior to the Closing; (iii)&nbsp;election pursuant to Section 108(i) of the Code made
effective on or prior to the Closing; (iv)&nbsp;intercompany transaction or excess loss account
described in Treasury Regulations under Section&nbsp;1502 of the Code (or any comparable or similar
provisions of applicable Law); (v)&nbsp;installment sale or open transaction disposition made on or
prior to the Closing; or (vi)&nbsp;prepaid amount received on or prior to the Closing. During the
preceding three (3)&nbsp;years, no claim has been made by a Governmental Authority in the United States
and, to the Knowledge of the Company, in a foreign jurisdiction, in either case, where none of the
Company or any of its Subsidiaries files Tax Returns that the Company or its Subsidiary, as
applicable, is or may be liable for a material amount of income or franchise Taxes in that
jurisdiction, which Taxes have not been paid or adequately reserved for, in accordance with GAAP,
on the consolidated financial statements included in the most recent Company SEC Documents.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Neither the Company nor any of its Subsidiaries is (or has been) included in any
affiliated, consolidated, combined or unitary group, other than any such group for which the
Company, any Subsidiary or any predecessor of any Subsidiary, as applicable, is or was the common
parent. Neither the Company nor any of its Subsidiaries has any actual or potential liability for
Taxes of any Person other than the Company or any of its Subsidiaries (i)&nbsp;under Treasury Regulation
Section&nbsp;1.1502-6 (or any comparable or similar provisions of applicable Law, including any
arrangement for group or consortium relief), (ii)&nbsp;as a transferee or successor, (iii)&nbsp;by contract
or (iv)&nbsp;otherwise. Neither the Company nor any of its Subsidiaries is a party to (or is bound by)
any Tax sharing, allocation or indemnity agreement or any similar agreement, arrangement or
practice with respect to Taxes. No power of attorney with respect to a material amount of Taxes
has been executed or filed with any Governmental Authority by or on behalf of the Company or any of
its Subsidiaries, which power of attorney remains in effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;The current liability with respect to unpaid Taxes of the Company and each of its
Subsidiaries as of the date of the most recent Company SEC Documents does not, in the aggregate,
exceed by a material amount the amount of the current liability accruals with respect to Taxes
(excluding reserves for deferred Taxes) reflected on the consolidated financial statements included
in the most recent Company SEC Documents. The consolidated financial statements of the Company
comply with the requirements of the Financial Accounting Standards Board (&#147;<B>FASB</B>&#148;) Interpretation
No.&nbsp;48 (Accounting for Uncertainty in Income Taxes), as codified in FASB SAC 740 (&#147;<B>FIN 48</B>&#148;). Since
the date of the most recent Company SEC Documents, neither the Company nor any of its Subsidiaries has incurred any
liability with respect to Taxes arising from extraordinary gains or losses (within the meaning of
GAAP) outside the ordinary course of business in accordance with past custom and practice. The
Company has authorized Parent to access the work papers of the outside auditors of the Company and
its Subsidiaries with respect to (i)&nbsp;the components of the accrual for deferred Taxes contained on
the consolidated financial statements included in the most recent Company SEC Documents and (ii)
compliance with FIN 48.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Except as would not be reasonably expected to have, individually or in the aggregate, a
Company Material Adverse Effect, (i)&nbsp;all transactions between and among the
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-31-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Company and any of its Subsidiaries have been made at arm&#146;s length for all applicable Tax purposes, and (ii)&nbsp;the Company
and each of its Subsidiaries have satisfied the documentation requirements for all transfer pricing
arrangements for purposes of Section&nbsp;482 of the Code (and any comparable or similar provisions of
applicable Law). Neither the Company nor any of its Subsidiaries has a material amount of deferred
gain or loss arising out of any deferred intercompany transactions (as described in Treasury
Regulation&nbsp;Section&nbsp;1.1502-13). The Company has made available to Parent true and complete copies
of (i)&nbsp;all material Tax Returns (including amendments) of the Company and each of its Subsidiaries
for all taxable periods for which the applicable statute of limitations has not yet expired; (ii)
all material Tax rulings, revenue agent reports, settlement agreements, and &#147;closing agreements&#148; as
described in Section&nbsp;7121 of the Code (or any comparable or similar provisions of applicable Law)
submitted by, received by or agreed to by or on behalf of the Company or any of its Subsidiaries
for all taxable periods for which the applicable statute of limitations has not yet expired; and
(iii)&nbsp;all schedules identifying each Tax exposure that the Company or any of its Subsidiaries has
recognized in accordance with FIN 48 (or any comparable or similar provisions of applicable Law).
In the event Proposed Treasury Regulation&nbsp;Section&nbsp;1.6012-2 were finalized in its current form,
neither the Company nor any of its Subsidiaries would be required to disclose any items other than
those addressed in the schedules identified in clause (iii)&nbsp;of the immediately preceding sentence.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;Neither the Company nor any of its Subsidiaries is a party to any &#147;reportable transaction&#148;
as defined in Treasury Regulation&nbsp;Section&nbsp;1.6011-4 (or, to the Knowledge of the Company, any
comparable or similar provisions of applicable Law). Neither the Company nor any of its
Subsidiaries has constituted (or will constitute) a &#147;distributing corporation&#148; or a &#147;controlled
corporation&#148; (in each case, within the meaning of Section&nbsp;355(a)(1) of the Code) in the three (3)
years prior to the Closing. Neither the Company nor any of its Subsidiaries has filed an Internal
Revenue Service Form&nbsp;8832 or otherwise elected to change its classification for federal income Tax
purposes.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.18 <U>Employee Benefit Plans</U>. (a)&nbsp;Section&nbsp;4.18(a) of the Company Disclosure Schedule
contains a true and complete list, as of the date hereof, of each material deferred compensation,
incentive compensation, sales incentive, stock purchase, stock option and other equity or
equity-based compensation plan, program, agreement or arrangement; each severance or termination
pay, medical, surgical, hospitalization, disability, Section&nbsp;125 flexible benefit, life insurance,
retiree health insurance, retiree life insurance, and other &#147;welfare&#148; plan, fund or program (within
the meaning of Section&nbsp;3(1) of ERISA; each retirement, defined benefit pension, savings, individual
account based savings, supplemental retirement plan, profit-sharing, stock bonus or other &#147;pension&#148;
plan, fund or program (within the meaning of Section&nbsp;3(2) of ERISA); each fringe benefit, bonus, employment, consulting, retention, change in control,
termination or severance plan, program, fund, agreement or arrangement; and each other material
employee benefit plan, fund, program or agreement or arrangement, in each case, whether oral or
written, whether or not subject to ERISA, that is, in each case, sponsored, maintained or
contributed to or required to be contributed to by the Company, any of its Subsidiaries or its or
their ERISA Affiliates, or to which the Company, any of its Subsidiaries or any of its or their
ERISA Affiliates is party, for the benefit of any director, employee, consultant, or independent
contractor or former director, employee, consultant or independent contractor of the Company or any
of its Subsidiaries or with respect to which the Company or any of its Subsidiaries has or
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->-32-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">could have any liability, contingent or otherwise, including as a result of its or their ERISA
Affiliates, other than a Foreign Plan (as defined in <U>Section&nbsp;4.18(k)</U>) (the &#147;<B>Company
Plans</B>&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;With respect to each Company Plan, the Company has made available to Parent true and
complete copies of (i)&nbsp;each Company Plan and any amendments thereto, (ii)&nbsp;the most recent summary
plan descriptions with respect to each Company Plan, to the extent applicable, (iii)&nbsp;any related
trust or other funding vehicle, (iv)&nbsp;the most recent Form&nbsp;5500 and (v)&nbsp;the most recent
determination or opinion letter received from the Internal Revenue Service with respect to each
Company Plan intended to qualify under Section&nbsp;401 of Code. Each Company Plan intended to be
&#147;qualified&#148; within the meaning of Section 401(a) of the Code has been determined by the Internal
Revenue Service to be so qualified or, if no such determination has been made, an application for
such determination is pending with the Internal Revenue Service. Nothing has occurred with respect
to the operation of each such Company Plan which would reasonably be expected to cause the loss of
such qualification or exemption or the imposition of any material liability, penalty or tax under
ERISA or under the Code.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;No Company Plan is a &#147;multiemployer plan,&#148; as such term is defined in Section&nbsp;3(37) of
ERISA, nor is any Company Plan subject to Section&nbsp;302 or Title IV of ERISA or Section&nbsp;412 of the
Code. There are no material unfunded liabilities (as defined in Section&nbsp;4001(a)(17) of ERISA) of
any Company Plan subject to Title IV of ERISA, Section&nbsp;302 of ERISA or Section&nbsp;412 of the Code, for
which any of Parent, the Company, the Surviving Company or any of its or their Subsidiaries or its
or their ERISA Affiliates, could reasonably be expected to incur liability under Title IV of ERISA,
Section&nbsp;302 of ERISA or Section&nbsp;412 of the Code. No liability under Title IV, Section&nbsp;302 of ERISA
or Section&nbsp;412 of the Code has been incurred by the Company, any of its Subsidiaries or any of its
or their ERISA Affiliates that has not been satisfied in full, and no condition exists that
presents a risk to Parent, Company, the Surviving Company, any of its or their Subsidiaries or any
of its or their ERISA Affiliates of incurring any such liability, other than liability for premiums
due the Pension Benefit Guaranty Corporation arising in the ordinary course (which premiums have
been paid when due) and other than liabilities that would not reasonably be expected, individually
or in the aggregate, to be material to the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Neither the Company, any of its Subsidiaries nor any of its or their ERISA Affiliates
have, within the six (6)&nbsp;years immediately preceding the date of this Agreement, withdrawn or
partially withdrawn from any &#147;multiemployer plan,&#148; as such term is defined in Section&nbsp;3(37) of
ERISA. Neither the Company, any of its Subsidiaries nor any of its or their ERISA Affiliates have,
within the past twelve (12)&nbsp;months, received written notice from any &#147;multiemployer plan&#148; (as such term is defined in Section&nbsp;3(37) of ERISA) that it is in
reorganization or is insolvent, that increased contributions may be required to avoid a reduction
in plan benefits or the imposition of any excise Tax, or that such plan intends to terminate or has
terminated.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Each Company Plan has been drafted, operated and administered in all material respects in
accordance with its terms and the requirements of all applicable Laws, including but not limited to
ERISA and the Code, except that, with respect to any Company Plan acquired in connection with the
acquisition of Alpharma, Inc., to the Knowledge of the Company, each such plan has been drafted,
operated and administered in all material respects in
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-33-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">accordance with its terms and the requirements of all applicable Laws, including but not limited to ERISA and the Code.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;Except to the extent required by Section&nbsp;4980B of the Code, no Company Plan provides
medical, surgical, hospitalization, death or similar benefits (whether or not insured) for
directors, consultants, independent contractors, employees or former directors, consultants,
independent contractors, or employees of the Company or any of its Subsidiaries for periods
extending beyond the last day of the month of their retirement or other termination of service. No
Company Plan is funded, in whole or in part, through a voluntary employee&#146;s beneficiary association
exempt from taxation under Section&nbsp;501(c)(9) of the Code.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;Neither the execution or delivery of this Agreement nor the consummation of the Merger
will, either alone or in conjunction with any other event, (i)&nbsp;entitle any current or former
director, employee, consultant or independent contractor of the Company or any of its Subsidiaries
to severance pay or any other payment, except as expressly provided in this Agreement, (ii)
increase the amount or value of any benefit or compensation otherwise payable or required to be
provided to any such director, employee, consultant or independent contractor, or (iii)&nbsp;accelerate
the time of payment or vesting of compensation due any such director, employee, consultant or
independent contractor. No payment or benefit paid or provided, or to be paid or provided, whether
contingent or otherwise, to current or former employees, directors or other service providers of or
to the Company or any of its Subsidiaries (including pursuant to this Agreement) will fail to be
deductible for federal income Tax purposes under Section&nbsp;280G of the Code. No Company Plan or
other agreement with any employee provides for a &#147;gross-up&#148; or similar payment in respect of any
Taxes that may become payable under Section&nbsp;409A or Section&nbsp;4999 of the Code.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;Within the three (3)&nbsp;years immediately preceding the date of this Agreement, neither the
Company nor any of its Subsidiaries have made any payments that have, or has been or is a party to
any agreement, contract, arrangement or plan that have resulted, or will result, separately or in
the aggregate, in the payment of any compensation which would be subject to the deduction limit
imposed by Code Section&nbsp;162(m).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;There are no pending Actions, or to the Knowledge of the Company, threatened Actions,
audits or investigations against any Company Plan, the assets of any of the trusts under such plans
or the plan sponsor or the plan administrator, or against any fiduciary of any Company Plans, or
otherwise involving any Company Plan (other than routine claims for benefits).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)&nbsp;All contributions, premiums and benefit payments under or in connection with the Company
Plans required to have been made under the terms of any Company Plan or pursuant to ERISA, the Code
and applicable Law have been timely made in all material respects and all obligations in respect of
each Company Plan, including, with respect to any period on or before the Acceptance Time, have
been properly accrued and reflected in the Company SEC Documents.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k)&nbsp;To the Company&#146;s Knowledge, Section&nbsp;4.18(k) of the Company Disclosure Schedule contains a
true and complete list, as of the date hereof, of each Foreign
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->-34-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Plan. The term &#147;<B>Foreign Plan</B>&#148; shall mean (i)&nbsp;any material plan that would be a Company Plan under <U>Section&nbsp;4.18(a)</U> except for
the fact that it is maintained, sponsored or contributed to primarily for the benefit of any
director, employee, consultant, or independent contractor or former director, employee, consultant
or independent contractor of the Company or any of its Subsidiaries or with respect to which the
Company or any of its Subsidiaries has or could have any liability, contingent or otherwise, as a
result of its or their ERISA Affiliates who are or were providing services outside the United
States and (ii)&nbsp;any plan that would be a Company Plan except for the fact that it is subject to
any Law other than U.S. federal, state or local Law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.19 <U>Employment Matters</U>. (a)&nbsp;Section&nbsp;4.19(a) of the Company Disclosure Schedule contains
a true and complete table listing the number of employees employed by the Company and its
Subsidiaries as of August&nbsp;31, 2010 in each jurisdiction (by locality) in which the Company and/or
its Subsidiaries regularly conduct business. Neither the Company nor any of its Subsidiaries is a
party to any collective bargaining agreements or any other labor-related agreements with any labor
union, labor organization or works council (&#147;<B>Collective Bargaining Agreements</B>&#148;), and no employees
of the Company or any of its Subsidiaries are represented by any labor union, labor organization or
works council in connection with their employment with the Company or any Subsidiary. There are no
labor representation proceedings or petitions seeking a labor representation proceeding presently
pending before the National Labor Relations Board or any other labor relations tribunal or any
other Governmental Authority. To the Knowledge of the Company, there are no organizational
campaigns, petitions or other activities or proceedings of any labor union, workers&#146; council or
labor organization seeking recognition of a collective bargaining unit with respect to, or
otherwise attempting to represent, any of the employees of the Company or any of its Subsidiaries
or compel the Company or any of its Subsidiaries to bargain with any such labor union, works
council or labor organization; there are no strikes, slowdowns, walkouts, work stoppages or other
labor-related controversies pending or, to the Knowledge of the Company threatened; and neither the
Company nor any of its Subsidiaries has experienced any such strike, slowdown, walkout, work
stoppage or other labor-related controversy within the past three (3)&nbsp;years.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Within the past eighteen (18)&nbsp;months, neither the Company nor any of its Subsidiaries has
failed to provide advance notice of layoffs or terminations as required by the Worker Adjustment
and Retraining Notification Act or any state or local Laws, or any applicable Law for employees
outside the United States, regarding the termination or layoff of employees or has incurred any
liability or obligation which remains unsatisfied under such Laws.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;The Company and its Subsidiaries are in compliance in all material respects with all
applicable Laws relating to the employment of labor (including, employment or labor standards,
labor relations, occupational health and safety, human rights, workers&#146; compensation, severance
payment, employment equity, pay equity, wage, hour and medical leave). No material claim with
respect to payment of wages, salary or overtime pay is now pending or, to the Knowledge of the
Company, threatened against the Company or any of its Subsidiaries, before any Governmental
Authority, and there is no material charge or material proceeding before any Governmental Authority
with respect to a violation of any occupational safety or health standards that is now pending or,
to the Knowledge of the Company, threatened against the Company or any of its Subsidiaries.
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->-35-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;As of October&nbsp;1, 2010, no current employee of the Company or any of its Subsidiaries at
the vice president-level or above has given written notice to the Company or any of its
Subsidiaries that any such employee intends to terminate his or her employment with the Company or
any of its Subsidiaries.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.20 <U>Environmental Matters</U>. (a)&nbsp;Except as would not be reasonably expected to have,
individually or in the aggregate, a Company Material Adverse Effect:
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) to the Knowledge of the Company, there is no pending or threatened Environmental
Claim or Environmental Liability regarding the Company or any of its Subsidiaries or any
property currently, or formerly owned, operated or leased by the Company or its
Subsidiaries;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) with respect to real property that is currently owned, leased or operated by the
Company and its Subsidiaries, and to the Knowledge of the Company, with respect to real
property that was formerly owned, leased or operated by the Company or any of its
Subsidiaries, there have been no releases, spills or discharges of Hazardous Materials at or
from any of such real properties that has caused environmental contamination at any location
that is reasonably likely to result in an obligation of the Company or any Subsidiary to
investigate or remediate such environmental contamination pursuant to applicable
Environmental Law or contractual agreement or otherwise result in any Environmental Claim or
Environmental Liability;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) neither (i)&nbsp;the Company or any Subsidiary thereof, (ii)&nbsp;nor to the Knowledge of
the Company, any predecessors of the Company or any Subsidiary thereof, (iii)&nbsp;nor to the
Knowledge of the Company any entity previously owned by the Company or any Subsidiary
thereof, has transported or arranged for the treatment, storage, handling, disposal or
transportation of any Hazardous Material at or to any third-party location that is
reasonably likely to result in an Environmental Claim or Environmental Liability;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) none of the Owned Real Property or Leased Real Property has any pending
obligations pursuant to the New Jersey Industrial Site Recovery Act N.J.S.A. 13:1K-6, et
seq. (&#147;<B>ISRA</B>&#148; ), as a result of entering or consummating this Agreement none of the Owned
Real Property or Leased Real Property will be subject to any ISRA obligations, and neither
the Company nor any Subsidiary thereof has any pending or, to the Knowledge of the Company, foreseeable obligations pursuant to ISRA
in regard to any property;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) neither the Company nor any Subsidiary thereof has, either expressly or by
operation of applicable Law, assumed or undertaken, or agreed to assume or undertake,
responsibility for any liability or obligation of any other Person arising under or relating
to Environmental Laws;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) to the Knowledge of the Company, the Company has provided Parent with (a)
environmental site assessments and substantially similar evaluations reasonably available
and in its possession respecting material environmental conditions at currently
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-36-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">owned and leased properties; and (b)&nbsp;the most recent written compliance audit reasonably available in
its possession for current operating industrial facilities; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii) to the Knowledge of the Company, there are no other activities, conditions or
circumstances, that would be reasonably likely to result in any material Environmental Claim
or Environmental Liability.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Except as would not be reasonably expected to be, individually or in the aggregate,
material to the Company and its Subsidiaries, taken as a whole, to the Knowledge of Company, the
Company and each of its Subsidiaries are, and for the past five years have been, in compliance with
all Environmental Laws (which compliance includes, but is not limited to, possession of all Permits
required under applicable Environmental Laws, and compliance with the terms and conditions
thereof).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Notwithstanding any other provision of this Agreement, this <U>Section&nbsp;4.20</U> sets
forth the sole and exclusive representations and warranties of the Company with respect to
Environmental Laws, Hazardous Materials and other environmental matters.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.21 <U>Regulatory Matters</U>. (a)&nbsp;Each of the Company and its Subsidiaries (or their
respective agents) has all material licenses, permits, franchises, variances, registrations,
exemptions, Orders and other governmental authorizations, consents, approvals and clearances, and
has submitted notices to, all Governmental Authorities, including, but not limited to, all
authorizations and registrations under the Federal Food, Drug and Cosmetic Act of 1938, as amended
(the &#147;<B>FDCA</B>&#148;), the Public Health Service Act of 1944, as amended (the &#147;<B>PHSA</B>&#148;), and the regulations
of the United States Food and Drug Administration (the &#147;<B>FDA</B>&#148;) promulgated thereunder, the Federal
Controlled Substances Act of 1970 and the regulations of the U.S. Drug Enforcement Administration
(the &#147;<B>DEA</B>&#148;) promulgated thereunder and all state controlled substance Laws and regulations and any
other Governmental Authority that is concerned with the quality, identity, strength, purity,
safety, efficacy, use, manufacturing, advertising, distribution and sale of the Company Products
(any such Governmental Authority, a &#147;<B>Company Regulatory Agency</B>&#148;) necessary for the Company or any
such Subsidiary to own, lease and operate its properties or other assets and to carry on and
operate its respective businesses as currently conducted (the &#147;<B>Company Permits</B>&#148;), and, except as
has not been and would not reasonably be expected to be, individually or in the aggregate, material
to the Company and its Subsidiaries, taken as a whole, all such Company Permits are valid, and in full force and effect. There has occurred no violation of, default
(with or without notice or lapse of time or both) under, or event giving to others any right of
termination, amendment or cancellation of, with or without notice or lapse of time or both, any
Company Permit, except as have not been and would not reasonably be expected to be, individually or
in the aggregate, material to the Company and its Subsidiaries, taken as a whole. The Company and
each of its Subsidiaries are in compliance in all material respects with the terms of all Company
Permits.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Since January&nbsp;1, 2008, all of the Company Products that are subject to the jurisdiction of
the FDA, DEA or any other Company Regulatory Agency are being manufactured, imported, exported,
processed, developed, labeled, stored, tested, marketed, advertised, promoted, detailed and
distributed by or, to the Knowledge of the Company, on behalf of the Company or its Subsidiaries in
compliance in all material respects with all
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->-37-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">applicable requirements under any Company Permit or Laws, including applicable statutes and implementing regulations administered or enforced by the
FDA, DEA or other Company Regulatory Agency, including those relating to investigational use,
premarket approval and applications or abbreviated applications to market a new Company Product, or
adopt or use a new Trademark.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Since January&nbsp;1, 2008, all preclinical studies and clinical trials, and other studies and
tests conducted by or, to the Knowledge of the Company, on behalf of the Company or any of its
Subsidiaries have been, and if still pending are being, conducted in compliance with all applicable
Laws, including, but not limited to, the FDCA and its applicable implementing regulations at 21
C.F.R. Parts 50, 54, 56, 58 and 312, except where such noncompliance has not been and would not
reasonably be expected to be, individually or in the aggregate, material to the Company and its
Subsidiaries, taken as a whole. Since January&nbsp;1, 2008, no clinical trial conducted by or, to the
Knowledge of the Company, on behalf of the Company or any of its Subsidiaries has been terminated
or suspended prior to completion for safety or other non-business reasons, and neither the FDA nor
any other applicable Company Regulatory Agency, clinical investigator that has participated or is
participating in, or institutional review board that has or has had jurisdiction over, a clinical
trial conducted by or, to the Knowledge of the Company, on behalf of the Company or any of its
Subsidiaries has commenced, or, to the Knowledge of the Company, threatened to initiate, any action
to place a clinical hold order on, or otherwise terminate, materially delay or suspend, any ongoing
clinical investigation conducted by or, to the Knowledge of the Company, on behalf of the Company
or any of its Subsidiaries.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Since January&nbsp;1, 2008, neither the Company nor any of its Subsidiaries has had any Company
Product or manufacturing site (whether Company-owned or that of a contract manufacturer for Company
Products) subject to a Company Regulatory Agency (including FDA and DEA) shutdown or import or
export prohibition, nor received any FDA Form&nbsp;483 or other Company Regulatory Agency written notice
of material inspectional observations, &#147;warning letters,&#148; &#147;untitled letters&#148; or written requests to
make material changes, in each case as it applies to the Company Products or any of the Company&#146;s
manufacturing or distribution processes or procedures that if not complied with has not, and would
not reasonably be expected, individually or in the aggregate, to have a Company Material Adverse
Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Section&nbsp;4.21(e) of the Company Disclosure Schedule sets forth a list, as of the date
hereof, of all recalls, field notifications, market withdrawals or replacements, written warnings,
&#147;dear doctor&#148; letters, investigator notices, safety alerts, post-approval &#147;serious adverse event&#148;
reports or other material written notice of action relating to an alleged lack of safety or
regulatory compliance of the Company Products issued by the Company and/or any of its Subsidiaries
since January&nbsp;1, 2008 (&#147;<B>Safety Notices</B>&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;Since January&nbsp;1, 2008, all manufacturing operations conducted by or, to the Knowledge of
the Company, for the benefit of the Company or any of its Subsidiaries have been conducted in
material compliance with applicable Laws, including the provisions of the FDA&#146;s current good
manufacturing practice regulations at 21 C.F.R. Parts 210-211 for Company Products sold in the
United States, and the respective counterparts thereof promulgated by Company Regulatory Agencies
in countries outside the United States, except where the failure to so comply has not been, and
would not reasonably be expected to be, individually or in the
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->-38-<!-- /Folio -->
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">aggregate, material to the Company
and its Subsidiaries, taken as a whole. There are no pending or, to the Knowledge of the Company,
threatened actions or proceedings by the FDA, DEA or any applicable foreign equivalent which would
prohibit or materially impede the sale of any product currently manufactured and/or sold by the
Company or any of its Subsidiaries into any market.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;Since January&nbsp;1, 2008, to the Knowledge of the Company, neither the Company, nor any of
its Subsidiaries, has committed any act, made any statement or failed to make any statement that
would reasonably be expected to provide a basis for the FDA or any other Company Regulatory Agency
to invoke its policy with respect to &#147;Fraud, Untrue Statements of Material Facts, Bribery, and
Illegal Gratuities&#148;, or similar policies, set forth in any applicable Laws. Since January&nbsp;1, 2008,
none of the Company, its Subsidiaries or, to the Knowledge of the Company, any of their respective
officers or key employees has been convicted of any crime or engaged in any conduct that has
resulted, or would reasonably be expected to result, in debarment under applicable Law, including,
without limitation, 21 U.S.C. Section&nbsp;335a. No Actions that would reasonably be expected to result
in such a material debarment are pending, and the Company has not received written notice that any
such Actions are threatened against the Company, its Subsidiaries, or any of their respective
officers or key employees.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;Each of the Company and its Subsidiaries, and to the Knowledge of the Company its
respective directors, officers, employees, and agents (while acting in such capacity) is, and at
all times has been in compliance with all Health Care Laws applicable to the Company or any of its
Subsidiaries or by which any or their respective properties, businesses, products or other assets
is bound or affected, including, to the extent applicable, the federal Anti-kickback Statute (42
U.S.C. &#167; 1320a-7b(b)), the Anti-Inducement Law (42 U.S.C. &#167; 1320a-7a(a)(5)), the civil False Claims
Act (31 U.S.C. &#167;&#167; 3729 et seq.), the administrative False Claims Law (42 U.S.C. &#167; 1320a-7b(a)), the
Health Insurance Portability and Accountability Act of 1996 (42 U.S.C. &#167; 1320d et seq.), the
exclusion Laws (42 U.S.C. &#167; 1320a-7), the Food Drug and Cosmetic Act (21 U.S.C. &#167;&#167; 301 et seq.),
the Controlled Substances Act (21 U.S.C. &#167;&#167; 801 et seq), the Medicare Program (Title XVIII of the
Social Security Act), the Medicaid Program (Title XIX of the Social Security Act), the regulations
promulgated pursuant to such Laws, requirements of the Medicaid Drug Rebate Program (42 U.S.C.
&#167; 1396r-8) and any state supplemental rebate
program, requirements of Medicare average sales price reporting (42 U.S.C. &#167; 1395w-3a), the
Public Health Service Act (42 U.S.C. &#167; 256b), the VA Federal Supply Schedule (38 U.S.C. &#167; 8126),
state pharmaceutical assistance programs and regulations under such Laws (collectively, &#147;<B>Health
Care Laws</B>&#148;), except for non-compliance that has not been and would not reasonably be expected to
be, individually or in the aggregate, material to the Company and its Subsidiaries, taken as a
whole. Since January&nbsp;1, 2008, none of the Company or any of its Subsidiaries has received any
written notification, written correspondence or any other written communication from any
Governmental Authority, including, without limitation, the FDA, the DEA, the Centers for Medicare
and Medicaid Services, and the Department of Health and Human Services Office of Inspector General,
specifically alleging material non-compliance by, or liability of, the Company or any of its
Subsidiaries, under any Health Care Laws.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;None of the Company or any of its Subsidiaries is a party to any corporate integrity
agreements, monitoring agreements, consent decrees, settlement orders, or other similar
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-39-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">written
agreements, in each case, entered into with or imposed by any Company Regulatory Agency, other than
any such agreement, decree or order that has been previously disclosed in any other filing with a
Company Regulatory Agency.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)&nbsp;Neither the Company nor any of its Subsidiaries has received any written notice from the
FDA, DEA or any other Governmental Authority that it has commenced, or threatened to initiate, any
action to withdraw approval, place sales or marketing restrictions on or request the recall of any
Company Product, or that it has commenced, or threatened to initiate, any action to enjoin or place
restrictions on the production of any Company Products.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k)&nbsp;As to the Company Products for which a biological license application, new drug
application, abbreviated new drug application, investigational new drug application or similar
state or foreign regulatory application has been approved, the Company and its Subsidiaries are in
compliance with 21 U.S.C. &#167;&#167; 355, Section&nbsp;351 of the PHSA or 21 C.F.R. Parts 312, 314, 600 or 601
et seq., respectively, and all applicable similar state and foreign regulatory requirements of any
Governmental Authority, and all terms and conditions of such licenses or applications, except for
any such failure or failures to be in compliance that have not been, and would not reasonably be
expected to be, individually or in the aggregate, material to the Company and its Subsidiaries,
taken as a whole. As to each drug for which the Company has material sales, the Company and any
relevant Subsidiary of the Company, and the officers, employees or agents of the Company and any
Subsidiary of the Company, have included in the application for such drug, where required, the
certification described in 21 U.S.C. &#167; 335a(k)(1) and the list described in 21 U.S.C. &#167; 335a(k)(2)
and each such certification and list was true and complete in all material respects when made. In
addition, the Company and each of its Subsidiaries is in compliance with all applicable
registration and listing requirements set forth in 21 U.S.C. &#167; 360 and 21 C.F.R. Part&nbsp;207, except
for failures to so comply that have not been, and would not reasonably be expected to be,
individually or in the aggregate, material to the Company and its Subsidiaries, taken as a whole.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l)&nbsp;Notwithstanding any other provision of this Agreement, this <U>Section&nbsp;4.21</U> sets
forth the sole and exclusive representations and warranties of the Company with respect to the
regulatory matters described in this <U>Section&nbsp;4.21</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.22 <U>Insurance</U>. (a)&nbsp;Except as would not reasonably be expected to be,
individually or in the aggregate, material to the Company and its Subsidiaries, taken as a whole,
each insurance policy under which the Company or any of its Subsidiaries is an insured or otherwise
the principal beneficiary of coverage (collectively, the &#147;<B>Insurance Policies</B>&#148;) is in full force and
effect and all related premiums have been paid to date.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The Company and its Subsidiaries are in compliance with the terms and conditions of the
Insurance Policies, except for any non-compliance as would not reasonably be expected, individually
or in the aggregate, to have a Company Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Except as has not, and would not reasonably be expected, individually or in the aggregate,
to have a Company Material Adverse Effect, neither the Company nor any of its Subsidiaries is in
breach or default (including any such breach or default with respect to the payment of premiums or
the giving of notice under any such policy) under any Insurance Policy,
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-40-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">and, to the Knowledge of
the Company, no event has occurred which, with notice or lapse of time, would constitute such
breach or default, or permit termination or modification, under such policy.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.23 <U>Brokers and Finder&#146;s Fees</U>. Except for Credit Suisse Securities (USA)&nbsp;LLC
(the &#147;<B>Company Financial Advisor</B>&#148;), the fees and expenses of which will be paid by the Company, no
broker, investment banker, financial advisor or other Person is entitled to any broker&#146;s, finder&#146;s,
financial advisor&#146;s or other similar fee or commission in connection with the Transactions based
upon arrangements made by or on behalf of the Company or any of its Subsidiaries. The Company has
heretofore made available to Parent the material terms of the engagement letter, including fees,
between the Company and the Company Financial Advisor pursuant to which such firm would be entitled
to any payment relating to the Transactions and any other transactions contemplated by this
Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.24 <U>Opinion of Financial Advisor</U>. The Company&#146;s Board of Directors has
received the opinion of the Company Financial Advisor, to the effect that, as of the date of the
opinion, and based upon and subject to the considerations, limitations and other matters set forth
therein, each of the Offer Price and the Merger Consideration to be received pursuant to this
Agreement by Company Shareholders is fair, from a financial point of view, to the Company
Shareholders.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.25 <U>Antitakeover Statutes</U>. The Company&#146;s Board of Directors has duly taken
all actions so that no &#147;fair price,&#148; &#147;moratorium,&#148; &#147;control share acquisition,&#148; &#147;interested
shareholder,&#148; &#147;business combination&#148; or other similar anti-takeover statute or regulation enacted
under state or federal Laws in the United States (including under the TBCA and the Tennessee
Business Combination Act) will prohibit the execution, delivery or performance of or compliance
with this Agreement or the Transactions.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.26 <U>Foreign Corrupt Practices and International Trade Practices</U>.
(a)&nbsp;To the Knowledge of the Company, neither the Company or its Subsidiaries, nor any of their
respective directors, officers, employees, agents, or representatives has directly or indirectly
offered or paid anything of value to a Foreign Official for the purpose of obtaining or retaining
business or securing an improper advantage.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;To the Knowledge of the Company, neither the Company or its Subsidiaries, nor any of their
respective directors, officers, employees, agents, or representatives has directly or indirectly
taken any action in violation of any export restrictions, anti-boycott regulations, embargo
regulations or other similar U.S. or foreign Laws. None of the Company&#146;s directors, officers, or,
to the Knowledge of the Company, employees, agents or representatives is a &#147;specially designated
national&#148; or blocked Person under U.S. sanctions administered by the Office of Foreign Assets
Control of the U.S. Department of the Treasury (&#147;<B>OFAC</B>&#148;). To the Knowledge of the Company, the
Company has not engaged in any business with any person or in any country that it is prohibited for
a U.S. Person to engage in any business with or in under U.S. sanctions administered by OFAC.
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->-41-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE V</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>REPRESENTATIONS AND WARRANTIES OF PARENT</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as disclosed in the disclosure letter delivered by Parent to the Company (the &#147;<B>Parent
Disclosure Letter</B>&#148;) simultaneously with the execution of this Agreement, Parent and Merger Sub
jointly and severally represent and warrant to the Company as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.01 <U>Organization, Standing and Corporate Power</U>. Each of Parent and Merger
Sub is a corporation duly organized, validly existing and in good standing (or equivalent status,
to the extent such concept exists) under the Laws of the state of its incorporation, formation or
organization, as the case may be, and has all requisite corporate power and authority to carry on
its business as now being conducted.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.02 <U>Corporate Authorization</U>. Each of Parent and Merger Sub has all necessary
corporate power and authority to execute and deliver this Agreement and all other agreements and
documents contemplated hereby to which each is a party and to perform their respective obligations
hereunder and to consummate the Transactions. The consummation by Parent of the Transactions has
been duly authorized by its Board of Directors. The execution, delivery and performance by Merger
Sub of this Agreement, and the consummation by Merger Sub of the Transactions, has been duly
authorized and adopted by its Board of Directors and approved by Parent (or one or more
subsidiaries of Parent) as the shareholder or shareholders of Merger Sub. Except for filing the
Articles of Merger with the Secretary of State of the State of Tennessee, no other corporate action
on the part of Parent and Merger Sub is necessary to authorize the execution, delivery and
performance by Parent and Merger Sub of this Agreement and the consummation by them of the
Transactions. This Agreement has been duly executed and delivered by Parent and Merger Sub and,
assuming due authorization, execution and delivery of this Agreement by the Company, constitutes a
legal, valid and binding obligation of each of Parent and Merger Sub, enforceable against each of
them in accordance with its terms (subject to the Bankruptcy and Equity Exception).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.03 <U>Governmental Authorization</U>. Except for (a)&nbsp;filings required under, and
compliance with other applicable requirements of, (i)&nbsp;the Exchange Act, and any other applicable
federal securities Laws (ii)&nbsp;state securities or &#147;blue sky&#148; Laws and (iii)&nbsp;the rules and
regulations of the NYSE, (b)&nbsp;the filing of the Articles of Merger with the Secretary of State
of the State of Tennessee pursuant to the TBCA, (c)&nbsp;compliance with the TBCA, or any
applicable Tennessee anti-takeover or investor protection statute and (d)&nbsp;filings required under,
and compliance with other applicable requirements of, the HSR Act or any foreign antitrust,
competition or similar Laws, no consents or approvals of, or filings with, any Governmental
Authority are necessary for the execution and delivery of this Agreement by Parent and Merger Sub
and the consummation by the Parent and Merger Sub of the Transactions, other than such other
consents, approvals or filings that, if not obtained, made or given, would not reasonably be
expected to have, individually or in the aggregate, a Parent Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.04 <U>No-Conflict</U>. Neither the execution and delivery of this Agreement by
Parent or Merger Sub, nor the consummation by Parent or Merger Sub of the Transactions, nor
compliance by Parent or Merger Sub with any of the provisions of this
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-42-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Agreement, will (a)&nbsp;conflict
with or violate the charter or by-laws (or similar documents) of Parent or Merger Sub, (b)&nbsp;assuming
that the consents, approvals and filings referred to in <U>Section&nbsp;5.03</U> are obtained and made,
violate any Restraint or Law applicable to Parent or any of its Subsidiaries (including Merger
Sub), or (c)&nbsp;violate, breach or constitute a default (or an event which, with the notice or lapse
of time, or both, would constitute a default) under any of the terms, conditions or provisions of
any Contract to which Parent, Merger Sub or any of their respective Subsidiaries is a party or to
which they may be bound, except in the case of clauses (b)&nbsp;and (c)&nbsp;for such violations, breaches or
defaults as would not reasonably be expected to have, individually or in the aggregate, a Parent
Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.05 <U>Ownership and Operations of Merger Sub</U>. Parent owns, and at the Effective
Time will own, beneficially and of record, all of the outstanding capital stock of Merger Sub
either directly or indirectly through one or more of its wholly-owned subsidiaries. Merger Sub was
formed solely for the purpose of engaging in the Transactions, has engaged in no other business
activities, has not incurred any material obligations or liabilities except pursuant to this
Agreement and has conducted its operations only as contemplated by this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.06
<U>Information Supplied</U>. (a)&nbsp;The information supplied by Parent, Merger
Sub for inclusion or incorporation by reference in the Schedule&nbsp;14D-9 will, at the time the
Schedule&nbsp;14D-9 is filed with the SEC, and at the time the Schedule&nbsp;14D-9 is first sent to the
Company Shareholders, not contain any untrue statement of material fact or omit to state any
material fact required to be stated therein or necessary to make the statements therein, in the
light of the circumstances under which they are made, not misleading.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The Offer Documents that will be provided to the Company Shareholders in connection with
the Offer will, when filed with the SEC, comply as to form in all material respects with the
applicable requirements of the Exchange Act and all other applicable Laws. The Offer Documents
will, at the time the Offer Documents are filed with the SEC or at the time the Offer Documents are
first sent to the Company Shareholders not contain any untrue statement of material fact or omit to
state any material fact required to be stated therein or necessary to make the statements therein,
in the light of the circumstances under which they are made, not
misleading; <u>provided</u>, <u>however</u>,
that no representation or warranty is made by Parent or Merger Sub with respect to information
supplied by the Company or any of their directors,
officers, employees, affiliates, agents or other representatives for inclusion or
incorporation by reference in the Offer Documents.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.07 <U>Brokers and Other Advisors</U>. Except for J.P. Morgan Securities LLC (the
&#147;<B>Parent Financial Advisor</B>&#148;), the fees and expenses of which will be paid by Parent, no broker,
investment banker, financial advisor or other Person is entitled to any broker&#146;s, finder&#146;s,
financial advisor&#146;s or other similar fee or commission, or the reimbursement of expenses, in
connection with the Transactions based upon arrangements made by or on behalf of Parent or any of
its Subsidiaries.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.08 <U>Sufficient Funds</U>. Parent&#146;s and Merger Sub&#146;s obligations hereunder are
not subject to any conditions regarding Parent&#146;s, Merger Sub&#146;s or any other Person&#146;s ability to
obtain financing for the Transactions. Parent and Merger Sub have, and will
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-43-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">have as of the
Acceptance Time and Effective Time and the Closing, sufficient cash available to pay all amounts to
be paid by Parent and Merger Sub in connection with this Agreement and the Transactions, including
Parent&#146;s and Merger Sub&#146;s costs and expenses, the aggregate Merger Consideration on the terms and
conditions contained in this Agreement, and there is no restriction on the use of such cash for
such purpose.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.09 <U>Company Stock</U>. (a)&nbsp;For purposes of the applicable provisions of the
TBCA and the Company Charter Documents, neither Parent nor Merger Sub, alone or together with any
other Person (i)&nbsp;is, nor at any time during the last three (3)&nbsp;years has it been, an &#147;interested
shareholder&#148; of the Company under the TBCA or Company Charter Documents or (ii)&nbsp;has taken any
action that would cause any anti-takeover statute under the TBCA to be applicable to this
Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Neither Parent nor Merger Sub nor any of their respective Affiliates beneficially owns (as
defined in Rule&nbsp;13d-3 under the Exchange Act), directly or indirectly, or is the record holder of,
and is not a party to any Contract for the purpose of acquiring, holding, voting or disposing of,
in each case, any shares of capital stock of the Company, except for any such shares that may be
owned by any employee benefit or other plan administered by or on behalf of Parent or any of its
Subsidiaries, to the extent the determination to acquire such shares was not directed by Parent or
Merger Sub.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE VI</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>COVENANTS</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.01 <U>Conduct of the Company</U>. (a)&nbsp;The Company covenants and agrees as to
itself and its Subsidiaries that, from the date of this Agreement until the earlier of the
Effective Time and termination of this Agreement in accordance with <U>Section&nbsp;8.01</U>, except as
(i)&nbsp;specifically permitted by any other provision of this Agreement (or as set forth in Section
6.01(a) of the Company Disclosure Schedule), (ii)&nbsp;required by applicable Law or the regulations or
requirements of any stock exchange or regulatory organization applicable to the Company or any of
its Subsidiaries or (iii)&nbsp;except with Parent&#146;s consent in writing, the business of the Company and
its Subsidiaries shall be conducted in the ordinary course consistent with the Company&#146;s past
practice and, to the extent consistent therewith, the Company and its Subsidiaries shall use their
respective commercially reasonable efforts to (w)&nbsp;preserve their assets, (x)&nbsp;keep available
the services of current officers, key employees and consultants of the Company and each of its
Subsidiaries, (y)&nbsp;preserve the Company&#146;s business organization intact and maintain its existing
relations and goodwill with customers, suppliers, distributors, creditors, lessors, consultants,
regulators, business partners, clinical trial investigators or managers of its clinical trials and
(z)&nbsp;comply in all material respects with applicable Law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Except as specifically permitted by any other provision of this Agreement (or as set forth
in Section&nbsp;6.01(b) of the Company Disclosure Schedule) or required by applicable Law or the
regulations or requirements of any stock exchange or regulatory organization applicable to the
Company, from the date of this Agreement until the earlier of the Effective Time and termination of
this Agreement in accordance with <U>Section&nbsp;8.01</U>, unless Parent otherwise consents in
writing, neither the Company nor any of its Subsidiaries shall:
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-44-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">





<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) amend the Company Charter Documents or other similar organizational documents;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) (A)&nbsp;issue, deliver, sell, grant, dispose of, pledge or otherwise encumber any
shares of capital stock of any class or any other ownership interest of the Company or any
of its Subsidiaries (the &#147;<B>Company Securities</B>&#148;), or any rights, warrants, options, calls,
commitments or any other agreements of any character to purchase or acquire any Company
Securities, or any securities or rights convertible into, exchangeable or exercisable for,
or evidencing the right to subscribe for, any Company Securities,
<u>provided</u> that the Company
may issue shares of Company Common Stock, solely upon the exercise or settlement of Company
Compensatory Awards that are outstanding on the date of this Agreement in accordance with
their terms as of the date of this Agreement or upon the exercise of the Top-Up Option, in
each case; (B)&nbsp;redeem, purchase or otherwise acquire any outstanding Company Securities, or
any rights, warrants, options, calls, commitments or any other agreements of any character
to acquire any Company Securities, except in connection with the exercise or settlement of
Company Compensatory Awards that are outstanding on the date of this Agreement and in
accordance with their terms as of the date of this Agreement and consistent with past
practice; (C)&nbsp;adjust, split, combine, subdivide or reclassify any Company Securities;
(D)&nbsp;enter into any Contract with respect to the sale, voting, registration or repurchase of
Company Common Stock, any other Company Securities or the capital stock of any Subsidiary of
the Company; or (E)&nbsp;except as required by the terms of this Agreement, amend (including by
reducing an exercise price or extending a term) or waive any of its rights under, or
accelerate the vesting under (except as required by the terms of the Company Stock Plan in
effect on the date of this Agreement), any provision of the Company Stock Plan or any
agreement evidencing any outstanding stock option or other right to acquire Company
Securities or any restricted stock purchase agreement or any similar or related contract;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) directly or indirectly acquire or agree to acquire in any transaction any Equity
Interest in, or business of, any firm, corporation, partnership, company, limited liability
company, trust, joint venture, association or other entity or division thereof or any
properties or assets (other than purchases of supplies and inventory in the ordinary
course of business consistent with past practice) if the aggregate amount of the
consideration paid or transferred by the Company and the Company&#146;s Subsidiaries in
connection with all such transactions would exceed $2,000,000;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) sell, pledge, dispose of, transfer, abandon, allow to lapse or expire, lease,
license, mortgage or otherwise encumber or subject to any Lien (including pursuant to a
sale-leaseback transaction or an asset securitization transaction) (other than a Permitted
Lien), any properties, rights or assets (including securities of the Company and the
Company&#146;s Subsidiaries, and the Company Intellectual Property) with a fair market value in
excess of $1,000,000 individually or $5,000,000 in the aggregate to any Person, except (A)
sales of inventory in the ordinary course of business consistent with past practices, (B)&nbsp;as
required to be effected prior to the Effective Time pursuant to Contracts in force on the
date of this Agreement and listed on Section&nbsp;6.01(b)(iv) of the Company Disclosure Schedule,
or (C)&nbsp;transfers among the Company and its Subsidiaries;
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-45-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) incur, create, assume or otherwise become liable for any Indebtedness for borrowed
money (including the issuance of any debt security and the assumption or guarantee of
obligations of any Person) (or enter into a &#147;keep well&#148; or similar agreement), including
through borrowings under any of the Company&#146;s existing credit facilities, or issue or sell
any debt securities or options, warrants, calls or other rights to acquire any debt
securities of the Company or any of its Subsidiaries, in each case in an amount in excess of
$2,000,000 in the aggregate;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) declare, set aside, make or pay any dividend or other distribution, whether
payable in cash, stock, property or otherwise, in respect of the Company Capital Stock;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii) (A)&nbsp;increase in any respect the compensation of any of its directors, officers or
employees, other than as required pursuant to applicable Law or the terms of Collective
Bargaining Agreements in effect on the date of this Agreement and listed in the Company
Disclosure Schedule (true and complete copies of which have been made available to Parent);
(B)&nbsp;grant any severance or termination benefits to any director, officer, employee,
independent contractor or consultant of the Company or any of its Subsidiaries, except as
required under the terms of any Company Plan or as required by applicable Law; (C)&nbsp;make any
new equity awards to any director, officer, employee or consultant of the Company or any of
its Subsidiaries; (D)&nbsp;take any action to accelerate the vesting or payment, or fund or in
any other way secure the payment of, compensation or benefits under any Company Stock Plan
or Company Plan to the extent not required by the terms of such Company Stock Plan or
Company Plan as in effect on the date of this Agreement; (E)&nbsp;enter into, establish, amend or
terminate any Company Plan, employment, retention or change in control agreement, Collective
Bargaining Agreements, bonus or other incentive compensation, profit sharing, health or
other welfare, stock option or other equity (or equity-based), pension, retirement,
vacation, severance, deferred compensation or other compensation or benefit plan, policy,
agreement, trust, fund or arrangement with, for or in respect of, any shareholder, director,
officer, other employee, consultant or Affiliate; or (F)&nbsp;change any actuarial or other
assumptions used to calculate funding obligations with respect to any Company Plan or
to change the manner in which contributions to such plans are made or the basis on
which such contributions are determined;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(viii) communicate in a writing that is intended for broad dissemination to the
Company&#146;s employees regarding compensation, benefits or other treatment they will receive in
connection with or following the Merger, unless any such communications are consistent with
prior directives or documentation provided to the Company by Parent (in which case, the
Company shall provide Parent with prior notice of and the opportunity to review and comment
upon any such communications);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ix) make any changes in financial accounting methods, principles or practices (or
change an annual accounting period), except insofar as may be required by GAAP, applicable
Law or regulatory guidelines;
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-46-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(x) write up, write down or write off the book value of any assets, in the aggregate,
in excess of $5,000,000, except in accordance with GAAP consistently applied;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xi) release, compromise, assign, settle or agree to settle any suit, action, claim,
proceeding or investigation (including without limitation any suit, action, claim,
proceeding or investigation relating to this Agreement or the Transactions), other than
compromises, settlements or agreements in the ordinary course of business consistent with
past practice that involve only the payment of monetary damages not in excess of $1,000,000
individually or $10,000,000 in the aggregate, in any case without the imposition of
equitable relief on, or the admission of wrongdoing by, the Company or any of its
Subsidiaries;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xii) (A)&nbsp;make, change or revoke any Tax election or adopt or change any method of Tax
accounting, (B)&nbsp;enter into any &#147;closing agreement&#148; as described in Section&nbsp;7121 of the Code
(or any comparable or similar provisions of applicable Law), settle or compromise any
liability with respect to Taxes or surrender any claim for a refund of Taxes, (C)&nbsp;file any
amended Tax Return, or (D)&nbsp;consent to any extension or waiver of the limitations period
applicable to any claim or assessment with respect of Taxes, in each case, to the extent
such action could materially affect Parent, the Company, or any of their Subsidiaries in a
taxable period (or portion thereof) ending after the Closing;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xiii) make or commit to any capital expenditures which (A)&nbsp;involve the purchase of
real property or (B)&nbsp;are not budgeted for in the Company&#146;s current annual capital plan, a
copy of which is in Section&nbsp;6.01(b)(xiii) of the Company Disclosure Schedule, having an
aggregate value in excess of $1,000,000;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xiv) (A)&nbsp;enter into or terminate any Material Contract (other than a confidentiality
agreement containing a standstill agreement as contemplated by <U>Section&nbsp;6.03</U>),
(B)&nbsp;materially modify, amend, waive any right under or renew any Material Contract, other
than (in the case of this clause (B)), in the ordinary course of business consistent with
past practice, (C)&nbsp;enter into or extend the term or scope of any Contract that purports to
restrict the Company, or any of its Subsidiaries or Affiliates or
any successor thereto, from engaging or competing in any line of business or in any
geographic area, or (D)&nbsp;enter into any Contract that would be breached by, or require the
consent of any Third Party in order to continue in full force following, consummation of the
Transactions;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xv) enter into any material joint venture, license, alliance, joint promotion,
co-marketing or development agreement or arrangement with any other Person, including with
respect to any products or products in development with any other Person;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xvi) fail to pay any required filing, prosecution, maintenance, or other fees, or
otherwise fail to make any document filings or payments required to maintain any material
Company Intellectual Property in full force and effect or to diligently prosecute
applications for registration of material Company Intellectual Property;
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-47-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xvii) announce, implement or effect any reduction in force, lay-off, early retirement
program, severance program or other program or effort concerning the termination of
employment of employees of the Company or any of its Subsidiaries, except in the ordinary
course of business and consistent with the Company&#146;s past practice;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xviii) make any investment (by contribution to capital, property transfers, purchase
of securities or otherwise) in, or loan or advance (other than travel and similar advances
to its employees in the ordinary course of business consistent with past practice) to, any
Person other than a direct or indirect wholly owned Subsidiary of the Company in the
ordinary course of business and consistent with the Company&#146;s past practice;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xix) hire or offer employment to any individual (other than with respect to employees
hired pursuant to offers of employment outstanding on the date hereof or with respect to
newly hired employees filling positions that are reasonably and in good faith deemed by the
Company to be essential and consistent with the Company&#146;s past practice;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xx) enter into, amend or cancel any Insurance Policies other than in ordinary course
of business, or seek a quote or proposal for any directors&#146; and officers&#146; liability
insurance and/or fiduciary liability insurance to be obtained by the Company pursuant to
<U>Section&nbsp;6.12</U>;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xxi) take any action that (1)&nbsp;would reasonably be expected to impose any material
delay in the obtaining of, or significantly increase the risk of not obtaining, any
authorizations, consents, orders, declarations or approvals of any Governmental Authority
necessary to consummate the Transactions or the expiration or termination of any applicable
waiting period, or (2)&nbsp;would be reasonably expected to increase the risk of any Governmental
Authority entering a Restraint prohibiting or impeding the consummation of the Transactions;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xxii) merge or consolidate the Company or any of its Subsidiaries with any Person or
adopt a plan of complete or partial liquidation or resolutions providing for a
complete or partial liquidation, dissolution, restructuring, recapitalization or other
reorganization of the Company or any of its Subsidiaries;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xxiii) (i)&nbsp;purchase any financial instruments; (ii)&nbsp;change in a material manner the
average duration of the Company&#146;s investment portfolio or the average credit quality of such
portfolio; (iii)&nbsp;materially change investment guidelines with respect to the Company&#146;s
investment portfolio; (iv)&nbsp;hypothecate, repo, encumber or otherwise pledge assets in the
Company&#146;s investment portfolio; or (v)&nbsp;invest surplus cash from operations in securities
other than U.S. Treasury bonds with a duration of three (3)&nbsp;months or less; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xxiv) authorize any of, or commit, resolve, propose or agree in writing or otherwise
to take any of, the foregoing actions.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.02 <U>Company Shareholder Meeting</U>. (a)&nbsp;If the approval of this Agreement by
the Company&#146;s shareholders is required by applicable Law, as soon as practicable
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-48-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">following the
consummation of the Offer and the expiration of any subsequent offering period, the Company shall
prepare and file with the SEC, the proxy statement that will be provided to the Company
Shareholders in connection with the solicitation of proxies for use at the Company Shareholder
Meeting, if any, (collectively, as amended or supplemented, the (&#147;<B>Proxy Statement</B>&#148;)) for the
solicitation of proxies from the Company Shareholders for use at the Company Shareholder Meeting.
The Parent and Merger Sub, as the case may be, shall furnish all information concerning Parent and
Merger Sub (and their respective Affiliates, if applicable) as the Company may reasonably request
in connection with the preparation and filing with the SEC of the Proxy Statement. Subject to
applicable Law, the Company shall use commercially reasonable efforts to cause the Proxy Statement
to be disseminated to the Company Shareholders as promptly as practicable following the filing
thereof with the SEC and confirmation from the SEC that it will not comment on, or that it has no
additional comments on, the Proxy Statement. Each of the Company, Parent and Merger Sub shall
promptly correct any information provided by it or any of its respective directors, officers,
employees, affiliates, agents or other representatives for use in the Proxy Statement if and to the
extent that such information contains any untrue statement of material fact or omits to state a
material fact required to be stated therein or necessary in order to make the statements therein,
in light of the circumstances under which they were made, not misleading. The Company shall take
all steps necessary to cause the Proxy Statement, as so corrected, to be filed with the SEC and
disseminated to the Company Shareholders, in each case as and to the extent required by applicable
Laws. The Company shall provide Parent, Merger Sub and their counsel a reasonable opportunity to
review and comment on the Proxy Statement prior to the filing thereof with the SEC, and the Company
shall give reasonable and good faith consideration to any comments made by Parent, Merger Sub and
their counsel (it being understood that Parent, Merger Sub and their counsel shall provide any
comments thereon as soon as reasonably practicable). The Company shall provide in writing to
Parent, Merger Sub and their counsel any comments or other communications, whether written or oral,
the Company or its counsel may receive from the SEC or its staff with respect to the Proxy
Statement promptly after such receipt, and the Company shall provide Parent, Merger Sub and their
counsel a reasonable opportunity to review and comment on any response to any such comments of the
SEC or its staff, and the Company shall give reasonable and good faith consideration to any
comments made by Parent, Merger Sub
and their counsel (it being understood that Parent, Merger Sub and their counsel shall provide
any comments thereon as soon as reasonably practicable) .
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;If required by applicable Law in order to consummate the Merger, the Company, acting
through the Company&#146;s Board of Directors, shall, in accordance with applicable Law and the Company
Charter Documents: (i)&nbsp;promptly and duly call, give notice of, convene and hold as soon as
reasonably practicable following the date hereof, a meeting of the Company Shareholders for the
purpose of approving the Transactions and this Agreement (the &#147;<B>Company Shareholders Meeting</B>&#148;) for
the purpose of obtaining the Company Shareholder Approval.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.03 <U>No Solicitation; Other Offers</U>. (a)&nbsp;Subject to <U>Section&nbsp;6.03(e)</U>,
until the date on which this Agreement is terminated pursuant to <U>Section&nbsp;8.01</U>, the Company
shall not, nor shall it authorize or permit any of its Subsidiaries, any of its or their respective
directors, officers or employees or any financial advisor, attorney, accountant or other advisor,
agent or representative (collectively, &#147;<B>Representatives</B>&#148;) retained by the Company or any of its
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->-49-<!-- /Folio -->
</DIV>



<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Subsidiaries to, directly or indirectly through another Person, except as otherwise provided
below, (i)&nbsp;solicit, initiate, or knowingly encourage (including by way of furnishing any non-public
information relating to the Company or any of its Subsidiaries), or knowingly induce or take any
other action which would reasonably be expected to lead to the making, submission or announcement
of, any proposal or inquiry that constitutes, or is reasonably likely to lead to, an Acquisition
Proposal, (ii)&nbsp;take any action to make the provisions of any &#147;fair price,&#148; &#147;moratorium,&#148; &#147;control
share acquisition,&#148; &#147;business combination&#148; or other similar anti-takeover statute or regulation
(including any transaction under, or a Third Party becoming an &#147;interested shareholder&#148; under, the
TBCA), or any restrictive provision of any applicable anti-takeover provision in the Company
Charter Documents, inapplicable to any transactions contemplated by an Acquisition Proposal (and,
to the extent permitted thereunder, the Company shall promptly take all steps necessary to
terminate any waiver that may have been heretofore granted, to any Person other than Parent or any
of Parent&#146;s Affiliates, under any such provisions), (iii)&nbsp;other than informing Persons of the
provisions contained in this <U>Section&nbsp;6.03</U>, enter into, continue or participate in any
discussions or any negotiations regarding any Acquisition Proposal or otherwise take any other
action to knowingly facilitate or knowingly induce any effort or attempt to make or implement an
Acquisition Proposal, (iv)&nbsp;approve, endorse or recommend an Acquisition Proposal or any letter of
intent, memorandum of understanding or other Contract contemplating an Acquisition Proposal or
requiring the Company to abandon or terminate its obligations under the Agreement or deliberately
fail to satisfy the Tender Offer Conditions; or (v)&nbsp;resolve, propose or agree to do any of the
foregoing. The Company shall, and shall cause its Subsidiaries and their respective
Representatives to, immediately cease and cause to be terminated all existing discussions or
negotiations with any Person previously conducted with respect to any Acquisition Proposal. The
Company shall promptly deny access to any data room (virtual or actual) containing any confidential
information previously furnished to any Third Party relating to any Acquisition Proposal to any
such Third Party.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Notwithstanding anything in this <U>Section&nbsp;6.03</U> to the contrary, at any time prior
to the time on which the Company has received the Company Shareholder Approval, in response to (i)
an unsolicited written Acquisition Proposal, received under circumstances not involving a breach of
<U>Section&nbsp;6.03(a)</U>, that the Company&#146;s Board of Directors determines in good faith (after
consultation with its financial advisor) constitutes or could reasonably be expected to result in a
Superior Proposal, or (ii)&nbsp;an inquiry relating to an Acquisition Proposal by a Person that the
Company&#146;s Board of Directors determines in good faith is credible and reasonably capable of making
a Superior Proposal (an &#147;<B>Inquiry</B>&#148;), the Company may, upon a good faith determination by the
Company&#146;s Board of Directors (after receiving the advice of its outside counsel) that failure to
take such action would be inconsistent with the Company&#146;s Board of Directors&#146; fiduciary duties to
the Company Shareholders under applicable Law, (x)&nbsp;furnish information with respect to the Company
and its Subsidiaries to the Person making such Acquisition Proposal or Inquiry (and such Person&#146;s
Representatives); <U>provided</U>, that, the Company and such Person enter into an Acceptable
Confidentiality Agreement; and <U>provided</U>, <U>further</U>, that all such information shall have been
previously provided to Parent or is provided to Parent at substantially the same time it is
provided to such Person and (y)&nbsp;participate in discussions or negotiations with the Person making
such Acquisition Proposal or Inquiry (and its Representatives) regarding such Acquisition Proposal
or Inquiry. The Company shall not
terminate, waive, amend, release or modify any material provision of any confidentiality
agreement to which it or any of its Subsidiaries is a party with respect to any Acquisition
</DIV>






<P align="center" style="font-size: 10pt"><!-- Folio -->-50-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Proposal in a manner that renders it not an Acceptable Confidentiality Agreement and shall enforce
the material provisions of any such agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;The Company shall promptly advise Parent in writing, and in no event later than
twenty-four (24)&nbsp;hours after receipt of any Acquisition Proposal or Inquiry, and shall, in any such
notice to Parent, indicate the identity of the Person making such Acquisition Proposal or Inquiry
and of the Company&#146;s intention to participate or engage in discussions or negotiations with, or
furnish non-public information to, such Person and the material terms and conditions of any
proposal or offer or the nature of any inquiries or contacts, and thereafter shall promptly keep
Parent reasonably informed of all material developments affecting the status and the material terms
of any such proposal, offer, inquiry or request and of the status of any such discussions or
negotiations.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;The Company&#146;s Board of Directors shall not (i)&nbsp;fail to make the Company Board
Recommendation to the Company Shareholders, (ii)&nbsp;withhold, withdraw, amend or modify in a manner
adverse to Parent, or publicly propose to withhold, withdraw, amend or modify in a manner adverse
to Parent, the Company Board Recommendation, (iii)&nbsp;adopt, approve, recommend, endorse or otherwise
declare advisable the adoption of any Acquisition Proposal (it being understood that, with respect
to a tender offer or exchange offer, taking a neutral position or no position (other than in a
communication made in compliance with Rule&nbsp;14d-9(f) promulgated under the Exchange Act) with
respect to any Acquisition Proposal shall be considered a breach of this clause (iii)), or (iv)
resolve, agree or publicly propose to take any such actions (each such foregoing action or failure
to act in clauses (i)&nbsp;through (iv)&nbsp;being referred to as a &#147;<B>Change in the Company Recommendation</B>&#148;);
provided, that the Company&#146;s Board of Directors may make a Change in the Company Recommendation
permitted by this <U>Section&nbsp;6.03(d)</U> and as provided in <U>Section&nbsp;6.03(e)</U>.
Notwithstanding the foregoing, the Company&#146;s Board of Directors may at any time prior to the
Acceptance Time:
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) effect a Change in the Company Recommendation in response to an Acquisition
Proposal if the Company&#146;s Board of Directors concludes in good faith, after consultation
with outside counsel, that the failure to take such action would be inconsistent with its
fiduciary duties to the Company Shareholders under applicable Law and the Company&#146;s Board of
Directors concludes in good faith, after consultation with the Company&#146;s financial advisor,
that the Acquisition Proposal constitutes a Superior Proposal;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) effect a Change in the Company Recommendation in response to the occurrence of an
Intervening Event if the Company&#146;s Board of Directors concludes in good faith, after
consultation with outside counsel, that the failure to effect such Change in the Company
Recommendation would be inconsistent with its fiduciary duties to the Company Shareholders
under applicable Law; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) terminate this Agreement pursuant to <U>Section&nbsp;8.01(d)(ii)</U> and enter into a
definitive agreement with respect to a Superior Proposal, but only if the Company receives
an Acquisition Proposal that the Company&#146;s Board of Directors concludes in
good faith constitutes a Superior Proposal and the Company&#146;s Board of Directors
concludes in good faith, after consultation with outside counsel, that the failure to enter
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-51-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">into such definitive agreement would be inconsistent with its fiduciary duties to the
Company Shareholders under applicable Law;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%"><U>provided</U> that in each case that, the Company complies with <U>Section&nbsp;6.03(e)</U>
prior to taking any of the actions set forth in clauses <U>Section&nbsp;6.03(d)(1)</U>,
<U>(2)</U> and <U>(3)</U> above.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Notwithstanding anything to the contrary set forth in <U>Section&nbsp;6.03(d)</U>, the Company
shall not be entitled to (i)&nbsp;make a Change in the Company Recommendation pursuant to <U>Section
6.03(d)(1)</U> or <U>Section&nbsp;6.03(d)(2)</U> or (ii)&nbsp;enter into any Company Acquisition Agreement
pursuant to <U>Section&nbsp;6.03(d)(3)</U> unless:
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) in the case of the matters referenced in <U>Section&nbsp;6.01(d)(1)</U> and <U>Section
6.01(d)(3)</U>, the Company has provided to Parent three (3)&nbsp;Business Days&#146; prior written
notice of its intention to make a Change in the Company Recommendation (a &#147;<B>Recommendation
Change Notice</B>&#148;), which Recommendation Change Notice shall specify that the Company&#146;s Board
of Directors is prepared to make a Change in the Company Recommendation, and shall contain a
description of the material terms of the Acquisition Proposal that the Company&#146;s Board of
Directors has determined constitutes a Superior Proposal, a statement that the Company&#146;s
Board of Directors has determined that such Acquisition Proposal constitutes a Superior
Proposal, a statement that the Company&#146;s Board of Directors intends to enter into an
agreement providing for such Superior Proposal, identifying the parties thereto, and
delivering to Parent a copy of the Company Acquisition Agreement and any other related
material documents for such Superior Proposal, in the form to be entered into (it being
understood and agreed that the delivery of such Recommendation Change Notice shall not, in
and of itself, be deemed to be a Change in the Company Recommendation), (B)&nbsp;at 5:00 pm, New
York time, at the end of the three Business Day period following the date of receipt of the
Recommendation Change Notice (or, in the event that the applicable Acquisition Proposal has
been materially revised or modified, at 5:00 pm, New York time, on the third
(3<SUP style="FONT-size: 85%; vertical-align: text-top">rd</SUP>) Business Day following the date of receipt of notice of such material
revision or modification, if later), such Acquisition Proposal has not been withdrawn and a
Change in the Company Recommendation or entry into a Company Acquisition Agreement continues
to be necessary in light of such Superior Proposal in order for the Company&#146;s Board of
Directors to comply with its fiduciary duties to the Company Shareholders under applicable
Law, after taking into account any changes to the terms of this Agreement offered by Parent,
(C)&nbsp;in the case of the matters referenced in <U>Section&nbsp;6.01(d)(3)</U>, the Company Board
approves or recommends such Superior Proposal and (D)&nbsp;in the case of the matters referenced
in <U>Section&nbsp;6.01(d)(3)</U>, the Company terminates this Agreement pursuant to <U>Section
8.01</U> and pays to Parent the Termination Fee payable pursuant to <U>Section 8.03</U>;
and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) in the case of the matters referenced in <U>Section&nbsp;6.03(d)(2)</U>, (A)&nbsp;the
Company has provided to Parent a Recommendation Change Notice, which Recommendation Change
Notice shall specify that the Company&#146;s Board of Directors is prepared to make a Change in
the Company Recommendation, and shall contain a
description of the Intervening Event that the Company has determined requires the
Change of Company Recommendation, including the basis for such determination (it
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-52-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">being understood and agreed that the delivery of such Recommendation Change Notice
shall not, in and of itself, be deemed to be a Change in the Company Recommendation) and (B)
at 5:00 pm, New York time, at the end of the three (3)&nbsp;Business Day period following the
date of receipt of the Recommendation Change Notice, a Change in the Company Recommendation
continues to be necessary in light of such Intervening Event in order for the Company&#146;s
Board of Directors to comply with its fiduciary duties to the Company Shareholders under
applicable Law, after taking into account any changes to the terms of this Agreement offered
by Parent.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;Nothing contained in this <U>Section&nbsp;6.03</U> or elsewhere in this Agreement shall
prohibit the Company from (i)&nbsp;taking and disclosing to the Company Shareholders a position
contemplated by Rule&nbsp;14d-9, Rule&nbsp;14e-2(a) or Item 1012(a) of Regulation&nbsp;M-A promulgated under the
Exchange Act or (ii)&nbsp;making any disclosure to the Company Shareholders if, in the good faith
judgment of the Company&#146;s Board of Directors, after consultation with outside counsel, failure so
to disclose would be inconsistent with its fiduciary duties under applicable Law; <U>provided</U>,
<U>however</U>, that this <U>Section&nbsp;6.03(f)</U> shall not affect the obligations of the Company
and the Company&#146;s Board of Directors and the rights of Parent and Merger Sub under <U>Sections
6.03(d)</U> and <U>6.03(e)</U> to the extent applicable to such disclosure (it being understood
that neither any &#147;stop, look and listen&#148; letter or similar communication of the type contemplated
by Rule&nbsp;14d-9(f) under the Exchange Act, nor any accurate disclosure of factual information (other
than the Company or the Company&#146;s directors taking any action set forth in <U>Sections&nbsp;6.03(d)</U>
and <U>6.03(e)</U>) to the Company Shareholders that is required to be made to such shareholders
under applicable Law or in satisfaction of the Company&#146;s Board of Directors&#146; fiduciary duties or
applicable Law, shall be deemed to be a Change in the Company Recommendation).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.04 <U>Reasonable Best Efforts</U>. (a)&nbsp;Each party shall make or cause to be made, in
cooperation with the other parties and to the extent applicable and as promptly as practicable, (i)
an appropriate filing of a Notification and Report Form pursuant to the HSR Act with respect to the
Merger and (ii)&nbsp;all other necessary filings, forms, declarations, notifications, registrations and
notices with other Governmental Entities under any other antitrust, competition, trade regulation,
or other Laws relating to the Merger. Each party shall use its reasonable best efforts to (i)
respond at the earliest practicable date to any requests for additional information made by the
United States Department of Justice or any other Governmental Authorities, (ii)&nbsp;act in good faith
and reasonably cooperate with the other party in connection with any investigation of any
Governmental Authority, (iii)&nbsp;furnish to each other all information required for any filing, form,
declaration, notification, registration and notice subject to advice of such party&#146;s antitrust
counsel, and (iv)&nbsp;take all other actions reasonably necessary to cause the expiration or
termination of the applicable waiting periods under the HSR Act or any foreign antitrust,
competition or similar Laws as soon as practicable and not extend any waiting period under the HSR
Act or any foreign antitrust, competition or similar Laws or enter into any agreement with a
Governmental Authority not to consummate the Merger, except with the prior written consent of the
other party, which consent shall not be unreasonably withheld or delayed. In connection with the
foregoing: (A)&nbsp;whenever possible, each party shall give the other party reasonable prior notice of
any communication with, and any proposed understanding or agreement with, any
Governmental Authority regarding any filings, forms, declarations, notifications,
registrations or notices, and permit the other to review and discuss in advance, and consider in
good faith the
</DIV>






<P align="center" style="font-size: 10pt"><!-- Folio -->-53-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">views of the other in connection with, any proposed communication, understanding or agreement
with any Governmental Authority with respect to the Merger subject to advice of such party&#146;s
antitrust counsel, (B)&nbsp;where reasonably practical, none of the parties hereto shall independently
participate in any meeting or conversation, or engage in any substantive conversation, with any
Governmental Authority in respect of any filings or inquiry without giving the other party prior
notice of the meeting or conversation and, unless prohibited by such Governmental Authority, the
opportunity to attend and/or participate, (C)&nbsp;if one party is prohibited by applicable Law or by
the applicable Governmental Authority from participating in or attending any meetings or
conferences or conversations, the attending party shall keep the other reasonably apprised with
respect thereto and (D)&nbsp;the parties hereto shall consult and cooperate with one another in
connection with any information or proposals submitted in connection with proceedings under or
relating to any antitrust Law. Without limiting the foregoing, the Company and Parent shall each
use its reasonable best efforts: (i)&nbsp;to avoid the entry of any Restraint and (ii)&nbsp;to eliminate
every impediment under any antitrust Law that may be asserted by any Governmental Authority so as
to enable the Closing to occur as soon as reasonably possible (and in any event no later than the
Termination Date). Notwithstanding the foregoing, neither Parent nor any of its Subsidiaries shall
be required to (i)&nbsp;propose, negotiate, commit to or effect any such sale, divestiture or
disposition of assets or business of Parent or the Company, or any of their respective
Subsidiaries, or offer to take or offer to commit to take any such action, <U>provided</U>, that
Parent shall be required to use commercially reasonable efforts to take such action, or effect such
sale, divestiture or disposition, where such action, sale, divestiture or disposition, individually
or in the aggregate, would not result in the one year loss of net sales revenues (as measured by
net 2010 sales revenue) in excess of $40,000,000, or (ii)&nbsp;commence or defend any suit, action, or
proceeding related to the foregoing or seek to avoid entry of, or to have vacated, overturned or
terminated, any Restraint.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Upon the terms and subject to the conditions set forth in this Agreement, each of Parent,
Merger Sub and the Company shall use its reasonable best efforts to take, or cause to be taken, all
actions, and to do, or cause to be done, and to assist and cooperate with the other party or
parties hereto in doing, all things reasonably necessary, proper or advisable under applicable Law
or otherwise to consummate and make effective, in the most expeditious manner practicable, the
transactions contemplated by this Agreement, including using reasonable best efforts to: (i)
obtain all necessary actions or non-actions, waivers, consents, approvals, orders and
authorizations from Governmental Authorities and make all necessary registrations, declarations and
filings with Governmental Authorities, that are necessary to consummate the Merger; and (ii)&nbsp;obtain
all necessary consents, waivers and approvals under any Material Contracts or Contracts set forth
on Section&nbsp;4.04 of the Company Disclosure Schedule, to which the Company or any of its Subsidiaries
is a party in connection with this Agreement and the consummation of the transactions contemplated
hereby.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.05 <U>Public Announcements</U>. The initial press release with respect to the execution and
delivery of this Agreement shall be a joint press release to be reasonably agreed upon by Parent
and the Company. Except as permitted by <U>Section&nbsp;6.03(d)</U>, Parent and the Company shall
consult with each other before issuing, and, to the extent practicable, give each other the
reasonable opportunity to review and comment upon, any press release or other public
statements with respect to the Transactions and consider in good faith the views of the other
party, and shall not issue any such press release or make any such public statement prior to such
</DIV>






<P align="center" style="font-size: 10pt"><!-- Folio -->-54-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">consultation, except as may be required by applicable Law, court process or by obligations
pursuant to any listing agreement with or rules of any securities exchange or trading market on
which securities of Parent or the Company are listed, in which case the party required to make the
release or announcement shall use its commercially reasonable efforts to allow the other party or
parties hereto reasonable time to comment on such release or announcement in advance of such
issuance (it being understood that the final form and content of any such release or announcement,
as well as the timing of any such release or announcement, shall be at the final discretion of the
disclosing party).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.06 <U>Access to Information</U>. (a)&nbsp;Upon reasonable advance notice and subject to applicable
Law, the Company shall (and shall cause its Subsidiaries to) afford to the officers, employees,
accountants, counsel, financial advisors, and other authorized Representatives of Parent reasonable
access during normal business hours, during the period prior to the Effective Time or the
termination of this Agreement, to all of its and its Subsidiaries&#146; properties, books, Contracts,
commitments, records, officers and employees, but only to the extent that such access does not
unreasonably interfere with the business or operations of the Company and its Subsidiaries (and, to
the extent required by applicable Law, access to personnel records will be provided only if
authorized by the specific employees), and, during such period, the Company shall (and shall cause
its Subsidiaries to) provide access promptly to Parent all other information concerning it and its
business, properties and personnel as Parent may reasonably request (including consultation on a
regular basis with the Company&#146;s agents, advisors, attorneys and Representatives with respect to
litigation matters); <U>provided,</U> <U>however</U>, that the foregoing access shall not include
the right to conduct environmental sampling of any kind at any real property without the prior
written consent of the Company; <U>provided</U>, <U>further</U>, that the Company may restrict
the foregoing access to the extent that (i)&nbsp;any Law applicable to the Company requires the Company
or its Subsidiaries to restrict or prohibit access to any such properties or information, (ii)&nbsp;the
information is subject to the approval of a Third Party or confidentiality obligations to a Third
Party, (iii)&nbsp;such disclosure would result in disclosure of any trade secrets of any Third Party or
(iv)&nbsp;disclosure of any such information or document could result in the loss of attorney-client
privilege (<U>provided</U> that the Company and/or counsel for the Company shall use their reasonable best
efforts to enter into such joint defense agreements or other arrangements, as appropriate, so as to
allow for such disclosure in a manner that does not result in the loss of attorney-client
privilege); <U>provided</U>, <U>however</U>, that with respect to clauses (i)&nbsp;through (iv)&nbsp;of this <U>Section
6.06(a)</U>, the Company shall use its reasonable best efforts to (A)&nbsp;obtain the required consent
of any Third Party to provide such access or disclosure, or (B)&nbsp;develop an alternative to providing
such information so as to address such matters that is reasonably acceptable to Parent and the
Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;With respect to the information disclosed pursuant to <U>Section&nbsp;6.06(a)</U> or
<U>Section&nbsp;6.17</U>, Parent shall comply with, and shall cause Parent&#146;s Representatives to comply
with, all of its obligations under the Confidentiality Agreement, which agreement shall remain in
full force and effect in accordance with its terms.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;After the date hereof, Parent and the Company shall cooperate to establish a mechanism
acceptable to both parties by which Parent will be permitted, prior to the
Acceptance Time or the termination of this Agreement and subject to applicable Law, to
communicate directly with the Company employees regarding employee related matters.
</DIV>






<P align="center" style="font-size: 10pt"><!-- Folio -->-55-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.07 <U>Shareholder Litigation</U>. Prior to the Acceptance Time or the termination of this
Agreement, (i)&nbsp;the Company shall promptly advise Parent in writing of any shareholder litigation
against the Company or its directors relating to this Agreement or the Transactions and shall keep
Parent fully informed regarding any such shareholder litigation and (ii)&nbsp;the Company shall control
such defense and this <U>Section&nbsp;6.07</U> shall not give Parent the right to direct such defense,
<U>provided</U>, that, that the Company shall give Parent the opportunity to participate in the
defense or settlement of any shareholder litigation against the Company and/or its directors or
executive officers relating to the Transactions or this Agreement, whether commenced prior to or
after the execution and delivery of this Agreement, and shall not settle or offer to settle any
such litigation without the prior written consent of Parent (which consent shall not be
unreasonably withheld, conditioned or delayed).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.08 <U>Section&nbsp;16 Matters</U>. Prior to the Effective Time, the Company, Parent and Merger Sub
shall take all such steps as may be required and permitted to cause the Transactions, including any
dispositions of Company Common Stock (including derivative securities with respect to such Company
Common Stock) by each individual who is or will be subject to the reporting requirements of Section
16(a) of the Exchange Act with respect to the Company, to be exempt under Rule&nbsp;16b-3 promulgated
under the Exchange Act.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.09 <U>Employee Matters</U>. (a)&nbsp;For purposes of this <U>Section&nbsp;6.09</U>, (i)&nbsp;the term
&#147;<B>Covered Employees</B>&#148; shall mean employees (other than employees covered by a Collective Bargaining
Agreement) who are actively employed by the Company or its Subsidiaries at the Effective Time; and
(ii)&nbsp;the term &#147;<B>Continuation Period</B>&#148; shall mean the period beginning at the Effective Time and
ending on the second anniversary of the Effective Time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Base Compensation</U>. For the Continuation Period, Parent shall provide, or shall
cause the Surviving Corporation to provide to each Covered Employee, an annual base salary or
hourly rate of pay that is no less than the base salary or hourly rate of pay that such Covered
Employee received from the Company immediately prior to the Effective Time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <U>Bonuses During Continuation Period</U>. Effective January&nbsp;1, 2011 (or, for Covered
Employees who participate in bonus plans of the Company other than the Executive Management
Incentive Award Plan, the Management Incentive Award Plan, or the Team-Based Employee Incentive
Award Plan, as of the first performance period beginning after the Effective Time) and during the
remainder of the Continuation Period, Parent shall, or shall cause its Subsidiaries to, provide to
each Covered Employee with annual cash bonus opportunity that is substantially comparable to those
offered by the Company immediately before the Effective Time at target base salary multiples (or
other target amounts) that are no less favorable than the target base salary multiples or other
targets in effect for such Covered Employee during 2010, but with payment based on achievement of
performance criteria determined by Parent and applicable generally to similarly-situated or
comparable employees of Parent and its Subsidiaries in a consistent and good faith manner during
the Continuation Period. Notwithstanding the foregoing, if the Effective Time occurs after
December&nbsp;31, 2010, the Company shall establish in
good faith, in reasonable consultation with Parent, annual cash bonus opportunities that are
consistent with the Company&#146;s past practice for any performance period that begins before the
Effective Time.
</DIV>






<P align="center" style="font-size: 10pt"><!-- Folio -->-56-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <U>Benefit Plans</U>. During the Continuation Period, Parent shall maintain or cause the
Surviving Corporation to maintain employee benefit plans, programs, policies and arrangements for
Covered Employees that are substantially similar in the aggregate to the Company Plans (other than
the bonus plans described in <U>Sections&nbsp;6.09(c)</U> above, long-term incentives, change in
control, retention, transition, stay or similar arrangements) that were in effect immediately prior
to the Effective Time; <U>provided</U>, that (i)&nbsp;with respect to Covered Employees who are subject to
Collective Bargaining Agreements, employee benefits shall be provided in accordance with the
applicable Collective Bargaining Agreements, and (ii)&nbsp;Parent&#146;s obligations under this <U>Section
6.09</U> shall be subject to such modifications as are necessary to comply with applicable Laws of
the foreign countries and their political subdivisions, and applicable labor agreements.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <U>Crediting of Payments</U>. In the event any Covered Employee first becomes eligible
to participate under any employee benefit plan, program, policy, or arrangement of the Parent or
Surviving Corporation (&#147;<B>Parent Employee Benefit Plan</B>&#148;) following the Effective Time, Parent shall,
or shall cause the Surviving Corporation to, (i)&nbsp;waive any pre-existing condition exclusions and
waiting periods with respect to participation and coverage requirements applicable to any Covered
Employee under any Parent Employee Benefit Plan providing medical, dental, or vision benefits to
the same extent such limitation would have been waived or satisfied under the employee benefit plan
Covered Employee participated in immediately prior to coverage under the Parent Employee Benefit
Plan; and (ii)&nbsp;provide each Covered Employee with credit for any co-payments and deductibles paid
prior to the Covered Employee&#146;s coverage under any Parent Employee Benefit Plan during the calendar
year in which such amount was paid, to the same extent such credit was given under the employee
benefit plan Covered Employee participated in immediately prior to coverage under the Parent
Employee Benefit Plan, in satisfying any applicable deductible or out-of-pocket requirements under
the Parent Employee Benefit Plan.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <U>Service Crediting</U>. As of the Effective Time, Parent shall recognize, or shall
cause the Surviving Corporation to recognize, all service of each Covered Employee prior to the
Effective Time, to the Company and its Subsidiaries (as well as predecessor entities of the Company
or any of its Subsidiaries) for purposes of eligibility to participate and vesting credit (but
excluding, other than with respect to severance and vacation benefits, entitlement to benefits and
benefit accrual); for the avoidance of doubt, service of each Covered Employee prior to the
Effective Time shall not be recognized for the purpose of any entitlement to participate in, or
receive benefits with respect to, any (i)&nbsp;non-elective employer contributions under any Parent
Section 401(k) plan or (ii)&nbsp;Parent retiree medical program in which any Covered Employee
participates after the Effective Time. In no event shall anything contained in this <U>Section
6.09(f)</U> result in any duplication of benefits for the same period of service.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) <U>Honoring of Collective Bargaining Agreements; Represented Employees</U>. With respect
to any employee actively employed by the Company or its Subsidiaries at the Effective Time whose
terms and conditions of employment are governed by any of the Collective Bargaining Agreements
listed on Section&nbsp;4.19(a) of the Company Disclosure
Schedule (each, a &#147;<B>Represented Employee</B>&#148;), Parent agrees to honor or cause to be honored the
Collective Bargaining Agreements listed on Section&nbsp;4.19(a) of the Company Disclosure Schedule as of
the Effective Time and to continue all terms and conditions of employment
</DIV>






<P align="center" style="font-size: 10pt"><!-- Folio -->-57-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">applicable to such Represented Employee under their respective Collective Bargaining Agreements
through the expiration, modification or termination of such agreements in conformity with
applicable Law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;Nothing in this <U>Section&nbsp;6.09</U> shall be construed to limit the right of Parent or
any of its Subsidiaries (including, following the Effective Time, the Company and its Subsidiaries)
to amend or terminate any Company Plan or other employee benefit plan, to the extent such amendment
or termination is permitted by the terms of the applicable plan, nor shall anything in this
<U>Section&nbsp;6.09</U> be construed to require the Parent or any of its Subsidiaries (including,
following the Effective Time, Company and its Subsidiaries) to retain the employment of any
particular Covered Employee for any fixed period of time following the Effective Time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;Without limiting the generality of <U>Section&nbsp;9.07</U>, the provisions of this
<U>Section&nbsp;6.09</U> are solely for the benefit of the parties hereto, and no current or former
employee, director or independent contractor or any other individual associated therewith shall be
regarded for any purpose as a third party beneficiary of the Agreement, and nothing herein shall be
construed as an amendment to any Company Plan or other employee benefit plan for any purpose.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.10 <U>Resignations</U>. Subject to <U>Section&nbsp;1.04</U>, prior to the Acceptance Time, at the
written request of Parent, the Company shall use reasonable best efforts to cause each director and
each officer of the Company and each Subsidiary of the Company to execute and deliver a letter
effectuating his or her resignation as a director or officer (but not as an employee) of such
Subsidiary effective as of the Acceptance Time. At the request of Parent, the Company will use
reasonable efforts to cooperate with Parent to effect the replacement of any such directors and
officers selected by Parent at the Acceptance Time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.11 <U>Company Convertible Notes</U>. From the date hereof, the Company shall use commercially
reasonable efforts to comply with the terms of the Indenture with respect to any right of holders
to convert the Company Convertible Notes or with respect to the Company&#146;s obligation to repurchase
the Company Convertible Notes from the holders thereof as a result of the transactions contemplated
hereby, including the delivery of any and all appropriate notices required by the terms of the
Indenture. Prior to taking any of the foregoing actions, the Company shall consult with and
reasonably cooperate with Parent with respect to the action and the intended manner and form
thereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.12 <U>Director and Officer Liability</U>. From and after the Acceptance Time, Parent shall
cause the Company or Surviving Corporation, as the case may be, to, to the extent permitted by
applicable Law, (a)&nbsp;indemnify, defend and hold harmless, against any costs or expenses (including
attorney&#146;s fees and expenses and disbursements), judgments, fines, losses, claims, damages or
liabilities incurred in connection with any claim, action, suit, proceeding or investigation,
whether civil, criminal, administrative or investigative, and provide advancement of expenses to,
all past and present directors and officers of the Company and its Subsidiaries (in all of their
capacities) to the same extent such persons are indemnified or have the right to
advancement of expenses as of the date of this Agreement by the Company pursuant to the
Company Charter Documents and the indemnification agreements of the Company, if any, in
</DIV>






<P align="center" style="font-size: 10pt"><!-- Folio -->-58-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">existence on the date hereof with any directors and officers of the Company (it being
understood that in no event shall Parent be obligated to provide any such indemnification under
circumstances in which the Company would not be so required), (b)&nbsp;include and cause to be
maintained in effect in the Company or the Surviving Corporation&#146;s (or any successor&#146;s), as the
case may be, charter and by-laws for a period of six (6)&nbsp;years after the Acceptance Time, the
current provisions regarding elimination of liability of directors, indemnification of officers,
directors and employees and advancement of expenses contained in the Company Charter Documents and
(c)&nbsp;cause to be maintained for a period of six (6)&nbsp;years after the Acceptance Time the current
policies of directors&#146; and officers&#146; liability insurance and fiduciary liability insurance
maintained by the Company (<U>provided</U> that the Surviving Corporation (or any successor) may
substitute therefor policies of at least the same coverage and amounts containing terms and
conditions which are, in the aggregate, no less advantageous to the insured) with respect to claims
arising from facts or events that occurred on or before the Acceptance Time (including for acts or
omissions occurring in connection with the approval of this Agreement and the consummation of the
Transactions), provided, however, that in no event will the Company or the Surviving Corporation,
as the case may be, be required to expend annually in excess of 250% of the annual premium
currently paid by the Company for such coverage (and to the extent the annual premium would exceed
250% of the annual premium currently paid by the Company for such coverage, the Company or the
Surviving Corporation, as the case may be, shall use reasonable best efforts to cause to be
maintained the maximum amount of coverage as is available for such 250% of such annual premium).
In addition, Company or the Surviving Corporation, as the case may be, may satisfy its obligations
under this <U>Section&nbsp;6.12</U> by purchasing a six-year &#147;tail&#148; prepaid policy on terms and
conditions no less advantageous to the indemnified parties, or any other person entitled to the
benefit of <U>Section&nbsp;6.12</U> of this Agreement, as applicable, than the existing directors&#146; and
officers&#146; liability (and fiduciary) insurance maintained by the Company, covering, without
limitation, the Transactions. If the Surviving Corporation or any of their respective successors
or assigns (i)&nbsp;shall consolidate with or merge into any other corporation or entity and shall not
be the continuing or surviving corporation or entity of such consolidation or merger or (ii)&nbsp;shall
transfer all or substantially all of its properties and assets to any individual, corporation or
other entity, then, and in each such case, proper provisions shall be made so that the successors
and assigns of the Surviving Corporation shall assume all of the obligations set forth in this
<U>Section&nbsp;6.12</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.13 <U>Notices of Certain Events</U>. Each of the Company and Parent shall promptly as
reasonably practicable notify the other:
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) upon becoming aware that any representation or warranty made by it in this
Agreement has become untrue or inaccurate in any material respect, or of any failure of such
Person to comply with or satisfy in any material respect any covenant, condition or
agreement to be complied with or satisfied by it under this Agreement; <U>provided</U>, <U>however</U>,
that no such notification shall affect or be deemed to modify any representation or warranty
of such Person set forth herein or the conditions to the obligations of the other party to
consummate the Merger, or the remedies available to the parties hereto, and <U>provided</U>,
<U>further</U>, that failure to give any such notice shall not be treated as a breach of covenant
for the purposes of <U>Section&nbsp;5</U> of <U>Annex A</U>, <U>Section&nbsp;8.01(c)(i)</U> or
<U>Section&nbsp;8.01(d)(i)</U>, as applicable;
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-59-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) to the extent the Company has Knowledge of such notice or communication, of any
written communication from any Person alleging that the consent of such Person is required
in connection with the Transactions contemplated by this Agreement;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) of any written communication from any Governmental Authority related to the
Transactions contemplated by this Agreement; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) of any Actions commenced and served on the Company or, to its Knowledge,
threatened in writing against the Company or any of its Subsidiaries or Parent and any of
its Subsidiaries, as the case may be, that, if pending on the date of this Agreement, would
have been required to have been disclosed pursuant to any Section of this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.14 <U>Takeover Statute</U>. If any &#147;fair price,&#148; &#147;moratorium,&#148; &#147;business combination,&#148; &#147;control
share acquisition&#148; or other form of anti-takeover statute or regulation shall become applicable to
the Transactions or the other transactions contemplated by this Agreement after the date of this
Agreement, each of the Company and Parent and the members of their respective Boards of Directors
shall grant such approvals and take such actions as are reasonably necessary so that the
Transactions and the other transactions contemplated hereby may be consummated as promptly as
practicable on the terms contemplated herein and otherwise act to eliminate or minimize the effects
of such statute or regulation on the Merger, and the other transactions contemplated hereby.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.15 <U>Deregistration; Stock Exchange Delisting</U>. Prior to the Effective Time, the Company
shall cooperate with Parent and use reasonable best efforts to take, or cause to be taken, all
actions, and do or cause to be done all things, reasonably necessary, proper or advisable on its
part under applicable Laws and rules and policies of NYSE to cause the delisting of the Company
Common Stock from NYSE as promptly as practicable after the Effective Time and deregistration of
the Company Common Stock under the Exchange Act as promptly as practicable after such delisting.
The Company shall not cause the Company Common Stock to be delisted from the NYSE prior to the
Effective Time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.16 <U>Fees and Expenses</U>. Except as provided in <U>Section&nbsp;8.03</U>, all fees and expenses
incurred in connection with this Agreement and the Transactions shall be paid by the party
incurring such fees or expenses, whether or not the Transactions are consummated.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.17 <U>Company Cooperation on Certain Matters.</U> After the date hereof and prior to the
Effective Time, Parent and the Company shall use reasonable best efforts to confer on a regular
basis regarding the general status of the ongoing operations of the Company and its Subsidiaries
and integration planning matters.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.18 <U>FIRPTA Affidavit</U>. Within three (3)&nbsp;Business Days of the Closing, the Company shall
deliver to Parent an affidavit satisfying the requirements of Section&nbsp;1445(b)(3) of the Code and
the Treasury Regulations promulgated thereunder, certifying that the Company is not and has not
been a &#147;United States real property holding corporation&#148; within the
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->-60-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">meaning of Section&nbsp;897 of the Code during the period described in Section&nbsp;897(c)(1)(A)(ii) of
the Code.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.19 <U>Merger Sub Obligations</U>. Parent agrees to take all action necessary to cause Merger
Sub or the Surviving Corporation, as applicable, to perform all of its respective agreements,
covenants and obligations under this Agreement.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE VII</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>CONDITIONS PRECEDENT TO THE MERGER</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;7.01 <U>Conditions to Each Party&#146;s Obligation to Effect the Merger</U>. The respective
obligations of each party to effect the Merger shall be subject to the satisfaction on or prior to
the Effective Time of the following conditions:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Company Shareholder Approval</U>. The Company Shareholder Approval shall have been
obtained, if and to the extent required under applicable Law, and, if Company Shareholder Approval
is not required under applicable Law, at least one (1)&nbsp;month shall have passed since the date a
copy of this Agreement was mailed to the Company Shareholders (to the extent required by Section
48-21-105(e) of the TBCA);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Purchase of Company Common Stock</U>. Parent or Merger Sub shall have accepted for
payment and paid for shares of Company Common Stock pursuant to the Offer in accordance with the
terms of this Agreement; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <U>No Restraints</U>. No order, injunction, judgment, decree or ruling (whether
temporary, preliminary or permanent) enacted, promulgated, issued or entered by any Governmental
Authority (collectively, &#147;<B>Restraints</B>&#148;) or Laws shall be in effect enjoining, restraining,
preventing or prohibiting consummation of the Merger or making consummation of the Merger illegal.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE VIII</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>TERMINATION</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;8.01 <U>Termination</U>. This Agreement may be terminated and the Transactions abandoned at any
time prior to the Acceptance Time:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;by mutual written agreement of the Company and Parent; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;by either the Company or Parent:
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) upon written notice to the other party, if the Acceptance Time shall not have
occurred on or prior to the close of banking business New York City time on the Termination
Date; <U>provided</U>, <U>however</U>, that the right to terminate this Agreement under this <U>Section
8.01(b)(i)</U> shall not be available to any party whose breach of any provision
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-61-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">of this Agreement has been the cause of, or resulted in, the failure of the Acceptance
Time to occur on or before the Termination Date;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) if a Restraint prohibiting the Offer and/or the Merger shall be in effect and have
become final and non-appealable; <U>provided</U>, <U>however</U>, that the right to terminate this
Agreement under this <U>Section&nbsp;8.01(b)(ii)</U> shall not be available to a party if the
issuance of such final, non-appealable Restraint was primarily due to the failure of such
party to perform in any material respect any of its obligations under this Agreement;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) if the Offer (as it may have been extended pursuant to <U>Section&nbsp;1.01</U>)
expires as result of the non-satisfaction of any Offer Condition or is terminated or
withdrawn pursuant to its terms in accordance with this Agreement without any shares of
Company Common Stock being purchased thereunder and the Company has not otherwise requested
that Parent and Merger Sub extend the Offer in accordance with <U>Section&nbsp;1.01(e)</U>; or
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;by Parent:
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) upon written notice to the Company, if the Company (A)&nbsp;shall have breached any of
the covenants or agreements contained in this Agreement to be complied with by the Company
such that the closing condition set forth in <U>Section&nbsp;5</U> of <U>Annex A</U> of this
Agreement would not be satisfied (other than in the case of a breach of the covenants or
agreements set forth in <U>Section&nbsp;6.03</U>) or (B)&nbsp;there exists a breach of any
representation or warranty of the Company contained in this Agreement such that the closing
condition set forth in <U>Section&nbsp;4</U> of <U>Annex A</U> of this Agreement would not be
satisfied, and, in the case of both (A)&nbsp;and (B), such breach or condition is not curable by
the Termination Date or, if curable, is not cured by the Termination Date; <U>provided,</U>
that the Company shall use reasonable best efforts to cure such breach as promptly as
practicable;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) if (A)&nbsp;a Change in the Company Recommendation shall have occurred, other than
pursuant to <U>Section&nbsp;6.01(d)(2)</U> (or any action by any committee of the Company&#146;s
Board of Directors which, if taken by the Company&#146;s full Board of Directors, would be a
Change in the Company Recommendation), (B)&nbsp;following the date any Acquisition Proposal or
any material modification thereto is first made public, sent or given to the shareholders of
the Company, the Company fails to issue a press release that expressly reaffirms the Company
Board Recommendation within ten Business Days following Parent&#146;s written request to do so
(which request may only be made once with respect to any such Acquisition Proposal and each
material modification thereto), (C)&nbsp;the Company or its Board of Directors shall approve or
recommend, or enter into or allow the Company or any of its Subsidiaries to enter into, a
Company Acquisition Agreement, (D)&nbsp;any tender offer or exchange offer is commenced by any
Third Party with respect to the outstanding Company Common Stock prior to the Acceptance
Time, and the Company&#146;s Board of Directors shall not have recommended that the Company
Shareholders reject such tender offer or exchange offer and not tender their Company Common
Stock into such tender offer or exchange offer within ten Business Days after commencement
of such tender offer or exchange offer, (E)&nbsp;the Company shall have failed to include the
Company Board Recommendation in the Schedule&nbsp;14D-9, or (F)&nbsp;the
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-62-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">Company or its
Board of Directors (or any committee thereof) shall publicly announce its intentions to
do any of actions specified in this <U>Section&nbsp;8.01(c)(ii)</U>;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) if since the date of this Agreement, there shall have occurred any event,
occurrence, development or state of circumstances, change, fact or condition that
individually or in the aggregate has had or would reasonably be expected to result in a
Company Material Adverse Effect;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) if the Company shall have breached (other than in an immaterial respect) any of
its obligations under <U>Section&nbsp;6.03</U>;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) if a Change in the Company Recommendation pursuant to <U>Section&nbsp;6.01(d)(2)</U>
(or any action by any committee of the Company&#146;s Board of Directors which, if taken by the
Company&#146;s full Board of Directors, would be a Change in the Company Recommendation pursuant
to <U>Section&nbsp;6.01(d)(2)</U>) shall have occurred; or
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;by the Company:
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) if (A)&nbsp;Parent shall have breached any of its representations or warranties
contained in this Agreement or (B)&nbsp;Parent shall have failed to perform all obligations,
covenants or agreements required to be performed by them under this Agreement, in each case,
which breach or failure to perform (i)&nbsp;is not curable by the Termination Date or, if
curable, is not cured by the Termination Date; <U>provided,</U> that Parent shall use
reasonable best efforts to cure such breach as promptly as practicable and (ii)&nbsp;would
reasonably be expected to prevent, materially impede or delay the Acceptance Time beyond the
Termination Date; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) at any time prior to the Acceptance Time, if the Company&#146;s Board of Directors
determines to enter into a definitive Company Acquisition Agreement providing for a Superior
Proposal, but only if the Company is not in material breach of Section&nbsp;6.03, and shall
concurrently with such termination enter into the Company Acquisition Agreement and pay the
Termination Fee concurrently with such termination.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;8.02 <U>Effect of Termination</U>. In the event of the termination of this Agreement as provided
in <U>Section&nbsp;8.01</U>, written notice of such termination shall be given to the other party or
parties hereto, specifying the provision of this Agreement pursuant to which such termination is
made, and this Agreement shall forthwith become null and void (other than <U>Section&nbsp;6.06(b)</U>,
<U>Section&nbsp;6.16</U>, this <U>Section&nbsp;8.02</U>, <U>Section&nbsp;8.03</U> and Article&nbsp;IX, all of which
shall survive termination of this Agreement), and there shall be no liability or other obligation
on the part of Parent, Merger Sub or the Company or their respective Subsidiaries, or its or their
respective shareholders, controlling Persons or Representatives, <U>provided</U>, <U>however</U>, that except as
set forth in <U>Section&nbsp;8.03</U>, nothing contained in this <U>Section&nbsp;8.02</U> shall relieve
Parent, Merger Sub or the Company from liability for fraud or knowing and willful breach (other
than in any immaterial respect) of their respective covenants and agreements set forth in this
Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;8.03 <U>Termination Fee</U>. In the event that this Agreement is terminated by Parent pursuant to <U>Section
8.01(c)(ii)(A)</U>, <U>(C)</U> or <U>(E)</U> or <U>Section&nbsp;8.01(c)(ii)(F)</U> (with respect to
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-63-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">any of the events described in <U>Section&nbsp;8.01(c)(ii)(A)</U>, <U>(C)</U> or <U>(E)</U>) or the
Company pursuant to <U>Section&nbsp;8.01(d)(ii)</U>, and
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 4%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) during the thirty (30)&nbsp;calendar day period following the date of this
Agreement the Company received a written Acquisition Proposal from a Third Party and
during such period the Board of Directors of the Company determined in good faith
(after consultation with its financial advisor) that such Acquisition Proposal
constituted or could reasonably be expected to result in a Superior Proposal, and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 4%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) the Acquisition Proposal referred to in (A)&nbsp;above constituted the basis for
the Company taking or failing to take the action that gave rise to Parent&#146;s or the
Company&#146;s right to terminate this Agreement,
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">then, the Company shall pay to Parent a termination fee of $75,000,000 (the <B>&#147;Tier I Termination
Fee&#148; </B>). The Termination Fee payable pursuant to this <U>Section&nbsp;8.03(a)</U> shall be paid no
later than the second (2nd) Business Day following termination in the case of <U>Section
8.01(c)(ii)(A)</U>, <U>(C)</U> or <U>(E)</U> or <U>Section&nbsp;8.01(c)(ii)(F)</U> (with respect to
any of the events described in <U>Section&nbsp;8.01(c)(ii)(A)</U>, <U>(C)</U> or <U>(E)</U>) and
concurrently (or the next Business Day if payment is not feasible on the same day) with termination
in the case of <U>Section&nbsp;8.01(d)(ii)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;In the event that this Agreement is terminated by Parent pursuant to <U>Section
8.01(c)(ii)(A)</U>, <U>(C</U>) or <U>(E)</U> or <U>Section&nbsp;8.01(c)(ii)(F)</U> (with respect to
any of the events described in <U>Section&nbsp;8.01(c)(ii)(A</U>), <U>(C)</U> or <U>(E)</U>) or
<U>Section&nbsp;8.01(c)(v)</U>, or the Company pursuant to <U>Section&nbsp;8.01(d)(ii)</U> and the Tier I
Termination Fee is not payable pursuant to <U>Section&nbsp;8.03(a)</U>, then the Company shall pay to
Parent a termination fee of $110,000,000 (the &#147;<B>Tier II Termination Fee</B>,&#148; collectively with the
Tier I Termination Fee, the &#147;<B>Termination Fee</B>&#148; ), <U>plus</U>, in the case of a termination
pursuant to <U>Section&nbsp;8.01(c)(v)</U>, Parent&#146;s Expenses actually incurred by Parent on or prior
to the termination of this Agreement; <U>provided</U> that in no event shall the Company be
required to reimburse Parent&#146;s Expenses in excess of $15,000,000. The Termination Fee and any
Expenses payable pursuant to this <U>Section&nbsp;8.03(a)</U> shall be paid no later than the second
(2nd) Business Day following termination in the case of <U>Section&nbsp;8.01(c)(ii)(A)</U>, <U>(C)</U>
or <U>(E)</U> or <U>Section&nbsp;8.01(c)(ii)(F)</U> (with respect to any of the events described in
<U>Section&nbsp;8.01(c)(ii)(A)</U>, <U>(C)</U> or <U>(E)</U>) or <U>Section&nbsp;8.01(c)(v)</U> and
concurrently (or the next Business Day if payment is not feasible on the same day) with termination
in the case of <U>Section&nbsp;8.01(d)(ii)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;In the event that (i) (A)&nbsp;this Agreement is terminated pursuant to <U>Section
8.01(c)(ii)(B)</U> or <U>(D)</U> or <U>Section&nbsp;8.01(c)(ii)(F)</U> (with respect to any of the
events described in <U>Section&nbsp;8.01(c)(ii)(B)</U> or <U>(D)</U>), and
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 4%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) during the thirty (30)&nbsp;calendar day period following the date of this
Agreement a Third Party commenced a tender offer or exchange offer with respect to
the outstanding Company Common Stock or a Third Party made public,
sent or gave to the shareholders of the Company, an Acquisition Proposal or any
material modification thereof, and
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->-64-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 4%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) the tender offer, exchange offer or Acquisition Proposal referred to in (A)
above constituted the basis for the Company taking or failing to take the action
that gave rise to Parent&#146;s right to terminate this Agreement; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 4%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(C) within 12&nbsp;months after such termination, the Company or any Company
Subsidiary enters into a definitive agreement to engage in a transaction that
constitutes an Acquisition Proposal or consummates a transaction that constitutes an
Acquisition Proposal (<U>provided</U> that for purposes of this <U>Section&nbsp;8.03(c)</U>,
the term &#147;<B>Acquisition Proposal</B>&#148; shall have the meaning assigned to such term in
<U>Section&nbsp;10.01(a)</U>, except that the references to 15% shall be deemed to be
references to 50%),
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">then, the Company shall pay to Parent the Tier I Termination Fee no later than two (2)&nbsp;Business
Days after the earlier of the execution of such definitive agreement or consummation of the
transaction that constitutes an Acquisition Proposal.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;In the event that (i) (A)&nbsp;this Agreement is terminated pursuant to <U>Section
8.01(c)(ii)(B)</U> or <U>(D)</U> or <U>Section&nbsp;8.01(c)(ii)(F)</U> (with respect to any of the
events described in <U>Section&nbsp;8.01(c)(ii)(B)</U> or <U>(D)</U>) and the Tier I Termination Fee
is not payable pursuant to <U>Section&nbsp;8.03(c)</U> or (B)&nbsp;after the date of this Agreement and
prior to the Acceptance Time an Acquisition Proposal shall have been publicly disclosed (and not
publicly withdrawn prior to the Acceptance Time) and this Agreement is terminated pursuant to
<U>Section&nbsp;8.01(b)(i)</U>, <U>Section&nbsp;8.01(b)(iii)</U> (at any time during which the Minimum
Condition has not been satisfied), <U>Section&nbsp;8.01(c)(i)</U>, or <U>Section&nbsp;8.01(c)(iv)</U>; and
(ii)&nbsp;within 12&nbsp;months after such termination, the Company or any Company Subsidiary enters into a
definitive agreement to engage in a transaction that constitutes an Acquisition Proposal or
consummates a transaction that constitutes an Acquisition Proposal (provided that for purposes of
this <U>Section&nbsp;8.03(d)</U>, the term &#147;<B>Acquisition Proposal</B>&#148; shall have the meaning assigned to
such term in <U>Section&nbsp;10.01(a)</U>, except that the references to 15% shall be deemed to be
references to 50%), then the Company shall pay to Parent the Tier II Termination Fee no later than
two (2)&nbsp;Business Days after the earlier of the execution of such definitive agreement or
consummation of the transaction that constitutes an Acquisition Proposal.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;All payments under this <U>Section&nbsp;8.03</U> shall be made by wire transfer of immediately
available funds to an account designated in writing by Parent.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;Each of the Company and Parent acknowledges that the agreements contained in this
<U>Section&nbsp;8.03</U> are an integral part of this Agreement. Accordingly, in the event that the
Company shall fail to pay the Termination Fee or Expenses when due, the Company shall reimburse
Parent for all reasonable costs and expenses incurred or accrued by it (including reasonable fees
and expenses of counsel) in connection with the collection under and enforcement of this
<U>Section&nbsp;8.03</U> with interest on the amount of the Termination Fee from the date that such
payment was required to be made until the date of actual payment at the prime lending rate
prevailing during such period as published in <I>The Wall Street Journal</I>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;The parties hereto agree that the payment of the Termination Fee shall be the sole and
exclusive remedy available to Parent and Merger Sub with respect to this Agreement and the Merger
in the event any payments become due and payable, and, upon payment of the
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->-65-<!-- /Folio -->
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">applicable amount, the Company shall have no further liability to Parent and Merger Sub
hereunder.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE IX</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>MISCELLANEOUS</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.01 <U>No Additional Representations</U>. To the fullest extent permitted by applicable Law,
none of the Company, Parent, Merger Sub, their Affiliates or their respective Subsidiaries,
shareholders, controlling Persons or Representatives shall have any liability or responsibility
whatsoever to any other party hereto, its Affiliates or any of their respective Subsidiaries,
shareholders, controlling Persons or Representatives on any basis (including in contract or tort,
under federal or state securities Laws or otherwise) based upon any information provided or made
available, or statements made (or any omissions therefrom), to such party, its Affiliates or any of
their respective Subsidiaries, shareholders, controlling Persons or Representatives, including in
respect of the specific representations and warranties of the Company set forth in Article&nbsp;IV of
this Agreement and in respect of the specific representations and warranties of Parent and Merger
Sub set forth in Article&nbsp;V of this Agreement, except as and only to the extent expressly set forth
in this Agreement with respect to such representations and warranties and subject to the
limitations and restrictions contained in this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.02 <U>No Survival of Representations and Warranties</U>. None of the representations and
warranties in this Agreement or in any instrument delivered pursuant to this Agreement shall
survive the Acceptance Time. This <U>Section&nbsp;9.02</U> shall not limit the survival of any
covenant or agreement of the parties hereto in the Agreement which by its terms contemplates
performance after the Acceptance Time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.03 <U>Amendment or Supplement</U>. At any time prior to the Effective Time, this Agreement may
be amended or supplemented in any and all respects, whether before or after receipt of the Company
Shareholder Approval, by written agreement signed by all of the
parties hereto; <u>provided</u>, <u>however</u>,
that following approval of this Agreement by the Company Shareholders, there shall be no amendment
of or change to the provisions of this Agreement which by Law would require further approval by the
Company Shareholders without such approval.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.04 <U>Extension of Time, Waiver, etc</U>. At any time prior to the Effective Time, any party
may, subject to applicable Law, (a)&nbsp;waive any inaccuracies in the representations and warranties of
any other party hereto, (b)&nbsp;extend the time for the performance of any of the obligations or acts
of any other party hereto or (c)&nbsp;to the extent permitted by applicable Law, waive compliance by the
other party with any of the agreements contained in this Agreement or, except as otherwise provided
in this Agreement, waive any of such party&#146;s conditions. Notwithstanding the foregoing, no failure
or delay by the Company, Parent or Merger Sub in exercising any right hereunder shall operate as a
waiver of rights, nor shall any single or partial exercise of such rights preclude any other or
further exercise of such rights or the exercise of any other right hereunder. Any agreement on the
part of a party hereto to any
such extension or waiver shall be valid only if set forth in an instrument in writing signed
on behalf of such party.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-66-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.05 <U>Assignment</U>. Neither this Agreement nor any of the rights, interests or obligations
hereunder shall be assigned by any of the parties hereto, in whole or in part (whether by operation
of Law or otherwise), without the prior written consent of the other parties, and any attempt to
make any such assignment without such consent shall be null and void, except that Merger Sub may
assign, in its sole discretion, any or all of its rights, interests and obligations under this
Agreement to any one or more direct or indirect wholly-owned Subsidiaries of Parent without the
consent of the Company, but no such assignment shall relieve Merger Sub of any of its obligations
under this Agreement. Subject to the preceding sentence, this Agreement will be binding upon,
inure to the benefit of and be enforceable by the parties hereto and their respective successors
and assigns.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.06 <U>Counterparts</U>. This Agreement may be executed in counterparts (including by facsimile
or pdf) (each of which shall be deemed to be an original but all of which taken together shall
constitute one and the same agreement) and shall become effective when one or more counterparts
have been signed by each of the parties hereto and delivered to the other parties. Copies of
executed counterparts transmitted by facsimile or electronic transmission shall be considered
original executed counterparts for purposes of this <U>Section&nbsp;9.06</U>, <u>provided</u> that receipt of
copies of such counterparts is confirmed.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.07 <U>Entire Agreement; No Third-Party Beneficiaries</U>. This Agreement, including the
exhibits and annexes hereto, the Company Disclosure Schedule, the Parent Disclosure Letter, the
documents and instruments relating to the Merger referred to in this Agreement and the
Confidentiality Agreement (a)&nbsp;constitute the entire agreement, and supersede all prior agreements
and understandings, both written and oral, among the parties hereto with respect to the subject
matter of this Agreement and (b)&nbsp;except for the provisions of <U>Section&nbsp;6.12</U>, are not
intended to confer upon any Person other than the parties hereto any rights, benefits or remedies.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.08 <U>Governing Law; Jurisdiction; Waiver of Jury Trial</U>. (a)&nbsp;THIS AGREEMENT SHALL BE
GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF DELAWARE, APPLICABLE TO
CONTRACTS EXECUTED IN AND TO BE PERFORMED ENTIRELY WITHIN THAT STATE, REGARDLESS OF THE LAWS THAT
MIGHT OTHERWISE GOVERN UNDER APPLICABLE PRINCIPLES OF CONFLICTS OF LAWS<B>; PROVIDED, HOWEVER, THAT
MATTERS INVOLVING THE INTERNAL CORPORATE AFFAIRS OF PARENT, MERGER SUB OR THE COMPANY SHALL BE
GOVERNED BY THE LAWS OF THE JURISDICTION IN WHICH SUCH CORPORATION OR COMPANY IS ORGANIZED AND THAT
THE LAWS OF THE STATE OF TENNESSEE SHALL APPLY AS MAY BE NECESSARY TO LEGALLY EFFECT THE MERGER AND
THE RELATED PROVISIONS IN ARTICLES II AND III HEREOF.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;All actions and proceedings arising out of or relating to this Agreement, or the
negotiation, validity or performance of this Agreement, or the Merger shall be heard and determined
in the Chancery Court of the State of Delaware, and the parties irrevocably submit to
the exclusive jurisdiction of such courts (and, in the case of appeals, appropriate appellate
courts therefrom) in any such action or proceeding and irrevocably waive the defense of an
inconvenient forum to the maintenance of any such action or proceeding. The consents to
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-67-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">jurisdiction set forth in this paragraph shall not constitute general consents to service of
process in the State of Delaware and shall have no effect for any purpose except as provided in
this paragraph and shall not be deemed to confer rights on any Person other than the parties
hereto. The parties agree that service of any court paper may be made in any manner as may be
provided under the applicable Laws or court rules governing service of process in such court. The
parties hereto agree that a final judgment in any such action or proceeding shall be conclusive and
may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by
applicable Law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;EACH OF THE PARTIES HERETO IRREVOCABLY WAIVES ANY AND ALL RIGHTS TO TRIAL BY JURY IN ANY
LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.09 <U>Specific Enforcement</U>. Notwithstanding <U>Section&nbsp;8.03</U>, the parties hereto agree
that irreparable damage would occur for which monetary damages would not be an adequate remedy in
the event that any of the provisions of this Agreement are not performed in accordance with the
terms hereof or are otherwise breached, and that the party seeking to enforce this Agreement
against such nonperforming party under this Agreement shall be entitled to specific performance and
the issuance of injunctive and other equitable relief. The parties hereto further agree to waive
any requirement for the securing or posting of any bond in connection with the obtaining of any
such injunctive or other equitable relief, this being in addition to any other remedy to which they
are entitled at Law or in equity.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.10 <U>Notices</U>. Except for notices that are specifically required by the terms of this
Agreement to be delivered orally, all notices, requests and other communications to any party
hereunder shall be in writing and shall be deemed given if delivered personally, facsimiled (which
is confirmed) and sent by overnight courier (providing proof of delivery) to the parties hereto at
the following addresses:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if to Parent or Merger Sub, to:
</DIV>


<DIV align="left" style="margin-left: 6%; text-indent: 0%; margin-right: 0%; font-size: 10pt; margin-top: 6pt">Pfizer Inc.<br>
235 East 42<SUP style="FONT-size: 85%; vertical-align: text-top">nd</SUP> Street<br>
New York, New York 10017<br>
Attention: Amy Schulman, Senior Vice President and General Counsel<br>
Facsimile No.: (212)&nbsp;573-0768</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;with a copy to:
</DIV>


<DIV align="left" style="margin-left: 6%; text-indent: 0%; margin-right: 0%; font-size: 10pt; margin-top: 6pt">Cadwalader, Wickersham &#038; Taft LLP<br>
One World Financial Center<br>
New York, NY 10281<br>
Attention: Dennis J. Block<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;William P. Mills<BR>
Facsimile No.: (212)&nbsp;504-6666</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-68-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if to the Company, to:
</DIV>


<DIV align="left" style="margin-left: 6%; text-indent: 0%; margin-right: 0%; font-size: 10pt; margin-top: 6pt">King Pharmaceuticals, Inc.<br>
400 Crossing Boulevard<br>
Bridgewater, NJ 08807<br>
Attention: James W. Elrod, Chief Legal Officer<br>
Facsimile No.: (423)&nbsp;990-0987</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;with a copy to:
</DIV>


<DIV align="left" style="margin-left: 6%; text-indent: 0%; margin-right: 0%; font-size: 10pt; margin-top: 6pt">Covington &#038; Burling LLP<br>
The New York Times Building<br>
620 Eighth Avenue<br>
New York, NY 10018<br>
Attention: Scott F. Smith<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Jack S. Bodner<br>
Facsimile No.: (212)&nbsp;841-1010</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">or such other address or facsimile number as such party may hereafter specify by like notice to the
other parties hereto. All such notices, requests and other communications shall be deemed received
on the date of receipt by the recipient if received prior to 5 p.m., local time, in the place of
receipt and such day is a Business Day in the place of receipt. Otherwise, any such notice,
request or communication shall be deemed not to have been received until the next succeeding
Business Day in the place of receipt.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.11 <U>Severability</U>. If any term or other provision of this Agreement is determined by a
court of competent jurisdiction to be invalid, illegal or incapable of being enforced by any rule
of Law or public policy, all other terms, provisions and conditions of this Agreement shall
nevertheless remain in full force and effect. Upon such determination that any term or other
provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in
good faith to modify this Agreement so as to effect the original intent of the parties hereto as
closely as possible to the fullest extent permitted by applicable Law in an acceptable manner to
the end that the Merger is fulfilled to the extent possible.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE X</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>DEFINITIONS</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;10.01 <U>Certain Definitions</U>. (a)&nbsp;As used herein, the following terms have the following
meanings:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Acceptable Confidentiality Agreement</B>&#148; means a confidentiality agreement that contains
provisions that are no less favorable in the aggregate to the Company than those contained in the
Confidentiality Agreement; <U>provided</U> that (i)&nbsp;an Acceptable Confidentiality Agreement need
not contain any &#147;standstill&#148; or similar covenant and (ii)&nbsp;an Acceptable Confidentiality Agreement
may include provisions that are less favorable in the aggregate to the Company than those contained
in the Confidentiality Agreement, so long as the Company offers
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-69-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">to amend the Confidentiality
Agreement concurrently with execution of such Acceptable Confidentiality Agreement to (y)&nbsp;include
substantially similar provisions for the benefit of the parties thereto and (z)&nbsp;waive any
&#147;standstill&#148; or similar covenant to the extent such Acceptable Confidentiality Agreement does not
contain any &#147;standstill&#148; or similar covenant.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Acquisition Proposal</B>&#148; means a <I>bona fide </I>proposal or offer from any Person (other than Parent
and its Subsidiaries) relating to any (i)&nbsp;merger, consolidation, share exchange, business
combination, recapitalization, liquidation, dissolution or other business combination or similar
transaction involving the Company or any of its Subsidiaries, pursuant to which any such Person
would own or control, directly or indirectly, 15% or more of the consolidated assets, revenues or
net income of the Company and its Subsidiaries, taken as a whole, (ii)&nbsp;sale, lease, license or
other disposition directly or indirectly by merger, consolidation, business combination, share
exchange, joint venture or otherwise, of assets of the Company (including Equity Interests of any
of its Subsidiaries) or any Subsidiary of the Company representing 15% or more of the consolidated
assets, revenues or net income of the Company and its Subsidiaries, taken as a whole, or to which
15% or more of the Company&#146;s revenues, earnings or assets on a consolidated basis are attributable,
taken as a whole, (iii)&nbsp;issuance or sale or other disposition (including by way of merger,
consolidation, business combination, share exchange, joint venture or similar transaction) of
Equity Interests representing 15% or more of the voting power of the Company, (iv)&nbsp;tender offer,
exchange offer or any other transaction or series of transactions in which any Person will acquire,
directly or indirectly, beneficial ownership or the right to acquire beneficial ownership of Equity
Interests representing 15% or more of the voting power of the Company or (v)&nbsp;any combination of the
foregoing.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Affiliate</B>&#148; means, with respect to any Person, any other Person directly or indirectly
controlling, controlled by, or under common control with such Person. As used in the definition of
Affiliate, the term &#147;control&#148; means possession, directly or indirectly, of the power to direct or
cause the direction of the management or policies of a Person, whether through the ownership of
voting securities, by contract or otherwise.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Business Day</B>&#148; means a day, other than Saturday, Sunday or other day on which commercial banks
in New York, New York are authorized or required by applicable Law to close.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Code</B>&#148; means the Internal Revenue Code of 1986, as amended.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Company Acquisition Agreement</B>&#148; means any merger, acquisition or other agreement which gives
effect to any Acquisition Proposal.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Company Capital Stock</B>&#148; means the Company Common Stock and the Company Preferred Stock.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Company Charter</B>&#148; means the Third Amended and Restated Charter of the Company, as amended on
or prior to the date hereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Company Common Stock</B>&#148; means the common stock of the Company, no par value.
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->-70-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Company Compensatory Award</B>&#148; means each Company Stock Option, Company PSU, Company RSU and
Company Restricted Stock Award.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Company Convertible Notes</B>&#148; means $400,000,000 aggregate principal amount of 1<FONT style="FONT-size: 70%"><SUP>1</SUP></FONT>/<FONT style="FONT-size: 60%">4</FONT>% Convertible
Senior Notes due April&nbsp;1, 2026, issued pursuant to the Indenture between the Company, the
Subsidiary Guarantors and The Bank of New York Trust Company, N.A., dated March&nbsp;29, 2006 (the
&#147;<B>Indenture</B>&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Company Disclosure Schedule</B>&#148; means the disclosure schedule dated the date hereof regarding
this Agreement that has been provided by the Company to Parent and Merger Sub.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Company Financial Statements</B>&#148; means collectively the audited consolidated financial
statements and unaudited consolidated interim financial statements of the Company, together with
the related notes and schedules thereto, included in the Company SEC Documents.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Company Intellectual Property</B>&#148; shall mean all registered and unregistered Intellectual
Property exclusively owned by the Company or its Subsidiaries, or co-owned or jointly owned by the
Company or its Subsidiaries with any Third Party.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Company Material Adverse Effect</B>&#148; means any event, occurrence, development or state of
circumstances, change, fact or condition that (i)&nbsp;prevents, materially impedes or materially delays
the consummation of the Merger to a date following the Termination Date or (ii)&nbsp;is materially
adverse to the financial condition, assets, liabilities, business or results of operations of the
Company and its Subsidiaries, taken as a whole; <u>provided</u>,
<u>however</u>, that a Company Material Adverse
Effect shall not be deemed to
include effects, events, occurrences, developments or state of circumstances, changes, facts
or conditions arising out of, relating to or resulting from: (A)&nbsp;changes generally affecting the
economy, financial or securities markets or political, legislative or regulatory conditions, to the
extent such changes do not adversely affect the Company and its Subsidiaries in a disproportionate
manner relative to other participants in the pain-management specialty pharmaceutical industry or
the animal health medicinal and nutritional products industry; (B)&nbsp;changes in the pain-management
specialty pharmaceutical industry or the animal health medicinal and nutritional products industry,
to the extent such changes do not adversely affect the Company and its Subsidiaries in a
disproportionate manner relative to other participants in such industries, respectively; (C)&nbsp;any
change in Law or the interpretation thereof, to the extent such changes do not adversely affect the
Company and its Subsidiaries in a disproportionate manner relative to other participants in the
pain-management specialty pharmaceutical industry or the animal health medicinal and nutritional
products industry, or any change in applicable accounting regulations or principles, including
GAAP, or the interpretation thereof; (D)&nbsp;acts of war, armed hostility or terrorism; (E)&nbsp;any change
directly attributable to the announcement of the Merger, including any litigation resulting
therefrom, <U>provided</U> that this clause (E)&nbsp;shall not apply for purposes of the Company&#146;s
representations and warranties contained in <U>Section&nbsp;4.04</U> of this Agreement or the accuracy
of such representations and warranties for purposes of <U>Section&nbsp;4</U> of <U>Annex A</U>; (F)
any failure by the Company to meet any internal or published industry analyst projections or
forecasts or estimates of revenues or earnings for any period ending on or after the date of this
Agreement (it being understood and agreed that the facts and circumstances giving rise to such
failure may be
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-71-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">deemed to constitute, and may be taken into account in determining whether there has
been, a Company Material Adverse Effect); (G)&nbsp;any change in the price or trading volume of the
Company Common Stock on the NYSE (it being understood and agreed that the facts and circumstances
giving rise to such change may be deemed to constitute, and may be taken into account in
determining whether there has been, a Company Material Adverse Effect); (H)&nbsp;compliance with the
terms (including covenants) of, or taking of any action required by, this Agreement, including any
negative impact on relationships with employees of the Company or its Subsidiaries or disruption in
supplier, distributor, landlord, partner or similar relationships as a result thereof; and (I)&nbsp;the
adverse consequences of Parent not granting the Company consent to take an action prohibited under
<U>Section&nbsp;6.01(b)</U> hereof if the Company requested such consent in accordance with the terms
of this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Company Preferred Stock</B>&#148; means the preferred stock of the Company, no par value.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Company Products</B>&#148; means all biological, drug, and vaccine products and agents, all animal
health products and all consumer products being developed, tested in clinical trials, manufactured,
sold, or distributed by the Company or any of its Subsidiaries.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Company PSU</B>&#148; means each award of performance shares of the Company outstanding under any
Company Stock Plan.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Company Restricted Stock Award</B>&#148; means each award with respect to a share of restricted
Company Common Stock outstanding
under any Company Stock Plan that is, at the time of determination, subject to forfeiture or
repurchase by the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Company RSU</B>&#148; means each award of restricted stock units or performance shares of the Company
outstanding under any Company Stock Plan.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Company Stock Option</B>&#148; means each compensatory option to purchase Company Common Stock
outstanding under any Company Stock Plan.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Company Stock Plan</B>&#148; means any stock option, stock incentive or other equity compensation plan
or non-plan agreement sponsored or maintained by the Company or any Subsidiary or Affiliate of the
Company, in each case, a true and complete list of each of which is set forth in Section&nbsp;4.18(a) of
the Company Disclosure Schedule.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Confidentiality Agreement</B>&#148; means the Confidentiality Agreement, dated July&nbsp;9, 2010 (as it may
be amended from time to time), between Parent and the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Contract</B>&#148; means, with respect to any Person, any of the agreements, contracts, leases
(whether for real or personal property), notes, bonds, mortgages, indentures, deeds of trust,
loans, evidences of Indebtedness, letters of credit, settlement agreements, franchise agreements,
undertakings, employment agreements, license agreements, instruments to which such Person or its
Subsidiaries is a party, whether oral or written.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Credit Agreement</B>&#148; means the Credit Agreement, dated as of May&nbsp;11, 2010, among the Company,
the Lenders Named Therein, Credit Suisse AG, as Administrative Agent,
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-72-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">as Collateral Agent and as
Swingline Lender, Credit Suisse Securities (USA)&nbsp;LLC, Bank of America, N.A., DnBNOR Bank ASA,
SunTrust Bank and U.S. Bank National Association, as Co-Syndication Agents, Credit Suisse
Securities (USA)&nbsp;LLC, as Sole Arranger and Sole Bookrunner.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Environmental Claim</B>&#148; means any and all written complaints, summons, citations, directives,
orders, decrees, claims, liens, litigation, investigations, notices of violation, judgments,
administrative, regulatory or judicial actions, suits, demands or proceedings, or notices of
noncompliance or violation by any Governmental Authority or Person involving or alleging potential
liability of the Company or any of its Subsidiaries arising out of or resulting from any violation
of any Environmental Law or the presence or Release of Hazardous Material at, from, or otherwise
relating to: (i)&nbsp;any of the Company&#146;s or its Subsidiaries&#146; facilities or any other properties or
facilities currently or formerly owned, leased, operated or otherwise used by Company or any of its
Subsidiary or any predecessor in interest; (ii)&nbsp;nearby properties or businesses; or (iii)&nbsp;any
facilities that received Hazardous Material generated by the Company or any of its Subsidiaries or
any predecessor in interest.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Environmental Laws</B>&#148; shall mean all applicable federal, state, local or foreign Laws,
statutes, regulations, ordinances, decrees, directives,
judgments, common law, or other enforceable requirements of Governmental Authorities, relating
to pollution or protection of human health and safety (including workplace health and safety) or
the environment, including, without limitation, Laws relating to Releases or threatened Release of
Hazardous Materials, the protection of human health as a result of exposure to Hazardous Materials,
the storage, transport or disposal of solid and hazardous waste, discharges of substances to
surface water or groundwater, air emissions, recordkeeping, notification, disclosure and reporting
requirements respecting Hazardous Materials, and all Laws relating to endangered or threatened
species of fish, wildlife and plants and the management or use of natural resources.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Environmental Liability</B>&#148; means all liabilities, monetary obligations, losses, damages of any
kind including without limitation punitive damages, consequential damages, treble damages, and
natural resource damages, costs and expenses (including all fees, disbursements and expenses of
counsel, experts and consultants, costs of investigations and feasibility studies, compliance
costs, abatement and cleanup costs), fines, penalties, sanctions and interest incurred as a result
of any claim or demand by any Governmental Authority or any Third Party or requirement of
Environmental Law, and which relate to any environmental condition, violation or alleged violation
of Environmental Laws or Releases of Hazardous Materials at, from, or otherwise relating to (i)&nbsp;any
of the Company&#146;s or its Subsidiaries&#146; facilities or any other properties or facilities currently or
formerly owned, leased, operated or otherwise used by Company or any of its Subsidiary, the Current
Company business or any predecessor in interest; (ii)&nbsp;nearby properties or businesses; or (iii)&nbsp;any
facilities that received Hazardous Material generated by the Company or any of its Subsidiaries or
any predecessor in interest.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Equity Interest</B>&#148; means any share, capital stock, partnership, limited liability company,
membership, member or similar interest in any Person, and any option, warrant, right or security
(including debt securities) convertible, exchangeable or exercisable thereto or therefor.
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->-73-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>ERISA</B>&#148; means the Employee Retirement Income Security Act of 1974, as amended.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>ERISA Affiliate</B>&#148; of any entity means any other entity that, together with such entity, would
be treated as a single employer under Section&nbsp;414 of the Code.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Exchange Act</B>&#148; means the Securities Exchange Act of 1934, as amended.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>&#147;Expenses&#148; </B>includes all documented out-of-pocket expenses (including all expenses and
disbursements of counsel, accountants, investment bankers, experts and consultants to a party
hereto and its affiliates and Representatives) incurred in connection with or related to due
diligence, the authorization, preparation, negotiation, execution and performance of this Agreement
and the transactions contemplated hereby and all other matters related thereto.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Foreign Official</B>&#148; is broadly interpreted and includes: (i)&nbsp;any elected or appointed official
of a Foreign Government (<I>e.g.</I>, a member of a ministry of health), (ii)&nbsp;any employee or person
acting for or on behalf of a Foreign Government official, Foreign Government agency, or enterprise
performing a function of a Foreign Government, (iii)&nbsp;any non-U.S. political party officer, employee
or person acting for or on behalf of a non-U.S. political party, or candidate for non-U.S.
political office, (iv)&nbsp;any employee or person acting for or on behalf of a public international
organization, and (v)&nbsp;any person otherwise categorized as an official of a Foreign Government under
local Law. For purposes of this definition, &#147;<B>Foreign Government</B>&#148; includes all levels and
subdivisions of non-U.S. governments (<I>i.e.</I>, local, regional, or national and administrative,
legislative, or executive). Without limiting the generality of the foregoing and for the avoidance
of doubt, for purposes of this Agreement, all Foreign Government employees and employees of
enterprises owned or controlled by Foreign Governments (<I>e.g.</I>, doctors employed in hospitals owned
or controlled by Foreign Governments, researchers employed by universities owned or controlled by
Foreign Governments, and Foreign Government ministers, civil servants, and regulators) are
considered Foreign Officials.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>GAAP</B>&#148; means generally accepted accounting principles in the United States.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Governmental Authority</B>&#148; means any federal, state or local, domestic, foreign or multinational
government, court, regulatory or administrative agency, commission, authority or other governmental
instrumentality.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Hazardous Materials</B>&#148; means any materials, chemicals, pollutants, contaminants, wastes, toxic
or hazardous substances, including without limitation petroleum and petroleum products or
compounds, gasoline, diesel fuel, solvents, asbestos and asbestos-containing materials,
polychlorinated biphenyls, lead and lead-based paints and materials, radon, radioactive materials,
pesticides, urea formaldehyde, and mold, (i)&nbsp;that can cause harm to living organisms, human
welfare, or the environment, (ii)&nbsp;that are regulated, or for which liability can be imposed,
pursuant to Environmental Laws, or (iii)&nbsp;the presence, handling, or management of which requires
registration, authorization, investigation or remediation under Environmental Laws, including by
example &#147;hazardous substances&#148; and &#147;hazardous wastes&#148; as defined in CERCLA and RCRA, respectively.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>HSR Act</B>&#148; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976.
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->-74-<!-- /Folio -->
</DIV>



<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Indebtedness</B>&#148; means, with respect to any Person, (i)&nbsp;indebtedness, notes payable, bonds,
debentures or other obligations of such Person for borrowed money, whether current, short-term or
long-term, secured or unsecured; (ii)&nbsp;lease obligations under leases which are classified as
capital leases of such Person under GAAP (excluding any operating leases of such Person under
GAAP); (iii)&nbsp;indebtedness created or arising under any conditional sale or other title retention
agreement with respect to property acquired by such Person; (iv)&nbsp;obligations of such Person for the
deferred purchase price of property or services (other than trade payables and obligations of such
Person to creditors incurred in the ordinary course of business); (v)&nbsp;obligations of such Person
pursuant to or evidenced by hedging, swap, factoring, interest rate, currency or commodity
derivatives arrangements or other similar instruments; (vi)&nbsp;off-balance sheet financing of such
Person including synthetic leases and project financing; (vii)&nbsp;indebtedness of another Person
referred to in clauses (i)&nbsp;through (vi)&nbsp;above guaranteed, directly or indirectly, jointly or
severally, in any manner by such Person; (viii)&nbsp;indebtedness referred to in clauses (i)&nbsp;through
(vii)&nbsp;above secured by (or for which the holder of such indebtedness has an existing right,
contingent or otherwise, to be secured by) any Lien on property or assets owned by such Person; and
(ix)&nbsp;reimbursement obligations of such Person with respect to letters of credit (other than (A)
letters of credit issued for the benefit of suppliers to support accounts payable to suppliers
incurred in the ordinary course of business consistent with past practices, (B)&nbsp;standby letters of
credit relating to workers&#146; compensation insurance and surety bonds, and (C)&nbsp;surety bonds and
customs bonds), bankers&#146; acceptance or similar facilities issued for the account of such Person.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Intellectual Property</B>&#148; means any or all of the following in any jurisdiction throughout the
world: (i)&nbsp;issued patents, patent applications (including provisional and Patent Cooperation Treaty
applications), supplementary protection certificates, and inventors&#146; certificates, including
divisions, continuations, continuations-in-part, renewals, substitutions, extensions, reissues, and
reexaminations of any of the foregoing (collectively, &#147;<B>Patents</B>&#148;; (ii)&nbsp;trademarks, service marks,
certification marks, collective marks, trade dress, trade names, corporate names, and other indicia
of origin or quality, and all registrations and applications for any of the foregoing (including
all renewals of same), and together with all goodwill associated with and symbolized by each of the
foregoing (collectively, &#147;<B>Trademarks</B>&#148;); (iii)&nbsp;Internet domain names; (iv)&nbsp;published and unpublished
original works of authorship, copyrights and moral rights therein and thereto, and registrations
and applications therefor, and all renewals, extensions, restorations and reversions thereof
(collectively, &#147;<B>Copyrights</B>&#148;); (v)&nbsp;any secret, confidential, or generally unknown information,
including formula, process, device, or compilation, used in a business and which gives its owner an
opportunity to obtain an advantage over competitors who do not know or use it (&#147;<B>Trade Secrets</B>&#148;);
(vi)&nbsp;all other intellectual property or intellectual property rights (in each case whether or not
subject to statutory registration or protection).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Intervening Event</B>&#148; means a material development or change in circumstances relating to the
financial condition, assets, liabilities, business or results of operations of the
Company and its Subsidiaries occurring or arising after the date hereof that was not known to
the Board of Directors of the Company as of the date hereof (and not relating to any Acquisition
Proposal or Inquiry); <U>provided</U>, <U>however</U>, that in no event shall the receipt,
existence or terms of an Acquisition Proposal or Inquiry or any matter relating thereto or
consequence thereof constitute an Intervening Event.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->-75-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>IP Governmental Authority</B>&#148; means the United States Patent and Trademark Office, the United
States Copyright Office, or any foreign equivalent thereof, or any foreign Governmental Authority
that performs the same or similar functions to either of the United States Patent and Trademark
Office or the United States Copyright Office with respect to the registration of Trademarks or
Copyrights or the issuance of Patents.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Knowledge</B>&#148; or &#147;<B>Known</B>&#148; means with respect to the Company, the actual knowledge of the
individuals listed on Section&nbsp;10.01(a) of the Company Disclosure Schedule.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>knowing and willful</B>&#148; or &#147;<B>knowingly and willfully</B>&#148;<B> ,&#148;</B>  &#147;<B>knowingly and
willfully</B>&#148;  means a breach that is a consequence of an
act undertaken by the breaching party with the knowledge that the taking of such act would, or
would be reasonably expected to, cause a breach of this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Law</B>&#148; means any federal, state, local, national or supranational or foreign law (including
common law), statute, ordinance, rule, regulation, Order, code ruling, decree, arbitration award,
agency requirement, license, permit, standard, binding guideline or policy, or other enforceable
requirements of any Governmental Authority, including without limitation any such laws or other
requirements of China.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Lien</B>&#148; means, with respect to any property or asset (including any security), any lien,
mortgage, pledge, encumbrance, security interest or deed of trust.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>NYSE</B>&#148; means the New York Stock Exchange.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Order</B>&#148; means any order, judgment or injunction.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Ordinary Course Agreements</B>&#148; means non-disclosure or confidentiality agreements, materials
transfer agreements, evaluation agreements, consulting agreements, sponsorship agreements (other
than research and development agreements), advertising agreements, Trademark use agreements (short
term and for limited use only), in each case, entered into by the Company or any of its
Subsidiaries in the ordinary course of business and <U>provided</U> that none of the foregoing
agreements are material to the Company and its Subsidiaries, taken as a whole.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Parent Material Adverse Affect</B>&#148; means any change, effect, event or occurrence that,
individually or in the aggregate, is or would reasonably be expected to prevent, materially delay
or materially impair the ability of Parent and Merger Sub to perform its obligations under this
Agreement or to consummate the Merger and the other transactions contemplated hereby.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Parent Stock</B>&#148; means the common stock, par value $0.05 per share, of Parent.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Permitted Liens</B>&#148; means any (i)&nbsp;statutory Liens for Taxes, business improvement district
charges, water and sewer charges, assessments and other lienable services and other governmental
charges and impositions not yet due or payable or that are being contested in good faith through
appropriate proceedings for which adequate reserves have been established, in accordance with GAAP,
on the consolidated financial statements included in the
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->-76-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">most recent Company SEC Documents, (ii)&nbsp;statutory Liens arising out of operation of Law, including carriers&#146;, warehousemen&#146;s, mechanics&#146;,
materialmen&#146;s, repairmen&#146;s or other similar Liens incurred in the ordinary course of business,
(iii)&nbsp;pledges or deposits in connection with workers&#146; compensation, unemployment insurance and
other social security legislation, (iv)&nbsp;with respect to Real Property, (1)&nbsp;all matters, whether or
not of record, that arise out of the actions of Parent or its agents, representatives or
contractors, (2)&nbsp;all easements, covenants, rights-of-way, restrictions and other encumbrances
affecting any Owned Real Property or Leased Real Property, (3)&nbsp;all Liens and other matters
disclosed, or in any title commitment, report, listing or policy, or in any survey or survey update
relating to the Real Property, in each case to the extent publicly available or made available by
the Company to Parent (including those relating to physical condition or variations in location or
dimension), and (4)&nbsp;any and all Laws affecting the Real Property (including any Laws relating to
zoning, building and the use, occupancy, subdivision or improvement of the Real Property);
<U>provided</U> that such matters described in clauses (1)&nbsp;through (4)&nbsp;do not prohibit or
materially impair the current use and operation of the Real Property subject thereto in the
business of the Company, (v)&nbsp;statutory landlords&#146; Liens and Liens granted to landlords under any
lease or sublease, (vi)&nbsp;intercompany liens by and among the Company and any of its Subsidiaries,
(vii)&nbsp;any Liens created pursuant to or in connection with this Agreement or disclosed in the
Company Disclosure Schedule, (viii)&nbsp;Liens approved in writing by Parent and (ix)&nbsp;Liens that,
individually or in the aggregate, do not materially impair the current use and operation of the
assets to which they relate.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Person</B>&#148; means an individual, corporation, limited liability company, partnership,
association, trust, unincorporated organization, charitable organization, institution, Governmental
Authority other entity or group (as defined in the Exchange Act).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Release</B>&#148; means any release, spill, emission, discharge, leaking, pumping, injection, deposit,
disposal, dispersal, leaching, migration, or other movement or presence in, into or through the
indoor or outdoor environment (including, without limitation, ambient air, surface water,
groundwater and surface or subsurface strata) or at or from any property.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Sarbanes-Oxley Act</B>&#148; means the Sarbanes-Oxley Act of 2002, including its rules and
regulations.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>SEC</B>&#148; means the United States Securities and Exchange Commission.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Securities Act</B>&#148; means the Securities Act of 1933, as amended.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Subsidiary</B>&#148; means any corporation, partnership, joint venture or other legal entity of which
Parent, the Company or such other Person, as the case may be (either alone or through or together
with any other Subsidiary), owns, directly or indirectly, a majority of the stock or other Equity
Interests the holders of which are generally entitled to vote for the election of the board of
directors or other governing body of such corporation, partnership, joint venture
or other legal entity, or any Person that would otherwise be deemed a &#147;subsidiary&#148; under Rule
12b-2 promulgated under the Exchange Act.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Superior Proposal</B>&#148; means a <I>bona fide </I>written Acquisition Proposal (provided, that for
purposes of this definition references to 15% in the definition of &#147;Acquisition Proposal&#148;
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->-77-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">shall be deemed to be references to 50%) which the Company&#146;s Board of Directors determines in good faith
(after consultation with its financial advisor) (i)&nbsp;to be reasonably likely to be consummated if
accepted and (ii)&nbsp;to be more favorable to the Company Shareholders from a financial point of view
than the Transactions, in each case, taking into account at the time of determination all relevant
circumstances, including the various legal, financial and regulatory aspects of the proposal, all
the terms and conditions of such proposal and this Agreement, any changes to the terms of this
Agreement offered by Parent in response to such Acquisition Proposal, and the ability of the Person
making such Acquisition Proposal to consummate the transactions contemplated by such Acquisition
Proposal (based upon, among other things, expectation of obtaining required approvals).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Tax Return</B>&#148; means any return, report, claim, certificate, form, statement, disclosure,
declaration or information return or statement (including any related or supporting information
attached and any amended or supplemental material provided with respect to any of the foregoing)
supplied to, or filed with, or required to be supplied to or filed with, a Governmental Authority,
in each case, with respect to Taxes.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Taxes</B>&#148; means (i)&nbsp;any federal, state, local, foreign, provincial or territorial taxes, fees,
levies, assessments and other governmental charges of any kind whatsoever, whether imposed directly
or through withholding (together with any and all interest, penalties, additions to tax and
additional amounts applicable with respect thereto), including income, franchise, premium, windfall
or other profits, gross receipts, property, production, transfer, alternative minimum, sales, use,
license, capital stock, payroll, employment, social security, workers&#146; compensation, unemployment
compensation, net worth, excise, withholding, severance, ad valorem and value added taxes; and (ii)
any transferee or secondary liability in respect of any tax (whether imposed by Law or contractual
arrangement).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Third Party</B>&#148; shall mean any Person, including as defined in Section 13(d) of the Exchange
Act, other than Parent or any of its Affiliates or the Company and any of its Affiliates, and the
Representatives of such Person.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Third Party Intellectual Property</B>&#148; means Intellectual Property that is owned exclusively by
one or more Third Parties.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Transactions</B>&#148; means the transactions contemplated by this Agreement, including the Offer, the
Merger and the Top-Up Option.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Treasury Regulations</B>&#148; means the regulations promulgated under the Code.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;10.02 <U>Other Definitional and Interpretative Provisions</U>. The words &#147;hereof&#148;, &#147;herein&#148; and
&#147;hereunder&#148; and words of like import used in this Agreement shall refer to this Agreement as a
whole and not to any particular provision of this Agreement. The captions herein are included for
convenience of reference only and shall be ignored in the construction or interpretation
hereof. References to Articles, Sections, Exhibits and Schedules are to Articles, Sections,
Exhibits and Schedules of this Agreement unless otherwise specified. All Exhibits and Schedules
annexed hereto or referred to herein are hereby incorporated in and made a part of this Agreement
as if set forth in full herein. Any capitalized terms used in any
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->-78-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Exhibit or Schedule but not otherwise defined therein, shall have the meaning as defined in this Agreement. Any singular term
in this Agreement shall be deemed to include the plural, and any plural term the singular.
Whenever the words &#147;include&#148;, &#147;includes&#148; or &#147;including&#148; are used in this Agreement, they shall be
deemed to be followed by the words &#147;without limitation&#148;, whether or not they are in fact followed
by those words or words of like import. References to any statute shall be deemed to refer to such
statute as amended from time to time and to any rules or regulations promulgated thereunder.
References to any agreement or contract are to that agreement or contract as amended, modified or
supplemented from time to time in accordance with the terms hereof and thereof. References to any
Person include the successors and permitted assigns of that Person. All references to &#147;dollars&#148; or
&#147;$&#148; are to United States dollars. This Agreement is the product of negotiation by the parties
having the assistance of counsel and other advisors and, accordingly, it is the intention of the
parties that this Agreement not be construed more strictly with regard to one party than with
regard to the others.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;<I>The remainder of this page has been intentionally left blank;<BR>
the next page is the signature page.</I>&#093;
</DIV>







<P align="center" style="font-size: 10pt"><!-- Folio -->-79-<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their
authorized officers as of the date set forth on the cover page of this Agreement.
</DIV>


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">PFIZER INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Frank A. D&#146;Amelio</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Frank A. D&#146;Amelio</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Senior Vice President and Chief Financial Officer</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">PARKER TENNESSEE CORP.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Douglas E. Giordano</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Douglas E. Giordano</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">President</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">KING PHARMACEUTICALS, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Brian A. Markison</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Brian A. Markison</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">President and Chief Executive Officer</TD>
    <TD>&nbsp;</TD>
</TR>
</TABLE>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt">&#091;Signature Page to Agreement and Plan of Merger&#093;
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U>ANNEX A</U>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>CONDITIONS TO THE OFFER</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding any other provisions of the Offer and in addition to Merger Sub&#146;s rights to
extend, amend or terminate the Offer in accordance with the provisions of the Agreement and
applicable Law, neither Parent nor Merger Sub shall be required to accept for payment or, subject
to any applicable rules and regulations of the SEC, including Rule&nbsp;14e-1(c) under the Exchange Act,
pay for any tendered shares of Company Common Stock, unless:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. There shall have been validly tendered and not validly withdrawn prior to the expiration of
the Offer (as it may have been extended pursuant to <U>Section&nbsp;1.01(e)</U> of the Agreement) the
minimum number of shares of Company Common Stock, which when added to the shares of Company Common
Stock already owned by Parent and its Subsidiaries represents the number of shares of Company
Common Stock required to approve the Agreement, the Merger and the other Transactions pursuant to
the Company Charter Documents and the TBCA at the Acceptance Time determined on a fully-diluted
basis (the number of shares of Company Common Stock on a &#147;fully-diluted basis&#148; shall equal the
number of shares of Company Common Stock then issued and outstanding, plus the number of shares of
Company Common Stock which the Company may be required to issue as of such date pursuant to options
(whether or not then vested or exercisable), rights, convertible or exchangeable securities (only
to the extent then convertible or exchangeable into shares of Company Common Stock) or similar
obligations then outstanding; <U>provided</U> that such number shall not include any such options,
rights, Company Restricted Stock Awards, convertible or exchangeable securities or similar
obligations that may be validly canceled at the Acceptance Time pursuant to <U>Section&nbsp;2.09</U>)
(such number of shares, the &#147;<B>Minimum Condition</B>&#148; );
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Each of (i)&nbsp;the waiting period (and any extension thereof) applicable to the Merger under
the HSR Act shall have been terminated or shall have expired, and (ii)&nbsp;all other authorizations,
consents, orders or approvals of, or declarations, notices or filings with, or expirations of
waiting periods imposed by, any Governmental Authority governing foreign antitrust or competition
Laws in connection with the Merger and the consummation of the other transactions contemplated
hereby by the Company, Parent and Merger Sub shall have been made or obtained (as the case may be)
(the &#147;<B>Regulatory Condition</B>&#148;) .
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. There shall be no (i)&nbsp;temporary restraining order, preliminary or permanent injunction or
other order issued by any Governmental Authority having authority over Parent, Merger Sub, the
Company or any Subsidiary of the Company that remains in effect, preventing the acquisition of or
payment for shares of Company Common Stock pursuant to the Offer, preventing consummation of the
Transactions contemplated hereby, or requiring divestiture of any or all of the shares of Company
Common Stock to be purchased pursuant to the Offer, the Merger or the other Transactions, or any
portion of the business or assets of Parent or the Company or any of their respective Subsidiaries
that would, in the aggregate, result in the one year loss of net sales revenues (as measured by net
2010 sales revenue) in excess of $40,000,000, in the aggregate, as a result of the Offer, the
Merger or the other Transactions, (ii)&nbsp;applicable Law enacted or applicable to the Offer or the
Transactions by a Governmental
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->Exh. A-1<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Authority having authority over Parent, Merger Sub or any Subsidiary of the Company that makes
the acquisition of or payment for shares of Company Common Stock pursuant to the Offer, or the
consummation of the Transactions, illegal or (iii)&nbsp;pending, or threatened in writing, proceeding by
any Governmental Authority having authority over Parent, Merger Sub, the Company or any Subsidiary
of the Company challenging or seeking to restrain or prohibit the acquisition of or payment for
shares of Company Common Stock pursuant to the Offer or the Transactions, or seeking to require
divestiture of any or all of the shares of Company Common Stock to be purchased pursuant to the
Offer, the Merger or the other Transactions or any portion of the business or assets of Parent or
the Company or any of their respective Subsidiaries that would, in the aggregate, result in the one
year loss of net sales revenues (as measured by net 2010 sales revenue) in excess of $40,000,000,
as a result of the Offer, the Merger or the other Transactions.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. (i)&nbsp;Each of the representations and warranties of the Company contained in <U>Section
4.01</U> (Organization, Standing and Corporate Power), <U>Section&nbsp;4.02</U> (Corporate
Authorization) and <U>Section&nbsp;4.10(i)</U> (Absence of Changes) shall be true and correct in all
respects as of the date of this Agreement and as of the Acceptance Time as if made as of such date,
(ii)&nbsp;the representations and warranties of the Company contained in <U>Section&nbsp;4.05</U>
(Capitalization) shall be true and correct other than in de minimis respects as of the date of this
Agreement and as of the Acceptance Time as if made on such date (except for those representations
and warranties which address matters only as of an earlier date which shall be true and correct as
of such date) and (iii)&nbsp;each of the other representations and warranties of the Company contained
in Article&nbsp;IV of this Agreement shall be true and correct (without giving effect to any exception
or qualification contained therein relating to materiality or a Company Material Adverse Effect as
of the date of this Agreement and as of the Acceptance Time, as if made as of such date (except for
those representations and warranties which address matters only as of an earlier date which shall
have been true and correct as of such earlier date), except in the case of this clause (iii), where
the failure of such other representations and warranties to be true and correct, individually or in
the aggregate, has not had, or would not be reasonably expected to have, a Company Material Adverse
Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. The Company shall have performed or complied in all material respects with all agreements
and covenants required to be performed or complied with by it under this Agreement at or prior to
the Acceptance Time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. The Company shall have furnished Parent with a certificate dated as of the date of
determination signed on its behalf by its Chief Executive Officer or Chief Financial Officer to the
effect that the conditions set forth in items (4), (5), and (7)&nbsp;of this <U>Annex A</U> have been
satisfied;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. Since the date of this Agreement, there shall not have occurred any event, occurrence,
development or state of circumstances, change, fact or condition that has had or would reasonably
be expected, individually or in the aggregate, to have a Company Material Adverse Effect; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. The Agreement shall not have been terminated in accordance with its terms.
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->Exh. A-2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The foregoing conditions are for the sole benefit of Parent and Merger Sub, may be asserted by
either Parent or Merger Sub, regardless of the circumstances giving rise to any such conditions
(<U>provided</U>, that nothing herein shall relieve any party hereto from any obligation or
liability such party has under the Agreement), and, except for the Minimum Condition, may be waived
by Parent or Merger Sub in whole or in part at any time and from time to time, subject to the terms
of the Agreement and applicable Law. The failure by Parent or Merger Sub at any time to exercise
any of the foregoing rights shall not be deemed a waiver of any such right, the waiver of such
right with respect to any particular facts or circumstances shall not be deemed a waiver with
respect to any other facts and circumstances, and each such right shall be deemed an ongoing right
which may be asserted at any time and from time to time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The capitalized terms used in this <U>Annex A</U> shall have the meanings set forth in the
Agreement to which it is annexed, except that the term &#147;Agreement&#148; shall be deemed to refer to the
agreement to which this <U>Annex A</U> is annexed.
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->Exh. A-3<!-- /Folio -->
</DIV>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
